{
    "studies": [
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT03239340",
                    "orgStudyIdInfo": {
                        "id": "D5161C00003"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "2017-002359-27",
                            "type": "EUDRACT_NUMBER"
                        }
                    ],
                    "organization": {
                        "fullName": "AstraZeneca",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib",
                    "officialTitle": "A Multicentre, Open-label, Single-arm, Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib",
                    "acronym": "ELIOS"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-09",
                    "overallStatus": "COMPLETED",
                    "startDateStruct": {
                        "date": "2018-05-30",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2023-09-19",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2023-09-19",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2017-07-27",
                    "studyFirstSubmitQcDate": "2017-08-01",
                    "studyFirstPostDateStruct": {
                        "date": "2017-08-04",
                        "type": "ACTUAL"
                    },
                    "resultsFirstSubmitDate": "2024-08-21",
                    "resultsFirstSubmitQcDate": "2024-08-21",
                    "resultsFirstPostDateStruct": {
                        "date": "2024-09-19",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-02",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "AstraZeneca",
                        "class": "INDUSTRY"
                    },
                    "collaborators": [
                        {
                            "name": "Parexel",
                            "class": "INDUSTRY"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "A multicentre, open-label, single-arm, molecular profiling study of patients with EGFR mutation-positive locally advanced or metastatic NSCLC treated with osimertinib.",
                    "detailedDescription": "Study design This is a phase II, open-label, single-arm tissue and plasma acquisition study assessing the efficacy, safety and underlying resistance mechanisms of osimertinib (80 mg orally, once daily) as first-line treatment in patients with locally advanced or metastatic EGFR mutation positive non-small cell lung cancer who are EGFR tyrosine kinase inhibitor treatment-na\u00efve and eligible for first-line treatment. Participants with EGFR mutation-positive non-small cell lung cancer will be required to consent to 2 mandatory tumour biopsies to be considered for enrolment in this study. The first biopsy will be done prior to initiating treatment with osimertinib and the second biopsy will be obtained any time between Investigator assessed, Response Evaluation Criteria in Solid Tumours version 1.1 (RECIST 1.1)-defined progression and before the start of any new anticancer treatment. A third optional biopsy may be taken during the course of treatment at the Investigator's discretion if the patient consents and if clinically feasible. Tumour tissue and plasma samples will be collected and examined for genetic and non genetic aberrations that may be important in determining response and resistance to the treatment that participants will receive as a part of their cancer care. Patients should continue on osimertinib until progression or until other treatment discontinuation criteria are met. However, if patients continue to show clinical benefit to treatment as judged by the Investigator, patients may continue to receive osimertinib beyond RECIST 1.1-defined progression. Therefore, there is no maximum duration of treatment. Tumour assessments will be performed at baseline and then every 8 weeks from study enrolment until 3.5 years, and then every 10 weeks until RECIST 1.1-defined. Patients will be followed up for a period of 28 days following discontinuation of osimertinib. Target patient population Male and female patients aged 18 years and over with locally advanced or metastatic pathologically confirmed adenocarcinoma of the lung, not amenable to curative surgery or radiotherapy. Patients will have a tumour that harbours one of the EGFR mutations known to be associated with EGFR tyrosine kinase inhibitor sensitivity, either alone or in combination with other EGFR mutations (EGFR mutation status determined by a local laboratory). Patients must be EGFR tyrosine kinase inhibitor treatment-na\u00efve and eligible to receive first line treatment with osimertinib. Osimertinib is an oral, potent, selective, irreversible inhibitor of both EGFR tyrosine kinase inhibitor sensitizing and resistance mutations in non-small cell lung cancer with a significant selectivity margin over wild type EGFR. Osimertinib (80 mg orally, once daily) will be administered. Doses may be reduced to 40 mg if needed."
                },
                "conditionsModule": {
                    "conditions": [
                        "EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer"
                    ],
                    "keywords": [
                        "EGFR, NSCLC, Lung Cancer, Biopsy, Molecular Profiling"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "NA",
                        "interventionModel": "SINGLE_GROUP",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 154,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Osimertinib",
                            "type": "EXPERIMENTAL",
                            "description": "An oral, potent, selective, irreversible inhibitor of both EGFR-tyrosine kinase inhibitor sensitizing and resistance mutations in non-small cell lung cancer",
                            "interventionNames": [
                                "Drug: Osimertinib"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Osimertinib",
                            "description": "Osimertinib is an oral, potent, selective, irreversible inhibitor of both EGFR-tyrosine kinase inhibitor sensitizing and resistance mutations in non-small cell lung cancer with a significant selectivity margin over wild type EGFR.",
                            "armGroupLabels": [
                                "Osimertinib"
                            ],
                            "otherNames": [
                                "TAGRISSO, AZD9291"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Proportion of Patients With a Given Tumour Genetic and Proteomic Marker at the Point of Disease Progression",
                            "description": "The frequency of genetic and proteomic markers at disease progression regardless of their prevalence was evaluated.",
                            "timeFrame": "Genetic and proteomic markers were assessed at baseline and progression (up to 5 years after baseline)"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Progression Free Survival (PFS)",
                            "description": "PFS is defined as the time from first dose of osimertinib until the date of Investigator assessed Response Evaluation Criteria in Solid Tumours (RECIST) 1.1-defined progression or death (by any cause in the absence of progression) regardless of whether the patient withdraws from therapy or receives another anticancer therapy prior to progression.",
                            "timeFrame": "From date of first dose until date of progression or death (by any cause in the absence of recurrence), up to 5 years"
                        },
                        {
                            "measure": "Objective Response Rate (ORR)",
                            "description": "ORR is defined as the number (%) of patients with at least one visit response of complete response (CR) or partial response (PR) that is confirmed at least 4 weeks later.",
                            "timeFrame": "From date of first dose until progression, or last evaluable assessment in the absence of progression, up to 5 years"
                        },
                        {
                            "measure": "Duration of Response (DoR)",
                            "description": "Duration of response is defined as the time from the date of first documented response, (that is subsequently confirmed) until date of documented progression or death in the absence of disease progression, the end of response should coincide with the date of progression or death from any cause used for the PFS endpoint. The time of the initial response will be defined as the latest of the dates contributing towards the first visit that was CR or PR that was subsequently confirmed.",
                            "timeFrame": "From date of first documentation of complete/partial response until the date of progression, or last evaluable RECIST assessment for participants that did not progress within 2 missed visits of last assessment, up to 5 years"
                        },
                        {
                            "measure": "Disease Control Rate (DCR)",
                            "description": "DCR is defined as percentage of patients with confirmed complete response, confirmed partial response or with stable disease.",
                            "timeFrame": "8 weeks"
                        },
                        {
                            "measure": "Time to Treatment Discontinuation or Death (TTD)",
                            "description": "TTD is defined as the time from the date of first dose of osimertinib to the earliest of treatment discontinuation or death.",
                            "timeFrame": "From date of first dose to treatment discontinuation or death (by any cause in the absence of recurrence), up to 5 years"
                        },
                        {
                            "measure": "Time to First Subsequent Therapy or Death (TFST)",
                            "description": "TFST is defined as the time from the date of first dose of osimertinib to the earlier of the date of anticancer therapy start date following study treatment discontinuation, or death.",
                            "timeFrame": "From date of first dose to start of subsequent anticancer therapy or death (by any cause in the absence of recurrence), up to 5 years"
                        },
                        {
                            "measure": "PFS in Patient Subgroups Defined by Molecular Profile: Epidermal Growth Factor Receptor (EGFR) Tumor Mutation at Baseline",
                            "description": "PFS is defined as the time from first dose of osimertinib until the date of Investigator assessed Response Evaluation Criteria in Solid Tumours (RECIST) 1.1-defined progression or death (by any cause in the absence of progression) regardless of whether the patient withdraws from therapy or receives another anticancer therapy prior to progression. PFS was analysed in patient subgroups defined by molecular profile, including but not limited to: EGFR tumor mutation at baseline-Exon19del or L858R",
                            "timeFrame": "From date of first dose until date of progression or death (by any cause in the absence of recurrence), up to 5 years"
                        },
                        {
                            "measure": "PFS in Patient Subgroups Defined by Molecular Profile: Detectable in Plasma-Derived ctDNA at Baseline",
                            "description": "PFS is defined as the time from first dose of osimertinib until the date of Investigator assessed Response Evaluation Criteria in Solid Tumours (RECIST) 1.1-defined progression or death (by any cause in the absence of progression) regardless of whether the patient withdraws from therapy or receives another anticancer therapy prior to progression. PFS was analysed in patient subgroups defined by molecular profile, including but not limited to: Exon19del or L858R detectable in plasma derived circulating tumour deoxyribonucleic acid (ctDNA) at baseline.",
                            "timeFrame": "From date of first dose until date of progression or death (by any cause in the absence of recurrence), up to 5 years"
                        },
                        {
                            "measure": "ORR in Patient Subgroups Defined by Molecular Profile: EGFR Tumor Mutation at Baseline",
                            "description": "ORR is defined as the number (%) of patients with at least one visit response of complete response or partial response that is confirmed at least 4 weeks later. ORR was analysed in patient subgroups defined by molecular profile: EGFR tumor mutation at baseline-Exon19del or L858R",
                            "timeFrame": "From date of first dose until progression, or last evaluable assessment in the absence of progression, up to 5 years"
                        },
                        {
                            "measure": "ORR in Patient Subgroups Defined by Molecular Profile: Detectable in Plasma Derived ctDNA at Baseline",
                            "description": "ORR is defined as the number (%) of patients with at least one visit response of complete response or partial response that is confirmed at least 4 weeks later. ORR was analysed in patient subgroups defined by molecular profile: Exon19del or L858R detectable in plasma derived ctDNA at baseline.",
                            "timeFrame": "From date of first dose until progression, or last evaluable assessment in the absence of progression, up to 5 years"
                        },
                        {
                            "measure": "TTD in Patient Subgroups Defined by Molecular Profile: EGFR Tumor Mutation at Baseline",
                            "description": "TTD is defined as the time from the date of first dose of osimertinib to the earliest of treatment discontinuation or death. TTD was analysed in patient subgroups defined by molecular profile: EGFR tumor mutation at baseline-Exon19del or L858R",
                            "timeFrame": "From date of first dose to treatment discontinuation or death (by any cause in the absence of recurrence), up to 5 years"
                        },
                        {
                            "measure": "TTD in Patient Subgroups Defined by Molecular Profile: Detectable in Plasma Derived ctDNA at Baseline",
                            "description": "TTD is defined as the time from the date of first dose of osimertinib to the earliest of treatment discontinuation or death. TTD was analysed in patient subgroups defined by molecular profile: Exon19del or L858R detectable in plasma derived ctDNA at baseline.",
                            "timeFrame": "From date of first dose to treatment discontinuation or death (by any cause in the absence of recurrence), up to 5 years"
                        },
                        {
                            "measure": "Tumour Shrinkage/Depth of Response in Patient Subgroups Defined by Molecular Profile: EGFR Tumor Mutation at Baseline",
                            "description": "Tumour shrinkage is defined as the best change from baseline in the sum of diameters of target lesions, in patient subgroups defined by molecular profile: EGFR tumor mutation at baseline-Exon19del or L858R. A negative change denotes a reduction in target lesion size.",
                            "timeFrame": "From date of first dose until last recorded post baseline RECIST target lesion assessment scan, up to 5 years"
                        },
                        {
                            "measure": "Tumour Shrinkage/Depth of Response in Patient Subgroups Defined by Molecular Profile: Detectable in Plasma Derived ctDNA at Baseline",
                            "description": "Tumour shrinkage is defined as the best change from baseline in the sum of diameters of target lesions, in patient subgroups defined by molecular profile: Exon19del or L858R detectable in plasma derived ctDNA at baseline. A negative change denotes a reduction in target lesion size.",
                            "timeFrame": "From date of first dose until last recorded post baseline RECIST target lesion assessment scan, up to 5 years"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Provision of informed consent prior\n2. Patients aged 18 years or older\n3. Patients with histological confirmation of locally advanced or metastatic NSCLC\n4. Patients with M1 stage according to the Tumor, Node and Metastasis Classification of Malignant Tumours (TNM)\n5. Patients with an EGFR deletion or mutation known (from tumour biopsy or plasma) to be associated with EGFR TKI sensitivity\n6. Existence of measurable or evaluable disease (as per RECIST 1.1 criteria).\n7. Possibility of obtaining sufficient tissue sample, via a biopsy or surgical resection of the primary tumour or metastatic tumour tissue\n8. WHO performance status 0-1\n9. Life expectancy \u226512 weeks\n10. Capacity to swallow\n11. Patients able to complete study and within geographical proximity allowing for adequate follow up\n12. Resolution of all acute toxic effects of previous anticancer therapy\n13. Female patients must be using highly effective contraceptive measures, and must have a negative pregnancy test prior to start of dosing if of childbearing potential\n14. Male patients must be willing to use barrier contraception\n\nExclusion Criteria:\n\n1. Locally advanced lung cancer candidate for curative treatment through radical surgery and/or radio(chemo)therapy\n2. Patients diagnosed with another lung cancer subtype\n3. Patients with an EGFR exon 20 insertion\n4. Patients with just one measurable or evaluable tumour lesion that has been resected or irradiated prior to their enrolment in the study\n5. Second active neoplasia\n6. Treatment with an investigational drug within five half-lives of the compound\n7. Participation in another clinical study with an investigational product (IP) during the last 3 weeks before the first day of study treatment\n8. Patients who have received prior immunotherapies\n9. Patients who have received prior EGFR treatments for lung cancer\n10. Patients who have received prior treatment with an EGFR TKI including in the adjuvant setting\n11. Patients who have received previous treatment for metastatic or stage IV disease\n12. Prior treatment with cytotoxic chemotherapy for advanced NSCLC\n13. Patients with a history of cancer that has been completely treated, with no evidence of malignant disease currently cannot be enrolled in the study if their chemotherapy was completed less than 6 months prior and/or have received a bone marrow transplant less than 2 years before the first day of study treatment\n14. Any unresolved toxicities from prior therapy greater than CTCAE grade 1 at the time of starting study treatment with the exception of alopecia and grade 2, prior platinum-therapy related neuropathy\n15. Any evidence of severe or uncontrolled systemic diseases, including uncontrolled hypertension and active bleeding diatheses or active infection (eg, patients receiving treatment for infection) including hepatitis C and human immunodeficiency virus (HIV), or active uncontrolled Hepatitis B virus (HBV) infection.\n16. Patients who have had a surgical procedure unrelated to the study within 14 days or major surgery within 1 month prior to the administration of the study drug\n17. Past medical history of interstitial lung disease (ILD), drug-induced ILD, radiation pneumonitis\n18. Any of the following cardiac criteria: Mean resting QT interval corrected for heart rate (QTc) more than 470 msec, obtained from 3 ECGs, using the screening clinic ECG machine derived QTc value. Any clinically important abnormalities in rhythm, conduction or morphology of resting ECG e.g. complete left bundle branch block, third degree heart block and second degree heart block. Any factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, hypokalaemia, hypomagnesaemia, hypocalcaemia, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age in first degree relatives or any concomitant medication known to prolong the QT interval\n19. Spinal cord compression, symptomatic and unstable brain metastases except for those patients who have completed definitive therapy, and have had a stable neurological status for at least 2 weeks after completion of definitive therapy. 20.Refractory nausea and vomiting, chronic gastrointestinal diseases, inability to swallow the formulated product or previous significant bowel resection that would preclude adequate absorption of osimertinib\n\n21.Inadequate bone marrow reserve or organ function 22.Female patients who are breastfeeding 23.Patients currently receiving medications or herbal supplements known to be potent inducers of cytochrome (CYP) 3A4.\n\n24.Patient unwilling to undergo a biopsy at the time of disease progression 25.History of hypersensitivity to active or inactive excipients of osimertinib or drugs with a similar chemical structure or class to osimertinib 26.Judgment by the Investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirements 27.Involvement in the planning and/or conduct of the study 28.Previous enrolment in the present study",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "maximumAge": "130 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Zosia Piotrowska, MD",
                            "affiliation": "Massachusetts General Hospital",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Research Site",
                            "city": "Athens",
                            "state": "Georgia",
                            "zip": "30607",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.96095,
                                "lon": -83.37794
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Atlanta",
                            "state": "Georgia",
                            "zip": "30307",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.749,
                                "lon": -84.38798
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Boston",
                            "state": "Massachusetts",
                            "zip": "02215",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.35843,
                                "lon": -71.05977
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Brescia",
                            "zip": "25100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.53558,
                                "lon": 10.21472
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Meldola",
                            "zip": "47014",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.12775,
                                "lon": 12.0626
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Monza",
                            "zip": "20900",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.58005,
                                "lon": 9.27246
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Parma",
                            "zip": "43126",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.79935,
                                "lon": 10.32618
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Roma",
                            "zip": "00152",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Terni",
                            "zip": "05100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 42.56335,
                                "lon": 12.64329
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Busan",
                            "zip": "47392",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 35.10278,
                                "lon": 129.04028
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Cheongiu",
                            "zip": "28644",
                            "country": "Korea, Republic of"
                        },
                        {
                            "facility": "Research Site",
                            "city": "Seongnam",
                            "zip": "13620",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.43861,
                                "lon": 127.13778
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Seoul",
                            "zip": "03722",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Seoul",
                            "zip": "05505",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Seoul",
                            "zip": "06591",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Seoul",
                            "zip": "135-710",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Johor Bahru",
                            "zip": "81100",
                            "country": "Malaysia",
                            "geoPoint": {
                                "lat": 1.4655,
                                "lon": 103.7578
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Kuantan",
                            "zip": "25100",
                            "country": "Malaysia",
                            "geoPoint": {
                                "lat": 3.8077,
                                "lon": 103.326
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Kuching",
                            "zip": "93586",
                            "country": "Malaysia",
                            "geoPoint": {
                                "lat": 1.54999,
                                "lon": 110.33333
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Lembah Pantai",
                            "zip": "59100",
                            "country": "Malaysia"
                        },
                        {
                            "facility": "Research Site",
                            "city": "Pulau Pinang",
                            "zip": "10450",
                            "country": "Malaysia",
                            "geoPoint": {
                                "lat": 3.55,
                                "lon": 102.56667
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "A Coru\u00f1a",
                            "zip": "15006",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 43.37135,
                                "lon": -8.396
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Barcelona",
                            "zip": "08035",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.38879,
                                "lon": 2.15899
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Las Palmas de Gran Canaria",
                            "zip": "35016",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 28.09973,
                                "lon": -15.41343
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Madrid",
                            "zip": "28046",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 40.4165,
                                "lon": -3.70256
                            }
                        },
                        {
                            "facility": "Research Site",
                            "city": "Sevilla",
                            "zip": "41009",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 37.38283,
                                "lon": -5.97317
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "seeAlsoLinks": [
                        {
                            "label": "Redacted CSR synopsis",
                            "url": "https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5161C00003&amp;attachmentIdentifier=0512bdf7-7e91-4862-b078-e8c798059269&amp;fileName=235434_CSR_Synopsis_28-June-24_Redacted_Approved_PDF_A.pdf&amp;versionIdentifier="
                        },
                        {
                            "label": "Redacted CSP",
                            "url": "https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5161C00003&amp;attachmentIdentifier=38f2807f-f212-4590-8e86-5b2d13cb3772&amp;fileName=235434_Protocol_13Aug_24_Redacted_Approved_PDF_A.pdf&amp;versionIdentifier="
                        },
                        {
                            "label": "Redacted SAP",
                            "url": "https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5161C00003&amp;attachmentIdentifier=806e2b73-bfa4-4a78-890a-f0655e38acb4&amp;fileName=235434_SAP_13Aug_24_Redacted_Approved_PDF_A.pdf&amp;versionIdentifier="
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "YES",
                    "description": "Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All request will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
                    "infoTypes": [
                        "STUDY_PROTOCOL",
                        "SAP"
                    ],
                    "timeFrame": "AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
                    "accessCriteria": "When a request has been approved AstraZeneca will provide access to the de-identified individual patient-level data in an approved sponsored tool . Signed Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access. For additional details, please review the Disclosure Statements at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
                    "url": "https://astrazenecagroup-dt.pharmacm.com/DT/Home"
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "preAssignmentDetails": "Participants meeting eligibility criteria predefined in protocol were enrolled in the study. All the assessments were performed as per the schedule of the assessments.",
                    "recruitmentDetails": "Participants were enrolled in this study from 30 May 2018 (First subject in) and analyses presented in this results form are based on a final data cut-off of 18 July 2023 and final database lock of 15 December 2023.",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Osimertinib 80mg",
                            "description": "Participants received Osimertinib 80mg orally once daily."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "154"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "33"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "121"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Other",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "26"
                                        }
                                    ]
                                },
                                {
                                    "type": "Patients who are ongoing in the study at DCO",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "10"
                                        }
                                    ]
                                },
                                {
                                    "type": "Death",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "40"
                                        }
                                    ]
                                },
                                {
                                    "type": "Lost to Follow-up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        }
                                    ]
                                },
                                {
                                    "type": "Physician Decision",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "16"
                                        }
                                    ]
                                },
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "27"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Osimertinib 80mg",
                            "description": "Participants received Osimertinib 80mg orally once daily."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "154"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "Years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "62.7",
                                                    "spread": "10.36"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "92"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "62"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race/Ethnicity, Customized",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "White",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "30"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "118"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Other",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race/Ethnicity, Customized",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Hispanic",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "6"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "148"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Proportion of Patients With a Given Tumour Genetic and Proteomic Marker at the Point of Disease Progression",
                            "description": "The frequency of genetic and proteomic markers at disease progression regardless of their prevalence was evaluated.",
                            "populationDescription": "The primary analysis set included all patients with evaluable paired biopsies, which were defined as follows: the first biopsy was taken prior to osimertinib treatment, and the second biopsy was taken at any time between Investigator-assessed RECIST 1.1-defined progression and before the start of any new anticancer treatment.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percentage of participants",
                            "timeFrame": "Genetic and proteomic markers were assessed at baseline and progression (up to 5 years after baseline)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Osimertinib 80 mg",
                                    "description": "Participants received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "51"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "AKT2; Copy Number Alteration: Type; amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "ALK; Rearrangement",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "APC; Copy Number Alteration; Type: loss",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "ARAF; Copy Number Alteration; Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "ASXL1; Short Variant; Type: Q588*",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "ATRX; Short Variant; Type: P599fs*22",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "AXL; Copy Number Alteration; Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "BCL2L2; Copy Number Alteration; Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "BRAF; Rearrangement",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "BRAF; Short variant; Type: G469A",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "BRAF; Short variant Type: V600E",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CBL; Short Variant; Type: R149Q",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CCND1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CCNE1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "5.9",
                                                    "lowerLimit": "1.23",
                                                    "upperLimit": "16.24"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CDK4 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CDK6 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CDKN1B Short Variant Type: S2*",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CDKN2A Copy Number Alteration Type: loss",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "15.7",
                                                    "lowerLimit": "7.02",
                                                    "upperLimit": "28.59"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CDKN2A; Short Variant Type: P38L",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CDKN2B Copy Number Alteration Type: loss",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "15.7",
                                                    "lowerLimit": "7.02",
                                                    "upperLimit": "28.59"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CRKL Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "CUL4A Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "DIS3 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "EGFR Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "11.8",
                                                    "lowerLimit": "4.44",
                                                    "upperLimit": "23.87"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "EGFR Rearrangement",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "EGFR Short Variant Type: C797S",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "7",
                                                    "lowerLimit": "5.70",
                                                    "upperLimit": "26.26"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "EGFR Short Variant Type: L858R",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "EMSY Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "ERBB2 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "FANCG Rearrangement",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "FGF10 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "FGF14; Copy Number Alteration; Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "FGF19 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "FGFR1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "FGFR3 Rearrangement",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "FGFR4 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "HGF Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "HRAS Short Variant Type: Q61R",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "IDH1 Short Variant Type: R132L",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "IGF1R Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "IRS2 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "KRAS Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "LYN Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "MAP2K1 Short Variant Type: E102_I103del",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "MCL1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "5.9",
                                                    "lowerLimit": "1.23",
                                                    "upperLimit": "16.24"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "MDM2 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "MET Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "17.6",
                                                    "lowerLimit": "8.40",
                                                    "upperLimit": "30.87"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "MTAP Copy Number Alteration Type: loss",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "13.7",
                                                    "lowerLimit": "5.70",
                                                    "upperLimit": "26.26"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "MYC Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "MYCN Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "NF1 Short Variant Type: M1I",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "NFE2L2 Short Variant Type: D29N",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "NFKBIA Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "9.8",
                                                    "lowerLimit": "3.26",
                                                    "upperLimit": "21.41"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "NKX2-1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "9.8",
                                                    "lowerLimit": "3.26",
                                                    "upperLimit": "21.41"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "NOTCH3 Rearrangement",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "NTRK1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "PARP1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "PDGFRB Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "PIK3CA Short Variant Type: E542K",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "PIM1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "RAD21 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "RB1 Copy Number Alteration Type: loss",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "RB1 Short Variant Type: Q846*",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "RICTOR Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "7.8",
                                                    "lowerLimit": "2.18",
                                                    "upperLimit": "18.88"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "SMAD4 Rearrangement",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "SMAD4 Short Variant Type: W524L",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "SPEN Short Variant Type: D2047fs*17",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "STK11 Copy Number Alteration Type: loss",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "STK11 Short Variant Type: K269fs*18",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "TERC Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "TERT Short Variant Type: promoter -146C>T",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "TET2 Short Variant Type: Q916*",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "TET2 Short Variant Type: V1862fs*13",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "TP53 Short Variant Type: R213*",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.0",
                                                    "lowerLimit": "0.05",
                                                    "upperLimit": "10.45"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "WHSC1L1 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "ZNF703 Copy Number Alteration Type: amplification",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.9",
                                                    "lowerLimit": "0.48",
                                                    "upperLimit": "13.46"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Progression Free Survival (PFS)",
                            "description": "PFS is defined as the time from first dose of osimertinib until the date of Investigator assessed Response Evaluation Criteria in Solid Tumours (RECIST) 1.1-defined progression or death (by any cause in the absence of progression) regardless of whether the patient withdraws from therapy or receives another anticancer therapy prior to progression.",
                            "populationDescription": "The full analysis set included all patients who received at least one dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Months",
                            "timeFrame": "From date of first dose until date of progression or death (by any cause in the absence of recurrence), up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Osimertinib 80 mg",
                                    "description": "Participants received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "154"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "16.4",
                                                    "lowerLimit": "12.7",
                                                    "upperLimit": "20.3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Objective Response Rate (ORR)",
                            "description": "ORR is defined as the number (%) of patients with at least one visit response of complete response (CR) or partial response (PR) that is confirmed at least 4 weeks later.",
                            "populationDescription": "The full analysis set included all patients who received at least one dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percentage of participants",
                            "timeFrame": "From date of first dose until progression, or last evaluable assessment in the absence of progression, up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Osimertinib 80 mg",
                                    "description": "Participants received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "154"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "73.4",
                                                    "lowerLimit": "65.66",
                                                    "upperLimit": "80.17"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Duration of Response (DoR)",
                            "description": "Duration of response is defined as the time from the date of first documented response, (that is subsequently confirmed) until date of documented progression or death in the absence of disease progression, the end of response should coincide with the date of progression or death from any cause used for the PFS endpoint. The time of the initial response will be defined as the latest of the dates contributing towards the first visit that was CR or PR that was subsequently confirmed.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib. The Duration of response is calculated for only participants with a confirmed response. Participants must have had measurable disease at baseline to be included in the study.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Months",
                            "timeFrame": "From date of first documentation of complete/partial response until the date of progression, or last evaluable RECIST assessment for participants that did not progress within 2 missed visits of last assessment, up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Osimertinib 80 mg",
                                    "description": "Participants received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "113"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "18.8",
                                                    "lowerLimit": "14.2",
                                                    "upperLimit": "22.3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Disease Control Rate (DCR)",
                            "description": "DCR is defined as percentage of patients with confirmed complete response, confirmed partial response or with stable disease.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percentage of participants",
                            "timeFrame": "8 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Osimertinib 80 mg",
                                    "description": "Participants received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "154"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "94.8",
                                                    "lowerLimit": "90.02",
                                                    "upperLimit": "97.73"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Time to Treatment Discontinuation or Death (TTD)",
                            "description": "TTD is defined as the time from the date of first dose of osimertinib to the earliest of treatment discontinuation or death.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Months",
                            "timeFrame": "From date of first dose to treatment discontinuation or death (by any cause in the absence of recurrence), up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Osimertinib 80 mg",
                                    "description": "Participants received Osimertinib 80 mg orally once daily with epidermal growth factor receptor (EGFR)."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "154"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "20.0",
                                                    "lowerLimit": "16.3",
                                                    "upperLimit": "23.8"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Time to First Subsequent Therapy or Death (TFST)",
                            "description": "TFST is defined as the time from the date of first dose of osimertinib to the earlier of the date of anticancer therapy start date following study treatment discontinuation, or death.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Months",
                            "timeFrame": "From date of first dose to start of subsequent anticancer therapy or death (by any cause in the absence of recurrence), up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Osimertinib 80 mg",
                                    "description": "Participants received Osimertinib 80 mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "154"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "32.1",
                                                    "lowerLimit": "24.0",
                                                    "upperLimit": "47.7"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "PFS in Patient Subgroups Defined by Molecular Profile: Epidermal Growth Factor Receptor (EGFR) Tumor Mutation at Baseline",
                            "description": "PFS is defined as the time from first dose of osimertinib until the date of Investigator assessed Response Evaluation Criteria in Solid Tumours (RECIST) 1.1-defined progression or death (by any cause in the absence of progression) regardless of whether the patient withdraws from therapy or receives another anticancer therapy prior to progression. PFS was analysed in patient subgroups defined by molecular profile, including but not limited to: EGFR tumor mutation at baseline-Exon19del or L858R",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Months",
                            "timeFrame": "From date of first dose until date of progression or death (by any cause in the absence of recurrence), up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Exon19del",
                                    "description": "Participants with Exon19del received Osimertinib 80mg orally once daily."
                                },
                                {
                                    "id": "OG001",
                                    "title": "L858R",
                                    "description": "Patient with L858R received Osimertinib 80 mg orally one daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "85"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "58"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "22.0",
                                                    "lowerLimit": "16.0",
                                                    "upperLimit": "27.6"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "12.9",
                                                    "lowerLimit": "10.8",
                                                    "upperLimit": "18.2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "PFS in Patient Subgroups Defined by Molecular Profile: Detectable in Plasma-Derived ctDNA at Baseline",
                            "description": "PFS is defined as the time from first dose of osimertinib until the date of Investigator assessed Response Evaluation Criteria in Solid Tumours (RECIST) 1.1-defined progression or death (by any cause in the absence of progression) regardless of whether the patient withdraws from therapy or receives another anticancer therapy prior to progression. PFS was analysed in patient subgroups defined by molecular profile, including but not limited to: Exon19del or L858R detectable in plasma derived circulating tumour deoxyribonucleic acid (ctDNA) at baseline.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Months",
                            "timeFrame": "From date of first dose until date of progression or death (by any cause in the absence of recurrence), up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Exon19del",
                                    "description": "Participants with Exon19del received Osimertinib 80mg orally once daily."
                                },
                                {
                                    "id": "OG001",
                                    "title": "L858R",
                                    "description": "Patient with L858R received Osimertinib 80 mg orally one daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "62"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "46"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "19.6",
                                                    "lowerLimit": "12.7",
                                                    "upperLimit": "24.0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "13.7",
                                                    "lowerLimit": "9.0",
                                                    "upperLimit": "18.2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "ORR in Patient Subgroups Defined by Molecular Profile: EGFR Tumor Mutation at Baseline",
                            "description": "ORR is defined as the number (%) of patients with at least one visit response of complete response or partial response that is confirmed at least 4 weeks later. ORR was analysed in patient subgroups defined by molecular profile: EGFR tumor mutation at baseline-Exon19del or L858R",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percentage of participants",
                            "timeFrame": "From date of first dose until progression, or last evaluable assessment in the absence of progression, up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Exon19del",
                                    "description": "Participants with Exon19del received Osimertinib 80mg orally once daily."
                                },
                                {
                                    "id": "OG001",
                                    "title": "L858R",
                                    "description": "Participants with L858R received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "85"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "58"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "82.4",
                                                    "lowerLimit": "72.57",
                                                    "upperLimit": "89.77"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "69.0",
                                                    "lowerLimit": "55.46",
                                                    "upperLimit": "80.46"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "ORR in Patient Subgroups Defined by Molecular Profile: Detectable in Plasma Derived ctDNA at Baseline",
                            "description": "ORR is defined as the number (%) of patients with at least one visit response of complete response or partial response that is confirmed at least 4 weeks later. ORR was analysed in patient subgroups defined by molecular profile: Exon19del or L858R detectable in plasma derived ctDNA at baseline.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Percentage of participants",
                            "timeFrame": "From date of first dose until progression, or last evaluable assessment in the absence of progression, up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Exon19del",
                                    "description": "Participants with Exon19del received Osimertinib 80mg orally once daily."
                                },
                                {
                                    "id": "OG001",
                                    "title": "L858R",
                                    "description": "Participants with L858R received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "62"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "46"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "85.5",
                                                    "lowerLimit": "74.22",
                                                    "upperLimit": "93.14"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "71.7",
                                                    "lowerLimit": "56.54",
                                                    "upperLimit": "84.01"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "TTD in Patient Subgroups Defined by Molecular Profile: EGFR Tumor Mutation at Baseline",
                            "description": "TTD is defined as the time from the date of first dose of osimertinib to the earliest of treatment discontinuation or death. TTD was analysed in patient subgroups defined by molecular profile: EGFR tumor mutation at baseline-Exon19del or L858R",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Months",
                            "timeFrame": "From date of first dose to treatment discontinuation or death (by any cause in the absence of recurrence), up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Exon19del 80 mg",
                                    "description": "Participants with Exon19del received Osimertinib 80mg orally once daily."
                                },
                                {
                                    "id": "OG001",
                                    "title": "L858R",
                                    "description": "Participants with L858R received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "85"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "58"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "25.5",
                                                    "lowerLimit": "19.6",
                                                    "upperLimit": "32.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "16.5",
                                                    "lowerLimit": "12.1",
                                                    "upperLimit": "21.7"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "TTD in Patient Subgroups Defined by Molecular Profile: Detectable in Plasma Derived ctDNA at Baseline",
                            "description": "TTD is defined as the time from the date of first dose of osimertinib to the earliest of treatment discontinuation or death. TTD was analysed in patient subgroups defined by molecular profile: Exon19del or L858R detectable in plasma derived ctDNA at baseline.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "Months",
                            "timeFrame": "From date of first dose to treatment discontinuation or death (by any cause in the absence of recurrence), up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Exon19del 80 mg",
                                    "description": "Participants with Exon19del received Osimertinib 80mg orally once daily."
                                },
                                {
                                    "id": "OG001",
                                    "title": "L858R",
                                    "description": "Participants with L858R received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "62"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "46"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "24.5",
                                                    "lowerLimit": "17.8",
                                                    "upperLimit": "29.6"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "16.5",
                                                    "lowerLimit": "12.1",
                                                    "upperLimit": "21.4"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Tumour Shrinkage/Depth of Response in Patient Subgroups Defined by Molecular Profile: EGFR Tumor Mutation at Baseline",
                            "description": "Tumour shrinkage is defined as the best change from baseline in the sum of diameters of target lesions, in patient subgroups defined by molecular profile: EGFR tumor mutation at baseline-Exon19del or L858R. A negative change denotes a reduction in target lesion size.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "Full Range",
                            "unitOfMeasure": "Percentage change",
                            "timeFrame": "From date of first dose until last recorded post baseline RECIST target lesion assessment scan, up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Exon19del",
                                    "description": "Participants with Exon19del received Osimertinib 80mg orally once daily."
                                },
                                {
                                    "id": "OG001",
                                    "title": "L858R",
                                    "description": "Participants with L858R received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "83"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "55"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-59.68",
                                                    "lowerLimit": "-100.0",
                                                    "upperLimit": "6.5"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-54.29",
                                                    "lowerLimit": "-100.0",
                                                    "upperLimit": "7.6"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Tumour Shrinkage/Depth of Response in Patient Subgroups Defined by Molecular Profile: Detectable in Plasma Derived ctDNA at Baseline",
                            "description": "Tumour shrinkage is defined as the best change from baseline in the sum of diameters of target lesions, in patient subgroups defined by molecular profile: Exon19del or L858R detectable in plasma derived ctDNA at baseline. A negative change denotes a reduction in target lesion size.",
                            "populationDescription": "The full analysis set included all patients who received at least 1 dose of Osimertinib.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "Full Range",
                            "unitOfMeasure": "Percentage change",
                            "timeFrame": "From date of first dose until last recorded post baseline RECIST target lesion assessment scan, up to 5 years",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Exon19del",
                                    "description": "Participants with Exon19del received Osimertinib 80mg orally once daily."
                                },
                                {
                                    "id": "OG001",
                                    "title": "L858R",
                                    "description": "Participants with L858R received Osimertinib 80mg orally once daily."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "60"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "44"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-60.80",
                                                    "lowerLimit": "-100.0",
                                                    "upperLimit": "6.5"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-58.33",
                                                    "lowerLimit": "-100.0",
                                                    "upperLimit": "7.6"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "5",
                    "timeFrame": "From Day 1 to Follow-up (28 days post last dose) up to 5 years",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Osimertinib 80 mg",
                            "description": "Participants received Osimertinib 80mg orally once daily.",
                            "deathsNumAffected": 40,
                            "deathsNumAtRisk": 154,
                            "seriousNumAffected": 53,
                            "seriousNumAtRisk": 154,
                            "otherNumAffected": 148,
                            "otherNumAtRisk": 154
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "COVID-19",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Gastroenteritis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Lower respiratory tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 12,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia aspiration",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Respiratory tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Sepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Tuberculosis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Urinary tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Urosepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Cervix carcinoma",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Blood loss anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Immune thrombocytopenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Adrenal insufficiency",
                            "organSystem": "Endocrine disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Hyperglycaemic hyperosmolar nonketotic syndrome",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Hypokalaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Hyponatraemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Confusional state",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Mania",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Peripheral sensory neuropathy",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Spinal cord compression",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Status epilepticus",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Acute coronary syndrome",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Atrial fibrillation",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Cardiac failure",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Cardiac failure acute",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Deep vein thrombosis",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Embolism",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Asthma",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Dyspnoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Haemoptysis",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Interstitial lung disease",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Pneumonitis",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Pneumothorax",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Respiratory failure",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Duodenitis",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Gastritis",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Vomiting",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Cholecystitis",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Subcutaneous emphysema",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Back pain",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Asthenia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "General physical health deterioration",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Platelet count decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Neutrophil count decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Acute kidney injury",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Haematuria",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Renal impairment",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Vaginal haemorrhage",
                            "organSystem": "Reproductive system and breast disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Electrocardiogram QT prolonged",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Femoral neck fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Fibula fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Foreign body aspiration",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Humerus fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Pelvic fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Wound dehiscence",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Pulmonary embolism",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 154
                                }
                            ]
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "COVID-19",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 14,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Paronychia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 36,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Upper respiratory tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 24,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Urinary tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 16,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 26,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Thrombocytopenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 9,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Decreased appetite",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 27,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Insomnia",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 10,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Dizziness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 11,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Cough",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 32,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Headache",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 11,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Dyspnoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 8,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Constipation",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 13,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Diarrhoea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 63,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Gastritis",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 8,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Mouth ulceration",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 15,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 17,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Stomatitis",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 22,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Vomiting",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 14,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Dermatitis acneiform",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 21,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Dry skin",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 30,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Pruritus",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 23,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Rash",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 26,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Arthralgia",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 16,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Back pain",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 18,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Pain in extremity",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 10,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Asthenia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 13,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 11,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Alanine aminotransferase increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 16,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Aspartate aminotransferase increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 14,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Gamma-glutamyltransferase increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 9,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Platelet count decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 11,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Weight decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 11,
                                    "numAtRisk": 154
                                }
                            ]
                        },
                        {
                            "term": "Productive cough",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA version 26.1",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 9,
                                    "numAtRisk": 154
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "No unpublished information contained herein may be disclosed without prior written approval from AstraZeneca AB. Access to this document must be restricted to relevant parties."
                    },
                    "pointOfContact": {
                        "title": "Global Clinical Lead",
                        "organization": "AstraZeneca",
                        "email": "information.center@astrazeneca.com",
                        "phone": "1-877-240-9479"
                    }
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "Prot",
                            "hasProtocol": true,
                            "hasSap": false,
                            "hasIcf": false,
                            "label": "Study Protocol",
                            "date": "2023-04-14",
                            "uploadDate": "2024-08-21T06:58",
                            "filename": "Prot_000.pdf",
                            "size": 2986719
                        },
                        {
                            "typeAbbrev": "SAP",
                            "hasProtocol": false,
                            "hasSap": true,
                            "hasIcf": false,
                            "label": "Statistical Analysis Plan",
                            "date": "2023-09-27",
                            "uploadDate": "2024-08-21T06:58",
                            "filename": "SAP_001.pdf",
                            "size": 1267071
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18",
                    "removedCountries": [
                        "Austria"
                    ]
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D008175",
                            "term": "Lung Neoplasms"
                        },
                        {
                            "id": "D002289",
                            "term": "Carcinoma, Non-Small-Cell Lung"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D012142",
                            "term": "Respiratory Tract Neoplasms"
                        },
                        {
                            "id": "D013899",
                            "term": "Thoracic Neoplasms"
                        },
                        {
                            "id": "D009371",
                            "term": "Neoplasms by Site"
                        },
                        {
                            "id": "D009369",
                            "term": "Neoplasms"
                        },
                        {
                            "id": "D008171",
                            "term": "Lung Diseases"
                        },
                        {
                            "id": "D012140",
                            "term": "Respiratory Tract Diseases"
                        },
                        {
                            "id": "D002283",
                            "term": "Carcinoma, Bronchogenic"
                        },
                        {
                            "id": "D001984",
                            "term": "Bronchial Neoplasms"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M11172",
                            "name": "Lung Neoplasms",
                            "asFound": "Lung Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5546",
                            "name": "Carcinoma, Non-Small-Cell Lung",
                            "asFound": "Non-small Cell Lung Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5534",
                            "name": "Carcinoma",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14979",
                            "name": "Respiratory Tract Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16658",
                            "name": "Thoracic Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11168",
                            "name": "Lung Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14977",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5540",
                            "name": "Carcinoma, Bronchogenic",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5260",
                            "name": "Bronchial Neoplasms",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "C000596361",
                            "term": "Osimertinib"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000092004",
                            "term": "Tyrosine Kinase Inhibitors"
                        },
                        {
                            "id": "D047428",
                            "term": "Protein Kinase Inhibitors"
                        },
                        {
                            "id": "D004791",
                            "term": "Enzyme Inhibitors"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D000970",
                            "term": "Antineoplastic Agents"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M145673",
                            "name": "Osimertinib",
                            "asFound": "Adverse events",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M2889",
                            "name": "Tyrosine Kinase Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25820",
                            "name": "Protein Kinase Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7951",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T22",
                            "name": "Tyrosine",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "AA",
                            "name": "Amino Acids"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06087640",
                    "orgStudyIdInfo": {
                        "id": "V118_24"
                    },
                    "organization": {
                        "fullName": "Seqirus",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults \u226565 Years of Age",
                    "officialTitle": "A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Subunit Inactivated Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults \u226565 Years of Age"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "ACTIVE_NOT_RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2023-10-23",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2026-11",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2026-12",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2023-09-28",
                    "studyFirstSubmitQcDate": "2023-10-11",
                    "studyFirstPostDateStruct": {
                        "date": "2023-10-18",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Seqirus",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "This Phase 3 study is a randomized, observer-blind study of MF59-adjuvanted influenza vaccine (aQIV or aTIV) compared with a non-adjuvanted influenza vaccine (QIV or TIV) in adults \u226565 years of age. The aim of the study is to evaluate MF59-adjuvanted influenza vaccine compared with non-adjuvanted influenza vaccine in the prevention of reverse transcription-polymerase chain reaction (RT-PCR)-confirmed influenza A and/or B in subjects \u226565 years of age."
                },
                "conditionsModule": {
                    "conditions": [
                        "Influenza, Human"
                    ],
                    "keywords": [
                        "Influenza",
                        "Vaccine",
                        "MF59 adjuvant",
                        "aQIV",
                        "aTIV",
                        "A/H1N1",
                        "A/H3N2",
                        "B/Yamagata",
                        "B/Victoria"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "PREVENTION",
                        "maskingInfo": {
                            "masking": "QUADRUPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 35800,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "MF59-adjuvanted influenza vaccine",
                            "type": "EXPERIMENTAL",
                            "description": "MF59-adjuvanted QIV containing 2 influenza type A strains and 2 influenza type B strains or MF59-adjuvanted TIV containing 2 influenza type A strains and 1 influenza type B strain",
                            "interventionNames": [
                                "Biological: aQIV or aTIV"
                            ]
                        },
                        {
                            "label": "Non-adjuvanted influenza vaccine",
                            "type": "OTHER",
                            "description": "Non-adjuvanted QIV containing 2 influenza type A strains and 2 influenza type B strains or Non-adjuvanted TIV containing 2 influenza type A strains and 1 influenza type B strain",
                            "interventionNames": [
                                "Biological: QIV or TIV"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "BIOLOGICAL",
                            "name": "aQIV or aTIV",
                            "description": "Participants receive a 0.5-mL intramuscular dose of aQIV or aTIV on Day 1. A 0.5 mL dose of aQIV contains nominally 15 \u00b5g of hemagglutinin (HA) of each of the 2 influenza type A strains and each of the 2 influenza B strains (total of 60 \u00b5g HA). A 0.5 mL dose of aTIV contains nominally 15 \u00b5g of HA of each of the 2 influenza type A strains and of the influenza B strain (total of 45 \u00b5g HA). The strain composition of aQIV and aTIV is that recommended by the World Health Organization (WHO) for quadrivalent and trivalent influenza vaccines, respectively, contemporaneous to the timing of the study.",
                            "armGroupLabels": [
                                "MF59-adjuvanted influenza vaccine"
                            ],
                            "otherNames": [
                                "Fluad Tetra/Quadrivalent or Fluad"
                            ]
                        },
                        {
                            "type": "BIOLOGICAL",
                            "name": "QIV or TIV",
                            "description": "Participants receive a 0.5-mL intramuscular dose of the non-adjuvanted QIV or TIV on Day 1. A 0.5 mL dose of QIV contains nominally 15 \u03bcg of HA of each of the 2 influenza type A strains and each of the 2 influenza B strains (total of 60 \u03bcg HA). A 0.5 mL dose of TIV contains nominally 15 \u03bcg of HA of each of the 2 influenza type A strains and of the influenza B strain (total of 45 \u03bcg HA). The strain composition of QIV and TIV is that recommended by the WHO for quadrivalent and trivalent influenza vaccines, respectively, contemporaneous to the timing of the study.",
                            "armGroupLabels": [
                                "Non-adjuvanted influenza vaccine"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Efficacy Endpoint: First-occurrence of RT-PCR-confirmed influenza, due to any influenza Type A and/or B virus (regardless of antigenic match), using the protocol-defined ILI definition",
                            "description": "ILI = influenza-like illness; RT-PCR = reverse transcription-polymerase chain reaction",
                            "timeFrame": "From 14 days after vaccination (ie study day 15) and until the end of influenza season (typically end of May for Northern Hemisphere [NH] influenza season and end of November for Southern Hemisphere [SH] influenza season)"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Efficacy Endpoint: First-occurrence of influenza, due to influenza Type A and/or B virus antigenically matched to the vaccine strains selected for the seasonal vaccine, using the protocol-defined ILI definition",
                            "timeFrame": "From 14 days after vaccination (ie study day 15) and until the end of influenza season (typically end of May for NH influenza season and end of November for SH influenza season)"
                        },
                        {
                            "measure": "Efficacy Endpoint: First-occurrence of culture-confirmed influenza, due to any influenza Type A and/or B virus (regardless of antigenic match), using the protocol-defined ILI definition",
                            "timeFrame": "From 14 days after vaccination (ie study day 15) and until the end of influenza season (typically end of May for NH influenza season and end of November for SH influenza season)"
                        },
                        {
                            "measure": "Efficacy Endpoint: First-occurrence of RT-PCR-confirmed influenza, due to any influenza Type A and/or B virus (regardless of antigenic match), using the modified CDC ILI definition",
                            "description": "CDC = Centers for Disease Control and Prevention",
                            "timeFrame": "From 14 days after vaccination (ie study day 15) and until the end of influenza season (typically end of May for NH influenza season and end of November for SH influenza season)"
                        },
                        {
                            "measure": "Efficacy Endpoint: First-occurrence of RT-PCR-confirmed influenza, due to any influenza Type A and/or B virus (regardless of antigenic match), using the WHO ILI definition",
                            "description": "WHO = World Health Organization",
                            "timeFrame": "From 14 days after vaccination (ie study day 15) and until the end of influenza season (typically end of May for NH influenza season and end of November for SH influenza season)"
                        },
                        {
                            "measure": "Efficacy Endpoint: First-occurrence of influenza, due to influenza Type A and/or B virus antigenically unmatched to the vaccine strains selected for the seasonal vaccine, using the protocol-defined ILI definition",
                            "timeFrame": "From 14 days after vaccination (ie study day 15) and until the end of influenza season (typically end of May for NH influenza season and end of November for SH influenza season)"
                        },
                        {
                            "measure": "Immunogenicity Endpoint: Pre- and post-vaccination hemagglutination inhibition (HI) geometric mean titers (GMTs) for the A/H1N1, A/H3N2, B/Yamagata, and B/Victoria vaccine strains",
                            "timeFrame": "Day 1 and Day 22"
                        },
                        {
                            "measure": "Immunogenicity Endpoint: GMT ratios (adjuvanted/non-adjuvanted) at Day 1 and Day 22 for the A/H1N1, A/H3N2, B/Yamagata, and B/Victoria vaccine strains",
                            "timeFrame": "Day 1 and Day 22"
                        },
                        {
                            "measure": "Immunogenicity Endpoint: Geometric mean fold increase (GMFI, Day 22/Day1) for the A/H1N1, A/H3N2, B/Yamagata, and B/Victoria vaccine strains",
                            "timeFrame": "Day 1 and Day 22"
                        },
                        {
                            "measure": "Immunogenicity Endpoint: Percentage of subjects achieving seroconversion for the A/H1N1, A/H3N2, B/Yamagata, and B/Victoria vaccine strains",
                            "description": "Seroconversion is defined as the percentage of subjects with either a pre-vaccination titer \\<1:10 and a post-vaccination titer \u22651:40 or a pre-vaccination titer \u22651:10 and a \u22654-fold increase in post-vaccination titer.",
                            "timeFrame": "Day 1 and Day 22"
                        },
                        {
                            "measure": "Immunogenicity Endpoint: Percentage of subjects with HI titer \u22651:40 for the A/H1N1, A/H3N2, B/Yamagata, and B/Victoria vaccine strains",
                            "timeFrame": "Day 1 and Day 22"
                        },
                        {
                            "measure": "Safety Endpoint: All adverse events (AEs) reported within 30 minutes after vaccination",
                            "timeFrame": "Day 1"
                        },
                        {
                            "measure": "Safety Endpoint: Serious adverse events (SAEs) reported during the entire study period",
                            "timeFrame": "Day 1 to Day 181 or the end of the influenza season, whichever is longer"
                        },
                        {
                            "measure": "Safety Endpoint: Adverse events of special interest (AESIs) reported during the entire study period",
                            "timeFrame": "Day 1 to Day 181 or the end of the influenza season, whichever is longer"
                        },
                        {
                            "measure": "Safety Endpoint: AEs leading to premature withdrawal from the study during the entire study period",
                            "timeFrame": "Day 1 to Day 181 or the end of the influenza season, whichever is longer"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\nIn order to participate in this study, all subjects must meet ALL of the inclusion criteria described.\n\n1. Adults of \u226565 years of age on the day of vaccination.\n2. Individuals who have voluntarily given written informed consent after the nature of the study has been explained according to local regulatory requirements, prior to study entry.\n3. Individuals who have the ability to comply with study procedures including follow-up.\n\nExclusion Criteria:\n\nIn order to participate in this study, all subjects must not meet any of the exclusion criteria described below:\n\n1. Bedridden subjects (i.e. confined to bed by sickness or old age).\n2. Subjects that are incapacitated and because of that in need of a Legally Authorized Representative.\n3. Receipt of any influenza vaccine within 6 months prior to enrollment or any plan to receive influenza vaccine while participating in the study.\n4. Hypersensitivity, including allergy, to any component of vaccines whose use is foreseen in this study, or severe allergic reaction (e.g. anaphylaxis) to previous influenza vaccination.\n5. Known history of Guillain-Barr\u00e9 syndrome or another demyelinating disease such as encephalomyelitis and transverse myelitis.\n6. Clinical conditions representing a contra-indication to intramuscular administration of vaccines or blood draw.\n7. Abnormal function of the immune system resulting from:\n\n   1. Clinical conditions;\n   2. Systemic administration of corticosteroids (PO/IV/IM) at a dose \u226520 mg/day of prednisone (or equivalent) for more than 14 consecutive days within 90 days prior to informed consent; Topical, inhaled and intranasal corticosteroids are permitted. Intermittent use (one dose in 30 days) of intra-articular corticosteroids are also permitted;\n   3. Administration of antineoplastic and immunomodulating agents or radiotherapy within 90 days prior to informed consent.\n8. Receipt of immunoglobulins or any blood products within 180 days prior to informed consent.\n9. Receipt of any investigational or non-registered product (drug or vaccine) other than the study vaccine within 30 days preceding the study vaccination, or planned use during the entire study period.\n10. Acute (severe) febrile illness.\n11. Any other clinical condition that, in the opinion of the investigator, might interfere with the results of the study or pose additional risk to the subject due to participation in the study.\n12. Study personnel or immediate family members (brother, sister, child, parent) or the spouse of study personnel.",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "65 Years",
                    "stdAges": [
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Clinical Program Director",
                            "affiliation": "Seqirus",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "05602-Universitair Ziekenhuis Gent",
                            "city": "Gent",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 51.05,
                                "lon": 3.71667
                            }
                        },
                        {
                            "facility": "05603-ResearchLink",
                            "city": "Linkebeek",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.76781,
                                "lon": 4.33688
                            }
                        },
                        {
                            "facility": "10005-MHAT Dr. Tota Venkova",
                            "city": "Gabrovo",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.87472,
                                "lon": 25.33417
                            }
                        },
                        {
                            "facility": "10018-Medical Center - Zdrave-1",
                            "city": "Kozloduy",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.77867,
                                "lon": 23.72067
                            }
                        },
                        {
                            "facility": "10029-Medical Centre Leo Clinic EOOD",
                            "city": "Lovech",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.13333,
                                "lon": 24.71667
                            }
                        },
                        {
                            "facility": "10007-Medical Center Hera EOOD",
                            "city": "Montana",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.4125,
                                "lon": 23.225
                            }
                        },
                        {
                            "facility": "10014-Multi-Profile Hospital For Active Treatment Dr. Stamen Iliev AD",
                            "city": "Montana",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.4125,
                                "lon": 23.225
                            }
                        },
                        {
                            "facility": "10019-MC Med Consult Pleven",
                            "city": "Pleven",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.41667,
                                "lon": 24.61667
                            }
                        },
                        {
                            "facility": "10022-Ambulatory Outpatient Medical Practice for First Patient Care Zaprin Pepelov",
                            "city": "Plovdiv",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.15,
                                "lon": 24.75
                            }
                        },
                        {
                            "facility": "10026-Multiprofile Hospital for Active Treatment Sv. Panteleymon - Plovdiv",
                            "city": "Plovdiv",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.15,
                                "lon": 24.75
                            }
                        },
                        {
                            "facility": "10004-Medical Center Prolet EOOD",
                            "city": "Ruse",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.85639,
                                "lon": 25.97083
                            }
                        },
                        {
                            "facility": "10012-Specialized Hospital For Active Treatment Of Pneumo-Phthisiatric Diseases Dr. Dimitar Gramatikov-Ruse EOOD",
                            "city": "Ruse",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.85639,
                                "lon": 25.97083
                            }
                        },
                        {
                            "facility": "10016-Diagnostic Consultative Center - 1 - Sevlievo EOOD",
                            "city": "Sevlievo",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 43.02583,
                                "lon": 25.11361
                            }
                        },
                        {
                            "facility": "10023-DCC-1 Sliven",
                            "city": "Sliven",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.68583,
                                "lon": 26.32917
                            }
                        },
                        {
                            "facility": "10006-DCC 22 - Sofia",
                            "city": "Sofia",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "facility": "10015-Medical Center Hera - Pulmonology Office",
                            "city": "Sofia",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "facility": "10021-Medical Center Intermedica",
                            "city": "Sofia",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "facility": "10028-Medical Center Excelsior OOD",
                            "city": "Sofia",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "facility": "10027-AIPPMP D-r Zhaneta Demireva",
                            "city": "Stamboliyski",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.13333,
                                "lon": 24.53333
                            }
                        },
                        {
                            "facility": "20307-CCR Brno s.r.o.",
                            "city": "Brno",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 49.19522,
                                "lon": 16.60796
                            }
                        },
                        {
                            "facility": "20310-MUDr. Jakub Strincl, s.r.o.",
                            "city": "Liberec",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 50.76711,
                                "lon": 15.05619
                            }
                        },
                        {
                            "facility": "20309-CCR Ostrava, s.r.o.",
                            "city": "Ostrava",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 49.83465,
                                "lon": 18.28204
                            }
                        },
                        {
                            "facility": "20308-Zdravi - fit, s.r.o.",
                            "city": "Protiv\u00edn",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 49.19949,
                                "lon": 14.21717
                            }
                        },
                        {
                            "facility": "20305-Prof. MUDr. Jiri Beran, s.r.o.",
                            "city": "\u010cesk\u00e9 Bud\u011bjovice",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 48.97447,
                                "lon": 14.47434
                            }
                        },
                        {
                            "facility": "20306-ADMED, s.r.o.",
                            "city": "\u010cesk\u00e9 Bud\u011bjovice",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 48.97447,
                                "lon": 14.47434
                            }
                        },
                        {
                            "facility": "24602-Oulu Vaccine Research Clinic",
                            "city": "Oulu",
                            "country": "Finland",
                            "geoPoint": {
                                "lat": 65.01236,
                                "lon": 25.46816
                            }
                        },
                        {
                            "facility": "24601-Tampere Vaccine Research Clinic",
                            "city": "Tampere",
                            "country": "Finland",
                            "geoPoint": {
                                "lat": 61.49911,
                                "lon": 23.78712
                            }
                        },
                        {
                            "facility": "24604-Turku Vaccine Research Clinic",
                            "city": "Turku",
                            "country": "Finland",
                            "geoPoint": {
                                "lat": 60.45148,
                                "lon": 22.26869
                            }
                        },
                        {
                            "facility": "26803-JSC Evex Hospitals",
                            "city": "Batumi",
                            "country": "Georgia",
                            "geoPoint": {
                                "lat": 41.64228,
                                "lon": 41.63392
                            }
                        },
                        {
                            "facility": "26801-LTD Hospital Service",
                            "city": "Kutaisi",
                            "country": "Georgia",
                            "geoPoint": {
                                "lat": 42.26791,
                                "lon": 42.69459
                            }
                        },
                        {
                            "facility": "26802-Acad. G. Chapidze Emergency Cardiology Center",
                            "city": "Tbilisi",
                            "country": "Georgia",
                            "geoPoint": {
                                "lat": 41.69411,
                                "lon": 44.83368
                            }
                        },
                        {
                            "facility": "26804-K. Eristavi National Center of Clinical Surgery",
                            "city": "Tbilisi",
                            "country": "Georgia",
                            "geoPoint": {
                                "lat": 41.69411,
                                "lon": 44.83368
                            }
                        },
                        {
                            "facility": "38003-University Hospital Consorziale Policlinico",
                            "city": "Bari",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.11148,
                                "lon": 16.8554
                            }
                        },
                        {
                            "facility": "38001-PO A. Manzoni di Lecco, ASST Lecco",
                            "city": "Lecco",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.85589,
                                "lon": 9.39704
                            }
                        },
                        {
                            "facility": "38004-Ospedale Fatebenefratelli e Oftalmico, ASST Fatebenefratelli Sacco",
                            "city": "Milano",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.46427,
                                "lon": 9.18951
                            }
                        },
                        {
                            "facility": "41002-Korea University Ansan Hospital",
                            "city": "Ansan",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.32361,
                                "lon": 126.82194
                            }
                        },
                        {
                            "facility": "41001-Inha University Hospital",
                            "city": "Incheon",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.45646,
                                "lon": 126.70515
                            }
                        },
                        {
                            "facility": "41004-Hallym University Kangnam Sacred Heart Hospital",
                            "city": "Seoul",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "41003-Ajou University Hospital",
                            "city": "Suwon",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.29111,
                                "lon": 127.00889
                            }
                        },
                        {
                            "facility": "44004-UAB InMedica",
                            "city": "Kaunas",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.90272,
                                "lon": 23.90961
                            }
                        },
                        {
                            "facility": "44008-JSC Saul\u0117s \u0160eimos Medicinos Centras",
                            "city": "Kaunas",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.90272,
                                "lon": 23.90961
                            }
                        },
                        {
                            "facility": "44009-Hospital of Lithuanian University of Health Sciences Kauno klinikos",
                            "city": "Kaunas",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.90272,
                                "lon": 23.90961
                            }
                        },
                        {
                            "facility": "44010-InlitaJSC Santara CTC",
                            "city": "Vilnius",
                            "country": "Lithuania",
                            "geoPoint": {
                                "lat": 54.68916,
                                "lon": 25.2798
                            }
                        },
                        {
                            "facility": "52802-Emotional Brain BV",
                            "city": "Almere",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.37535,
                                "lon": 5.25295
                            }
                        },
                        {
                            "facility": "60812-Health Index Multispecialty and Lying-In Clinic",
                            "city": "Bacoor",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.45903,
                                "lon": 120.92903
                            }
                        },
                        {
                            "facility": "60804-St. Michael Family Hospital",
                            "city": "Bulacan",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.79278,
                                "lon": 120.87889
                            }
                        },
                        {
                            "facility": "60813-Norzel Medical and Diagnostic Clinic",
                            "city": "Cebu",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 10.31672,
                                "lon": 123.89071
                            }
                        },
                        {
                            "facility": "60808-CT CARE Group",
                            "city": "Dasmari\u00f1as",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.32944,
                                "lon": 120.93667
                            }
                        },
                        {
                            "facility": "60801-Davao Doctors Hospital",
                            "city": "Davao City",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 7.07306,
                                "lon": 125.61278
                            }
                        },
                        {
                            "facility": "60802-West Visayas State University Medical Center",
                            "city": "Iloilo City",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 10.69694,
                                "lon": 122.56444
                            }
                        },
                        {
                            "facility": "60815-St Paul's Hospital Iloilo",
                            "city": "Iloilo City",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 10.69694,
                                "lon": 122.56444
                            }
                        },
                        {
                            "facility": "60816-St Paul's Hospital Iloilo",
                            "city": "Iloilo City",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 10.69694,
                                "lon": 122.56444
                            }
                        },
                        {
                            "facility": "60803-Philippine General Hospital",
                            "city": "Manila",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.6042,
                                "lon": 120.9822
                            }
                        },
                        {
                            "facility": "60811-Philippine General Hospital",
                            "city": "Manila",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.6042,
                                "lon": 120.9822
                            }
                        },
                        {
                            "facility": "60814-Manila Doctors Hospital",
                            "city": "Manila",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.6042,
                                "lon": 120.9822
                            }
                        },
                        {
                            "facility": "60805-San Juan de Dios Hospital",
                            "city": "Pasay",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.53748,
                                "lon": 121.00144
                            }
                        },
                        {
                            "facility": "60806-Quirino Memorial Medical Center",
                            "city": "Quezon City",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.6488,
                                "lon": 121.0509
                            }
                        },
                        {
                            "facility": "60817-Silang Specialist Medical Center",
                            "city": "Silang",
                            "country": "Philippines",
                            "geoPoint": {
                                "lat": 14.21567,
                                "lon": 120.97137
                            }
                        },
                        {
                            "facility": "61605-RCMed Oddzial Sochaczew",
                            "city": "Sochaczew",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.22944,
                                "lon": 20.23838
                            }
                        },
                        {
                            "facility": "61614-KO-MED Centra Kliniczne Staszow",
                            "city": "Stasz\u00f3w",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 50.56307,
                                "lon": 21.16593
                            }
                        },
                        {
                            "facility": "61615-ETG Warszawa",
                            "city": "Warsaw",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.22977,
                                "lon": 21.01178
                            }
                        },
                        {
                            "facility": "61616-FutureMeds Targowek",
                            "city": "Warsaw",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.22977,
                                "lon": 21.01178
                            }
                        },
                        {
                            "facility": "61617-FutureMeds Sp. z o.o.",
                            "city": "Wroc\u0142aw",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 51.1,
                                "lon": 17.03333
                            }
                        },
                        {
                            "facility": "61618-FutureMeds Lodz",
                            "city": "\u0141\u00f3d\u017a",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 51.75,
                                "lon": 19.46667
                            }
                        },
                        {
                            "facility": "64210-Sana Monitoring",
                            "city": "Bucuresti",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.42802,
                                "lon": 26.09665
                            }
                        },
                        {
                            "facility": "64204-Ames Research Center",
                            "city": "C\u0103l\u0103ra\u015fi",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.2051,
                                "lon": 27.31356
                            }
                        },
                        {
                            "facility": "64209-Clintrial Medical Center",
                            "city": "Re\u0219ca",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.17265,
                                "lon": 24.39243
                            }
                        },
                        {
                            "facility": "64211-Nova-Clin Medical Research Center",
                            "city": "Timi\u015foara",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 45.75372,
                                "lon": 21.22571
                            }
                        },
                        {
                            "facility": "71007-Josha Research Center",
                            "city": "Bloemfontein",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -29.12107,
                                "lon": 26.214
                            }
                        },
                        {
                            "facility": "71011-University of Cape Town Lung Institute",
                            "city": "Cape Town",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -33.92584,
                                "lon": 18.42322
                            }
                        },
                        {
                            "facility": "71014-TREAD Research",
                            "city": "Cape Town",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -33.92584,
                                "lon": 18.42322
                            }
                        },
                        {
                            "facility": "71015-Tiervlei Trial Centre",
                            "city": "Cape Town",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -33.92584,
                                "lon": 18.42322
                            }
                        },
                        {
                            "facility": "71001-Ubuntuclinical Research (Krugersdorp)",
                            "city": "Krugersdorp",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -26.08577,
                                "lon": 27.77515
                            }
                        },
                        {
                            "facility": "71005-Be Part Research",
                            "city": "Paarl",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -33.73378,
                                "lon": 18.97523
                            }
                        },
                        {
                            "facility": "71003-Limpopo Clinical Research Initiative",
                            "city": "Thabazimbi",
                            "country": "South Africa",
                            "geoPoint": {
                                "lat": -24.59165,
                                "lon": 27.41155
                            }
                        },
                        {
                            "facility": "72402-EAP Vic - CAP El Remei",
                            "city": "Barcelona",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.38879,
                                "lon": 2.15899
                            }
                        },
                        {
                            "facility": "72404-Hospital Universitario Son Espases",
                            "city": "Palma de Mallorca",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.56939,
                                "lon": 2.65024
                            }
                        },
                        {
                            "facility": "72401-Hospital Povisa",
                            "city": "Vigo",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 42.23282,
                                "lon": -8.72264
                            }
                        },
                        {
                            "facility": "15803-Taipei Medical University - Shuang Ho Hospital",
                            "city": "New Taipei City",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.01111,
                                "lon": 121.44583
                            }
                        },
                        {
                            "facility": "15801-China Medical University Hospital",
                            "city": "Taichung",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 24.1469,
                                "lon": 120.6839
                            }
                        },
                        {
                            "facility": "15802-National Cheng Kung University Hospital",
                            "city": "Tainan",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 22.99083,
                                "lon": 120.21333
                            }
                        },
                        {
                            "facility": "15804-Taipei Medical University - Wanfang Hospital",
                            "city": "Taipei",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "facility": "15805-Taipei Medical University - Taipei Medical University Hospital",
                            "city": "Taipei",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "facility": "79209-Hacettepe University Faculty of Medicine",
                            "city": "Ankara",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 39.91987,
                                "lon": 32.85427
                            }
                        },
                        {
                            "facility": "79207-Akdeniz University Faculty of Medicine",
                            "city": "Antalya",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 36.90812,
                                "lon": 30.69556
                            }
                        },
                        {
                            "facility": "79212-Dicle Universitesi Tip Fakultesi",
                            "city": "Diyarbak\u0131r",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 37.91363,
                                "lon": 40.21721
                            }
                        },
                        {
                            "facility": "79205-Goztepe Suleyman Yalcin City Hospital",
                            "city": "Istanbul",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 41.01384,
                                "lon": 28.94966
                            }
                        },
                        {
                            "facility": "79204 - Kocaeli University Faculty of Medicine",
                            "city": "Kocaeli",
                            "zip": "41380",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 39.62497,
                                "lon": 27.51145
                            }
                        },
                        {
                            "facility": "79211-Karadeniz Technical University Faculty of Medicine",
                            "city": "Trabzon",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 41.005,
                                "lon": 39.72694
                            }
                        },
                        {
                            "facility": "71601-Charles River Medical Group, Mutala Trust and Infectious Disease Research Laboratory",
                            "city": "Harare",
                            "country": "Zimbabwe",
                            "geoPoint": {
                                "lat": -17.82772,
                                "lon": 31.05337
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "YES",
                    "description": "Seqirus will consider on a case-by-case basis requests to share Individual Patient Data (IPD) with external bona-fide, qualified scientific and medical researchers. For information on the process and requirements for submitting a voluntary data sharing request for IPD, please contact Seqirus at seqirus.clinicaltrials@seqirus.com.",
                    "infoTypes": [
                        "STUDY_PROTOCOL",
                        "SAP"
                    ],
                    "timeFrame": "Requests for IPD will generally be considered once review by major regulatory authorities (ie FDA, EMA) is complete and the primary publication is available.",
                    "accessCriteria": "Proposed research should seek to answer a previously unanswered important medical or scientific question.\n\nApplicable country specific privacy and other laws and regulations will be considered and may prevent sharing of IPD.\n\nIf the request is approved and the researcher has executed an appropriate data sharing agreement, IPD that has been appropriately anonymized will be available."
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D007251",
                            "term": "Influenza, Human"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D012141",
                            "term": "Respiratory Tract Infections"
                        },
                        {
                            "id": "D007239",
                            "term": "Infections"
                        },
                        {
                            "id": "D009976",
                            "term": "Orthomyxoviridae Infections"
                        },
                        {
                            "id": "D012327",
                            "term": "RNA Virus Infections"
                        },
                        {
                            "id": "D014777",
                            "term": "Virus Diseases"
                        },
                        {
                            "id": "D012140",
                            "term": "Respiratory Tract Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M10295",
                            "name": "Influenza, Human",
                            "asFound": "Influenza",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10283",
                            "name": "Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6368",
                            "name": "Communicable Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14978",
                            "name": "Respiratory Tract Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12902",
                            "name": "Orthomyxoviridae Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17522",
                            "name": "Virus Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15149",
                            "name": "RNA Virus Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14977",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC01",
                            "name": "Infections"
                        },
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M17360",
                            "name": "Vaccines",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M35911",
                            "name": "MF59 oil emulsion",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9476",
                            "name": "Hemagglutinins",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Coag",
                            "name": "Coagulants"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05488067",
                    "orgStudyIdInfo": {
                        "id": "ATO-ALGS-XAN"
                    },
                    "organization": {
                        "fullName": "Children's Hospital of Fudan University",
                        "class": "OTHER"
                    },
                    "briefTitle": "Atorvastatin Therapy on Xanthoma in Alagille Syndrome",
                    "officialTitle": "The Safety and Efficacy of Atorvastatin on Xanthoma in Alagille Syndrome"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2022-03-22",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2025-03-22",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2025-03-22",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2022-08-01",
                    "studyFirstSubmitQcDate": "2022-08-03",
                    "studyFirstPostDateStruct": {
                        "date": "2022-08-04",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Children's Hospital of Fudan University",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "To observe the efficacy and safety of atorvastatin on xanthoma in Alagille syndrome through a prospective study.",
                    "detailedDescription": "Alagille syndrome (ALGS, OMIM 118450) is an important cause of chronic cholestasis in children, and the incidence rate is about 1:30000\\~1:50000. Most patients with ALGS have hypercholesterolemia. In severe cases, multiple xanthomas can be seen, and some patients are accompanied by severe itching and pain. Disfigured xanthomas affect the normal social interaction of patients, thereby causing physical and mental damage to children. At present, xanthoma caused by hypercholesterolemia can be cured by treating the primary disease, taking lipid-lowering drugs (such as bile acid chelators, ezetimibe, statins, etc.), or lipoprotein apheresis. If it affects the beauty or function, local treatment such as 33% trichloroacetic acid dot coating, carbon dioxide laser, liquid nitrogen freezing or surgical resection is feasible, and even surgical operation( such as portal vena cava anastomosis, liver transplantation). Compared with expensive lipoprotein apheresis and other invasive therapies, taking lipid-lowering drug has the advantages of higher acceptance, lower cost and higher safety. However, at present, there are no guidelines for application of oral lipid-lowering drugs in children under 6 years old with hypercholesterolemia. Therefore, the purpose of this study is to clarify the safety and efficacy of atorvastatin on xanthoma in ALGS , so as to provide reference for the treatment of ALGS patients' xanthomas.\n\nRisk prevention and treatment: The patients began to take atorvastatin from a small dose, followed up closely in the early stage (2-4 weeks) to see if the patients had obvious discomfort such as myalgia, and monitored the changes of Biochemistry (CK, ALT, AST, etc.). If moderate or more serious adverse reactions occurred during the trial or the following laboratory abnormalities occurred (CK exceeded 10 times the upper limit of normal; ALT or AST had been continued to rise, exceeding 2 times the baseline value), atorvastatin was temporarily stopped, and patients should be rechecked within 2 weeks. It is necessary to reevaluate and decide whether to restart atorvastatin treatment."
                },
                "conditionsModule": {
                    "conditions": [
                        "Alagille Syndrome",
                        "Atorvastatin",
                        "Xanthoma"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE4"
                    ],
                    "designInfo": {
                        "allocation": "NA",
                        "interventionModel": "SINGLE_GROUP",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 10,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Atorvastatin+ALGS-Xanthoma",
                            "type": "EXPERIMENTAL",
                            "description": "Drug: atorvastatin Dosage form: tablet Route of administration: oral Duration: 6 months \uff08After 6 months of medication, according to the actual situation of the patient, choose to maintain the original dosage, gradually reduce the dosage or stop the medication\uff09\n\nAdministration method:\n\nInitial dose: \u2460 \\< 1 year old: 1.25mg/d, qd; \u2461 1-5 years old: 2.5mg/d, qd; \u2462 6-9 years old: 5mg/d, qd; \u2463 \u2265 10 years old: 10mg/d, qd. The maximum dose is 40mg/d and not more than 1mg/kg/d. During the follow-up, the medication was adjusted according to the laboratory results until non-HDL-C\u22644.2mmol/L\uff08162 mg/dL\uff09, xanthoma disappear, or the patient had moderate or more serious adverse reactions.",
                            "interventionNames": [
                                "Drug: atorvastatin"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "atorvastatin",
                            "description": "Oral atorvastatin treatment for ALGS children with xanthoma",
                            "armGroupLabels": [
                                "Atorvastatin+ALGS-Xanthoma"
                            ],
                            "otherNames": [
                                "Lipitor"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Grade change of xanthoma",
                            "description": "The grade change of xanthoma would be assessed at the 3th/6th month after enrollment \u3010Explanation\uff1aXanthomas were graded as 0 = none, 1 = minimal, 2 =moderate, 3 = disfiguring, and 4 = disabling. Minimal xanthomas signified fewer than 20 scattered individual lesions, moderate represented more than 20 lesions that did not interfere with or limit activities, disfiguring represented large numbers of lesions that by their large numbers or size caused distortion of the face or xtremities, and disabling signified that the xanthomas interfered with function (such as hand use or ability to walk) because of excess size or number.\u3011",
                            "timeFrame": "from enrollment to the 3th/6th month"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "non-HDL-C change",
                            "description": "The non-HDL-C change would be measured at the 3th/6th month after enrollment \u3010Explanation: non-HDL-C is defined as the difference between total cholesterol and HDL-C\u3011",
                            "timeFrame": "from enrollment to the 3th/6th month"
                        },
                        {
                            "measure": "Incidence of adverse events",
                            "description": "It is a binary variable. Incidence Rates for adverse event\uff08including\uff1arhabdomyolysis and myopathy\uff0cliver enzymes exceeded twice the baseline value\uff0cnasopharyngitis, muscle pain\uff0cdiarrhea\uff0cnausea, fever\uff0curinary tract infection, joint swelling\uff0cepistaxis\uff0curticaria\uff0cetc.\uff09would be calculated.",
                            "timeFrame": "from enrollment to the 3th/6th month"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Meet the ALGS diagnostic criteria;\n* Xanthoma of skin;\n* Before treatment with atorvastatin,non-HDL-C\u22655.76mmol/L\uff08223 mg/dL\uff09;\n* Informed consent;\n* Age 0-17 years old, male or female;\n* Taking bile acid chelator (colenemide) has no obvious effect or intolerance.\n\nExclusion Criteria:\n\n* Liver transplantation has been performed;\n* In the recovery period of cholestasis, xanthoma is obviously subsiding;\n* Patients with serious systemic diseases and unstable vital signs;\n* Progressive active liver injury, such as continuous increase of transaminase;\n* Serious myopathy;\n* Known to be allergic to any component of atorvastatin;\n* The weight is less than 5kg.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "1 Day",
                    "maximumAge": "17 Years",
                    "stdAges": [
                        "CHILD"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Jianshe Wang, doctor",
                            "role": "CONTACT",
                            "phone": "18017590987",
                            "email": "jshwang@shmu.edu.cn"
                        },
                        {
                            "name": "Yiqiong Zhang, master",
                            "role": "CONTACT",
                            "phone": "13199536035",
                            "email": "21111240032@m.fudan.edu.cn"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Children's Hospital of Fudan University",
                            "status": "RECRUITING",
                            "city": "Shanghai",
                            "state": "Shanghai",
                            "zip": "201102",
                            "country": "China",
                            "contacts": [
                                {
                                    "name": "Jianshe Wang, doctor",
                                    "role": "CONTACT",
                                    "phone": "86-21-64931171",
                                    "email": "jshwang@shmu.edu.cn"
                                }
                            ],
                            "geoPoint": {
                                "lat": 31.22222,
                                "lon": 121.45806
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "31343788",
                            "type": "BACKGROUND",
                            "citation": "Gilbert MA, Bauer RC, Rajagopalan R, Grochowski CM, Chao G, McEldrew D, Nassur JA, Rand EB, Krock BL, Kamath BM, Krantz ID, Piccoli DA, Loomes KM, Spinner NB. Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification. Hum Mutat. 2019 Dec;40(12):2197-2220. doi: 10.1002/humu.23879. Epub 2019 Aug 26."
                        },
                        {
                            "pmid": "28492167",
                            "type": "BACKGROUND",
                            "citation": "Ben Ameur S, Chabchoub I, Telmoudi J, Belfitouri Y, Rebah O, Lacaille F, Aloulou H, Mehrzi A, Hachicha M. Management of cholestatic pruritus in children with Alagille syndrome: Case report and literature review. Arch Pediatr. 2016 Dec;23(12):1247-1250. doi: 10.1016/j.arcped.2016.09.004. Epub 2016 Oct 27."
                        },
                        {
                            "pmid": "32636080",
                            "type": "BACKGROUND",
                            "citation": "Martinsen MH, Klausen IC, Tybjaerg-Hansen A, Hedegaard BS. Autosomal recessive hypercholesterolemia in a kindred of Syrian ancestry. J Clin Lipidol. 2020 Jul-Aug;14(4):419-424. doi: 10.1016/j.jacl.2020.06.002. Epub 2020 Jun 8."
                        },
                        {
                            "pmid": "25907359",
                            "type": "BACKGROUND",
                            "citation": "Lin M, Dai H, Zhao S. Long-term atorvastatin-ezetimibe-probucol triple therapy for homozygous familial hypercholesterolaemia from early childhood. Cardiol Young. 2016 Jan;26(1):197-201. doi: 10.1017/S1047951115000591. Epub 2015 Apr 24."
                        },
                        {
                            "pmid": "32800790",
                            "type": "BACKGROUND",
                            "citation": "Sreedharan AV, Pek SLT, Tan TH, Tavintharan S, Yap F. Successful pharmacological management of a child with compound heterozygous familial hypercholesterolemia and review of the recent literature. J Clin Lipidol. 2020 Sep-Oct;14(5):639-645. doi: 10.1016/j.jacl.2020.07.006. Epub 2020 Jul 15."
                        },
                        {
                            "pmid": "32199148",
                            "type": "BACKGROUND",
                            "citation": "Luirink IK, Hutten BA, Greber-Platzer S, Kolovou GD, Dann EJ, de Ferranti SD, Taylan C, Bruckert E, Saheb S, Oh J, Driemeyer J, Farnier M, Pape L, Schmitt CP, Novoa FJ, Maeser M, Masana L, Shahrani A, Wiegman A, Groothoff JW. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry. Atherosclerosis. 2020 Apr;299:24-31. doi: 10.1016/j.atherosclerosis.2020.01.031. Epub 2020 Feb 18."
                        },
                        {
                            "pmid": "830579",
                            "type": "BACKGROUND",
                            "citation": "Shurberg JL, Resnick RH, Koff RS, Ros E, Baum RA, Pallotta JA. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis. Gastroenterology. 1977 Feb;72(2):301-4."
                        },
                        {
                            "pmid": "19765481",
                            "type": "BACKGROUND",
                            "citation": "Kakaei F, Nikeghbalian S, Kazemi K, Salahi H, Bahador A, Dehghani SM, Dehghani M, Nejatollahi SM, Shamsaeefar A, Khosravi MB, Malek-Hosseini SA. Liver transplantation for homozygous familial hypercholesterolemia: two case reports. Transplant Proc. 2009 Sep;41(7):2939-41. doi: 10.1016/j.transproceed.2009.07.028."
                        },
                        {
                            "pmid": "12499996",
                            "type": "BACKGROUND",
                            "citation": "Larrosa-Haro A, Saenz-Rivera C, Gonzalez-Ortiz M, Coello-Ramirez P, Vazquez-Camacho G. Lack of cholesterol-lowering effect of graded doses of cholestyramine in children with Alagille syndrome: a pilot study. J Pediatr Gastroenterol Nutr. 2003 Jan;36(1):50-3. doi: 10.1097/00005176-200301000-00011."
                        },
                        {
                            "pmid": "22813814",
                            "type": "BACKGROUND",
                            "citation": "Sheflin-Findling S, Arnon R, Lee S, Chu J, Henderling F, Kerkar N, Iyer K. Partial internal biliary diversion for Alagille syndrome: case report and review of the literature. J Pediatr Surg. 2012 Jul;47(7):1453-6. doi: 10.1016/j.jpedsurg.2012.04.008."
                        },
                        {
                            "pmid": "11242624",
                            "type": "BACKGROUND",
                            "citation": "Quek SC, Aw M, Quak SH, Prabhakaran K, Tan KC. Liver transplantation in a child with severe hypercholesterolaemia in Alagille syndrome. Ann Acad Med Singap. 2001 Jan;30(1):44-7."
                        },
                        {
                            "pmid": "35155971",
                            "type": "BACKGROUND",
                            "citation": "Nakajima H, Tsuma Y, Fukuhara S, Kodo K. A Case of Infantile Alagille Syndrome With Severe Dyslipidemia: New Insight into Lipid Metabolism and Therapeutics. J Endocr Soc. 2022 Jan 18;6(3):bvac005. doi: 10.1210/jendso/bvac005. eCollection 2022 Mar 1."
                        },
                        {
                            "pmid": "18394386",
                            "type": "BACKGROUND",
                            "citation": "Tapia Ceballos L, Picazo Angelin B, Ruiz Garcia C. [Use of statins in children]. An Pediatr (Barc). 2008 Apr;68(4):385-92. doi: 10.1157/13117712. Spanish."
                        },
                        {
                            "pmid": "27749649",
                            "type": "BACKGROUND",
                            "citation": "Melvin AJ, Montepiedra G, Aaron L, Meyer WA 3rd, Spiegel HM, Borkowsky W, Abzug MJ, Best BM, Crain MJ, Borum PR, Graham B, Anthony P, Shin K, Siberry GK; P1063 Study Team. Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia. Pediatr Infect Dis J. 2017 Jan;36(1):53-60. doi: 10.1097/INF.0000000000001352."
                        },
                        {
                            "pmid": "30091061",
                            "type": "BACKGROUND",
                            "citation": "Hari P, Khandelwal P, Satpathy A, Hari S, Thergaonkar R, Lakshmy R, Sinha A, Bagga A. Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial. Pediatr Nephrol. 2018 Dec;33(12):2299-2309. doi: 10.1007/s00467-018-4036-x. Epub 2018 Aug 8."
                        },
                        {
                            "pmid": "27678432",
                            "type": "BACKGROUND",
                            "citation": "Langslet G, Breazna A, Drogari E. A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia. J Clin Lipidol. 2016 Sep-Oct;10(5):1153-1162.e3. doi: 10.1016/j.jacl.2016.05.010. Epub 2016 Jun 7."
                        },
                        {
                            "pmid": "21259004",
                            "type": "BACKGROUND",
                            "citation": "Gandelman K, Glue P, Laskey R, Jones J, LaBadie R, Ose L. An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia. Pediatr Cardiol. 2011 Apr;32(4):433-41. doi: 10.1007/s00246-011-9885-z. Epub 2011 Jan 23."
                        },
                        {
                            "pmid": "27718491",
                            "type": "BACKGROUND",
                            "citation": "Araujo MB, Pacce MS. A 10-year experience using combined lipid-lowering pharmacotherapy in children and adolescents. J Pediatr Endocrinol Metab. 2016 Nov 1;29(11):1285-1291. doi: 10.1515/jpem-2016-0117."
                        },
                        {
                            "pmid": "23864222",
                            "type": "BACKGROUND",
                            "citation": "Niedra E, Chahal N, Manlhiot C, Yeung RS, McCrindle BW. Atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms. Pediatr Cardiol. 2014 Jan;35(1):89-92. doi: 10.1007/s00246-013-0746-9. Epub 2013 Jul 18."
                        },
                        {
                            "pmid": "31561960",
                            "type": "BACKGROUND",
                            "citation": "Tremoulet AH, Jain S, Jone PN, Best BM, Duxbury EH, Franco A, Printz B, Dominguez SR, Heizer H, Anderson MS, Glode MP, He F, Padilla RL, Shimizu C, Bainto E, Pancheri J, Cohen HJ, Whitin JC, Burns JC. Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm. J Pediatr. 2019 Dec;215:107-117.e12. doi: 10.1016/j.jpeds.2019.07.064. Epub 2019 Sep 24."
                        },
                        {
                            "pmid": "31069819",
                            "type": "BACKGROUND",
                            "citation": "Huang J, Li L, Zhang J, Gao C, Quan W, Tian Y, Sun J, Tian Q, Wang D, Dong J, Zhang J, Jiang R. Treatment of Relapsed Chronic Subdural Hematoma in Four Young Children with Atorvastatin and Low-dose Dexamethasone. Pharmacotherapy. 2019 Jul;39(7):783-789. doi: 10.1002/phar.2276. Epub 2019 May 28."
                        },
                        {
                            "pmid": "30595326",
                            "type": "BACKGROUND",
                            "citation": "Agrawal D, Manchanda SC, Sawhney JPS, Kandpal B, Jain R, Mehta A, Mohanty A, Passey R, Makhija A, Sharma MK. To study the effect of high dose Atorvastatin 40mg versus 80mg in patients with dyslipidemia. Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S8-S12. doi: 10.1016/j.ihj.2018.01.034. Epub 2018 Jan 31."
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D016738",
                            "term": "Alagille Syndrome"
                        },
                        {
                            "id": "D014973",
                            "term": "Xanthomatosis"
                        },
                        {
                            "id": "D013577",
                            "term": "Syndrome"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D004194",
                            "term": "Disease"
                        },
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        },
                        {
                            "id": "D002780",
                            "term": "Cholestasis, Intrahepatic"
                        },
                        {
                            "id": "D002779",
                            "term": "Cholestasis"
                        },
                        {
                            "id": "D001649",
                            "term": "Bile Duct Diseases"
                        },
                        {
                            "id": "D001660",
                            "term": "Biliary Tract Diseases"
                        },
                        {
                            "id": "D004066",
                            "term": "Digestive System Diseases"
                        },
                        {
                            "id": "D008107",
                            "term": "Liver Diseases"
                        },
                        {
                            "id": "D006330",
                            "term": "Heart Defects, Congenital"
                        },
                        {
                            "id": "D018376",
                            "term": "Cardiovascular Abnormalities"
                        },
                        {
                            "id": "D002318",
                            "term": "Cardiovascular Diseases"
                        },
                        {
                            "id": "D000015",
                            "term": "Abnormalities, Multiple"
                        },
                        {
                            "id": "D000013",
                            "term": "Congenital Abnormalities"
                        },
                        {
                            "id": "D030342",
                            "term": "Genetic Diseases, Inborn"
                        },
                        {
                            "id": "D052439",
                            "term": "Lipid Metabolism Disorders"
                        },
                        {
                            "id": "D008659",
                            "term": "Metabolic Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M16355",
                            "name": "Syndrome",
                            "asFound": "Syndrome",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M17710",
                            "name": "Xanthomatosis",
                            "asFound": "Xanthoma",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M19099",
                            "name": "Alagille Syndrome",
                            "asFound": "Alagille Syndrome",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6019",
                            "name": "Cholestasis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6020",
                            "name": "Cholestasis, Intrahepatic",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4935",
                            "name": "Bile Duct Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4946",
                            "name": "Biliary Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8883",
                            "name": "Gastrointestinal Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7255",
                            "name": "Digestive System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11107",
                            "name": "Liver Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9418",
                            "name": "Heart Defects, Congenital",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12",
                            "name": "Congenital Abnormalities",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20503",
                            "name": "Cardiovascular Abnormalities",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14",
                            "name": "Abnormalities, Multiple",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M23686",
                            "name": "Genetic Diseases, Inborn",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11639",
                            "name": "Metabolic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M27029",
                            "name": "Lipid Metabolism Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T260",
                            "name": "Alagille Syndrome",
                            "asFound": "Alagille Syndrome",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "BC06",
                            "name": "Digestive System Diseases"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        },
                        {
                            "abbrev": "BC16",
                            "name": "Diseases and Abnormalities at or Before Birth"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000069059",
                            "term": "Atorvastatin"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000924",
                            "term": "Anticholesteremic Agents"
                        },
                        {
                            "id": "D000960",
                            "term": "Hypolipidemic Agents"
                        },
                        {
                            "id": "D000963",
                            "term": "Antimetabolites"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D057847",
                            "term": "Lipid Regulating Agents"
                        },
                        {
                            "id": "D019161",
                            "term": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
                        },
                        {
                            "id": "D004791",
                            "term": "Enzyme Inhibitors"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M4854",
                            "name": "Benzocaine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M351",
                            "name": "Atorvastatin",
                            "asFound": "/mL",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4243",
                            "name": "Anticholesteremic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4278",
                            "name": "Hypolipidemic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4281",
                            "name": "Antimetabolites",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M28883",
                            "name": "Lipid Regulating Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21155",
                            "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7951",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T433",
                            "name": "Tannic Acid",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "CNSDep",
                            "name": "Central Nervous System Depressants"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Lipd",
                            "name": "Lipid Regulating Agents"
                        },
                        {
                            "abbrev": "Ot",
                            "name": "Other Dietary Supplements"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06650501",
                    "orgStudyIdInfo": {
                        "id": "2025-10900"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "500464",
                            "type": "OTHER_GRANT",
                            "domain": "Canadian Institutes of Health Research"
                        }
                    ],
                    "organization": {
                        "fullName": "McGill University Health Centre/Research Institute of the McGill University Health Centre",
                        "class": "OTHER"
                    },
                    "briefTitle": "Dabigatran for the Adjunctive Treatment of Staphylococcus Aureus Bacteremia",
                    "officialTitle": "Dabigatran for the Adjunctive Treatment of Staphylococcus Aureus Bacteremia: the DABI-SNAP Nested Randomized Controlled Trial",
                    "acronym": "DABI-SNAP"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "NOT_YET_RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2025-01-07",
                        "type": "ESTIMATED"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2029-01",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2029-01",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2024-10-18",
                    "studyFirstSubmitQcDate": "2024-10-18",
                    "studyFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR_INVESTIGATOR",
                        "investigatorFullName": "Emily McDonald",
                        "investigatorTitle": "Associate Professor of Medicine and Staff Scientist",
                        "investigatorAffiliation": "McGill University Health Centre/Research Institute of the McGill University Health Centre"
                    },
                    "leadSponsor": {
                        "name": "Emily McDonald",
                        "class": "OTHER"
                    },
                    "collaborators": [
                        {
                            "name": "University of Melbourne",
                            "class": "OTHER"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "This is an open-label randomized controlled trial which will enroll patients with S. aureus bacteremia who are already taking oral anticoagulant medications (apixaban, edoxaban, or rivaroxaban) for an approved indication (stroke prevention in atrial fibrillation, prevention or treatment of venous thromboembolism). We will randomize patients to continue their existing medication or change to another medication (dabigatran) which is approved for the original indication.\n\nDabigatran is approved in many countries for the treatment or prevention of venous thromboembolism or preventing stroke in atrial fibrillation. Unlike the other medications listed above, dabigatran seems to have activity against S. aureus in the test tube, in animal models, and in a smaller randomized controlled trial. We wish to determine if changing to dabigratran will improve outcomes in S. aureus bacteremia in people who otherwise would have a reason to be taking it.\n\nThis study is an approved sub-study of The Staphylococcus aureus Network Adaptive Platform (SNAP) trial (NCT05137119).\n\nIf positive, this study will support a second RCT in people who do not currently have an indication for anticoagulation."
                },
                "conditionsModule": {
                    "conditions": [
                        "Staphylococcus Aureus Endocarditis",
                        "Staphylococcus Aureus Septicemia",
                        "Staphylococcus Aureus Bacteremia",
                        "Staphylococcus Aureus Bloodstream Infection",
                        "S. Aureus Bacteremia",
                        "S. Aureus Bloodstream Infection"
                    ],
                    "keywords": [
                        "S. aureus bacteremia",
                        "S. aureus bloodstream infection",
                        "S. aureus endocarditis",
                        "Dabigatran",
                        "Edoxaban",
                        "Rivaroxaban",
                        "Apixaban"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE4"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "whoMasked": [
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 300,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Change to Dabigatran",
                            "type": "EXPERIMENTAL",
                            "description": "Patients will have their anticoagulation changed to dabigatran at the monograph approved dose for the indication, bleeding risk, and renal function.",
                            "interventionNames": [
                                "Drug: Dabigatran"
                            ]
                        },
                        {
                            "label": "Continue current anticoagulant",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Patients will continue their currently prescribed apixaban, edoxaban, or rivaroxaban",
                            "interventionNames": [
                                "Drug: Apixaban",
                                "Drug: edoxaban",
                                "Drug: Rivaroxaban"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Dabigatran",
                            "description": "Patients will be assigned to change to dabigatran at the monograph approved dose for their indication, bleeding risk, and renal function.",
                            "armGroupLabels": [
                                "Change to Dabigatran"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Apixaban",
                            "description": "Patients will continue taking their currently prescribed apixaban, edoxaban, or rivaroxaban",
                            "armGroupLabels": [
                                "Continue current anticoagulant"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "edoxaban",
                            "description": "Patients will continue taking their currently prescribed apixaban, edoxaban, or rivaroxaban",
                            "armGroupLabels": [
                                "Continue current anticoagulant"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Rivaroxaban",
                            "description": "Patients will continue taking their currently prescribed apixaban, edoxaban, or rivaroxaban",
                            "armGroupLabels": [
                                "Continue current anticoagulant"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Desirability of Outcome Ranking (DOOR)",
                            "description": "Desirability of Outcome Ranking (DOOR) - an ordinal outcome with 5 levels defined:\n\nRank 1 - Alive without complication Rank 2 - Alive with 1 complication Rank 3 - Alive with 2 complications Rank 4 - Alive with 3 complications Rank 5 - Dead\n\nComplications include:\n\n1. Clinical failure: Absence of resolution of clinical signs and symptoms of S. aureus bacteremia such that no additional antibiotic therapy is required or anticipated.\n2. Infectious Complications: Including new endocarditis; new evidence of other deep metastatic foci (e.g., osteomyelitis or deep abscess); relapse of MRSA bacteremia after a patient has sterilized their initial blood cultures; readmission for subsequent care of S. aureus bacteremia; need for unplanned source control procedures\n3. Serious adverse drug event (Common Terminology Criteria class 4) due to study drug OR adverse drug event (classes 1-3) leading to discontinuation of the study drug",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Clinical failure",
                            "description": "Defined as the absence of resolution of clinical signs and symptoms of S. aureus bacteremia such that no additional antibiotic therapy is required or anticipated for its treatment.",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        },
                        {
                            "measure": "Serious Adverse Event or Adverse Event Leading to Discontinuation",
                            "description": "Defined as a serious adverse drug event (Common Terminology Criteria for Adverse Events (CTCAE) class 4) presumed due to study drug OR adverse drug event (CTCAE classes 1-3) leading to discontinuation of the study drug",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        },
                        {
                            "measure": "All cause mortality",
                            "description": "Death from any cause",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        },
                        {
                            "measure": "Infectious Complications",
                            "description": "Defined as change in therapy for inadequate clinical response; new endocarditis; new evidence of other deep metastatic foci (e.g., osteomyelitis or deep abscess); relapse of MRSA bacteremia after a patient has sterilized their initial blood cultures; readmission for subsequent care of S. aureus bacteremia; need for unplanned source control procedures. New implies that the complication was not suspected at enrollment and is not a function of delay to diagnostic testing.",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        },
                        {
                            "measure": "Clinically relevant major bleeding",
                            "description": "This will be defined according to the criteria of the International Society on Thrombosis and Haemostasis as one or more of the following: fatal bleeding; symptomatic bleeding in a critical area or organ (including hemorrhagic stroke); bleeding that causes a fall in hemoglobin level of \u226520 g/L; or bleeding that requires a transfusion of 2 or more units of whole blood or red cells. For bleeds into non-critical areas, we will also record the site of bleeding.",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        },
                        {
                            "measure": "Clinically relevant venous thromboembolic events",
                            "description": "This will be defined as an acute objectively confirmed deep vein thrombosis (upper extremity, lower extremity, other such as portal vein, cerebral vein, splanchnic vein) and/or segment or proximal pulmonary embolism, which is symptomatic and/or necessitates specific treatment. Below knee DVT and superficial thrombophlebitis are not included. Pulmonary embolism needs to be, segmental or proximal. Subsegmental pulmonary embolisms are not included as they have poor interrater reliability and may represent artefact in up to 50% of cases.",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        },
                        {
                            "measure": "Clinically relevant stroke",
                            "description": "Stroke is defined as the acute onset of focal neurological dysfunction caused by brain, spinal cord, or retinal vascular injury because of infarction (ischemia). Ideally, at least one of the following should be present to confirm the diagnosis of stroke: confirmation by neurology, stroke specialist, or neurosurgical specialist, brain imaging (e.g., CT scan, MRI scan, or cerebral vessel angiography compatible with acute ischemia). If the acute focal signs represent a worsening of a previous deficit, these signs must persist for more than 24 hours and be accompanied by an appropriate new MRI or CT scan finding. In the absence of neuroimaging, a staff neurologist consult which makes the diagnosis of stroke will be considered.",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        },
                        {
                            "measure": "Clinically relevant acute myocardial infarction",
                            "description": "Patients with S. aureus bacteremia often have substantial physiological stresses which can be associated with rises in cardiac troponin (demand ischemia). For the purposes of this outcome, acute myocardial infarction is captured as a type 1 myocardial infarction: detection of rise and/or fall of cardiac biomarkers with at least one value above the 99th percentile of the upper reference limit together with evidence of myocardial ischemia. For the purposes of this pragmatic trial, such a myocardial infarction will be inferred from the opinions of the staff cardiologist, intensivist, or general internal medicine specialist. The peak troponin value will be recorded, and a redacted copy of the relevant consultant's note and ECGs will be uploaded for audit.",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        },
                        {
                            "measure": "Clinically relevant arterial thromboembolic event",
                            "description": "Clinical history compatible with sudden worsening of end organ or limb perfusion and confirmation by imaging (e.g., CT angiography, arterial doppler) or need for urgent surgery or thrombolysis.",
                            "timeFrame": "Day 90 post enrollment in the S. aureus Network Adaptive Platform Trial (NCT05137119)"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "The participant must meet all inclusion and exclusion criteria for the SNAP Platform (NCT05137119) and also the following inclusion and exclusion criteria:\n\nInclusion Criteria:\n\n* Patient is taking an oral Xa inhibitor for: stroke prevention in atrial fibrillation, treatment or secondary prevention of deep venous thrombosis or pulmonary embolism, prevention of VTE in patients who have undergone elective total hip or total knee replacement surgery provided there are 30 or more days of planned treatment remaining at the time of enrolment.\n\nExclusion Criteria:\n\n* Active bleeding (allowing up to 5 days from the index blood culture to randomize in the event anti-thrombotic therapy is resumed)\n* Anticipated major cardiac surgery, neurosurgery, or spine surgery within the next 3 days\n* Pregnancy\n* Known use of dabigatran within last month\n* Allergy to dabigatran\n* Concomitant use of amiodarone, ketoconazole, rifampin, verapamil, clopidogrel, prasugrel, or ticagrelor\n* eGFR \\< 30mL/minute calculated by Cockcroft-Gault equation using adjusted weight \\[if acute kidney injury can allow for up to 5 days from index blood culture to allow for recovery\\]\n* Off label use (e.g., metallic mechanical heart valve, left ventricular thrombus, antiphospholipid antibody syndrome)",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Lina Petrella",
                            "role": "CONTACT",
                            "phone": "514-934-1934",
                            "phoneExt": "23730",
                            "email": "lina.petrella@muhc.mcgill.ca"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Emily G McDonald, MD MSC",
                            "affiliation": "Research Institute of the McGill University Health Centre",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital)",
                            "city": "Montreal",
                            "state": "Quebec",
                            "zip": "H4A3S1",
                            "country": "Canada",
                            "contacts": [
                                {
                                    "name": "Lina Petrella",
                                    "role": "CONTACT",
                                    "phone": "514-934-1934",
                                    "phoneExt": "23730",
                                    "email": "lina.petrella@muhc.mcgill.ca"
                                },
                                {
                                    "name": "Emily G McDonald, MD MSc",
                                    "role": "CONTACT"
                                },
                                {
                                    "name": "Todd C Lee, MD MPH FIDSA",
                                    "role": "CONTACT"
                                },
                                {
                                    "name": "Matthew P. Cheng, MD SM",
                                    "role": "CONTACT"
                                },
                                {
                                    "name": "Patrick Lawler, MD MPH",
                                    "role": "CONTACT"
                                },
                                {
                                    "name": "Alexander Lawandi, MD MSc",
                                    "role": "CONTACT"
                                }
                            ],
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "31002679",
                            "type": "BACKGROUND",
                            "citation": "Lerche CJ, Christophersen LJ, Goetze JP, Nielsen PR, Thomsen K, Enevold C, Hoiby N, Jensen PO, Bundgaard H, Moser C. Adjunctive dabigatran therapy improves outcome of experimental left-sided Staphylococcus aureus endocarditis. PLoS One. 2019 Apr 19;14(4):e0215333. doi: 10.1371/journal.pone.0215333. eCollection 2019."
                        },
                        {
                            "pmid": "32478836",
                            "type": "BACKGROUND",
                            "citation": "Butt JH, Fosbol EL, Verhamme P, Gerds TA, Iversen K, Bundgaard H, Bruun NE, Larsen AR, Petersen A, Andersen PS, Skov RL, Gislason GH, Torp-Pedersen C, Kober L, Olesen JB. Dabigatran and the Risk of Staphylococcus aureus Bacteremia: A Nationwide Cohort Study. Clin Infect Dis. 2021 Aug 2;73(3):480-486. doi: 10.1093/cid/ciaa661."
                        },
                        {
                            "pmid": "22040101",
                            "type": "BACKGROUND",
                            "citation": "Vanassche T, Verhaegen J, Peetermans WE, VAN Ryn J, Cheng A, Schneewind O, Hoylaerts MF, Verhamme P. Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. J Thromb Haemost. 2011 Dec;9(12):2436-46. doi: 10.1111/j.1538-7836.2011.04529.x."
                        },
                        {
                            "pmid": "20810780",
                            "type": "BACKGROUND",
                            "citation": "Vanassche T, Verhaegen J, Peetermans WE, Hoylaerts MF, Verhamme P. Dabigatran inhibits Staphylococcus aureus coagulase activity. J Clin Microbiol. 2010 Nov;48(11):4248-50. doi: 10.1128/JCM.00896-10. Epub 2010 Sep 1."
                        },
                        {
                            "pmid": "29614521",
                            "type": "BACKGROUND",
                            "citation": "Peetermans M, Liesenborghs L, Peerlinck K, Wijngaerden EV, Gheysens O, Goffin KE, Hoylaerts MF, Jacquemin M, Verhaegen J, Peetermans WE, Verhamme P, Vanassche T; Staphylothrombin Investigators. Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition. Thromb Haemost. 2018 May;118(5):818-829. doi: 10.1055/s-0038-1639586. Epub 2018 Apr 3."
                        },
                        {
                            "pmid": "35717634",
                            "type": "BACKGROUND",
                            "citation": "Tong SYC, Mora J, Bowen AC, Cheng MP, Daneman N, Goodman AL, Heriot GS, Lee TC, Lewis RJ, Lye DC, Mahar RK, Marsh J, McGlothlin A, McQuilten Z, Morpeth SC, Paterson DL, Price DJ, Roberts JA, Robinson JO, van Hal SJ, Walls G, Webb SA, Whiteway L, Yahav D, Davis JS; Staphylococcus aureus Network Adaptive Platform (SNAP) Study Group. The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe. Clin Infect Dis. 2022 Nov 30;75(11):2027-2034. doi: 10.1093/cid/ciac476. Erratum In: Clin Infect Dis. 2023 Apr 17;76(8):1532-1533. doi: 10.1093/cid/ciac730."
                        }
                    ],
                    "seeAlsoLinks": [
                        {
                            "label": "Website for the S. aureus Network Adaptive Platform Trial (SNAP)",
                            "url": "https://www.snaptrial.com.au/"
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "UNDECIDED",
                    "description": "Data sharing policies are dependent on the policies of the SNAP Platform (NCT05137119)"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D007239",
                            "term": "Infections"
                        },
                        {
                            "id": "D003141",
                            "term": "Communicable Diseases"
                        },
                        {
                            "id": "D013203",
                            "term": "Staphylococcal Infections"
                        },
                        {
                            "id": "D016470",
                            "term": "Bacteremia"
                        },
                        {
                            "id": "D018805",
                            "term": "Sepsis"
                        },
                        {
                            "id": "D004696",
                            "term": "Endocarditis"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D020969",
                            "term": "Disease Attributes"
                        },
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        },
                        {
                            "id": "D016908",
                            "term": "Gram-Positive Bacterial Infections"
                        },
                        {
                            "id": "D001424",
                            "term": "Bacterial Infections"
                        },
                        {
                            "id": "D001423",
                            "term": "Bacterial Infections and Mycoses"
                        },
                        {
                            "id": "D018746",
                            "term": "Systemic Inflammatory Response Syndrome"
                        },
                        {
                            "id": "D007249",
                            "term": "Inflammation"
                        },
                        {
                            "id": "D006331",
                            "term": "Heart Diseases"
                        },
                        {
                            "id": "D002318",
                            "term": "Cardiovascular Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M10283",
                            "name": "Infections",
                            "asFound": "Infection",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6368",
                            "name": "Communicable Diseases",
                            "asFound": "Infection",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M20864",
                            "name": "Sepsis",
                            "asFound": "Bloodstream Infection",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M16869",
                            "name": "Toxemia",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M18877",
                            "name": "Bacteremia",
                            "asFound": "Bacteremia",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7858",
                            "name": "Endocarditis",
                            "asFound": "Endocarditis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M15996",
                            "name": "Staphylococcal Infections",
                            "asFound": "Staphylococcus Aureus",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M22700",
                            "name": "Disease Attributes",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4722",
                            "name": "Bacterial Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M19252",
                            "name": "Gram-Positive Bacterial Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12136",
                            "name": "Mycoses",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4721",
                            "name": "Bacterial Infections and Mycoses",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16355",
                            "name": "Syndrome",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20818",
                            "name": "Systemic Inflammatory Response Syndrome",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10293",
                            "name": "Inflammation",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9419",
                            "name": "Heart Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC01",
                            "name": "Infections"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000069552",
                            "term": "Rivaroxaban"
                        },
                        {
                            "id": "C522181",
                            "term": "Apixaban"
                        },
                        {
                            "id": "C552171",
                            "term": "Edoxaban"
                        },
                        {
                            "id": "D000069604",
                            "term": "Dabigatran"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D065427",
                            "term": "Factor Xa Inhibitors"
                        },
                        {
                            "id": "D000991",
                            "term": "Antithrombins"
                        },
                        {
                            "id": "D015842",
                            "term": "Serine Proteinase Inhibitors"
                        },
                        {
                            "id": "D011480",
                            "term": "Protease Inhibitors"
                        },
                        {
                            "id": "D004791",
                            "term": "Enzyme Inhibitors"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D000925",
                            "term": "Anticoagulants"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M288162",
                            "name": "Apixaban",
                            "asFound": "Automated",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M463",
                            "name": "Rivaroxaban",
                            "asFound": "Parkinson's Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M261011",
                            "name": "Edoxaban",
                            "asFound": "Methylphenidate",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M490",
                            "name": "Dabigatran",
                            "asFound": "Sodium chloride",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4244",
                            "name": "Anticoagulants",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M30513",
                            "name": "Factor Xa Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4307",
                            "name": "Antithrombins",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4306",
                            "name": "Antithrombin III",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14343",
                            "name": "Protease Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M18391",
                            "name": "Serine Proteinase Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M19609",
                            "name": "HIV Protease Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7951",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T18",
                            "name": "Serine",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "AnCoag",
                            "name": "Anticoagulants"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Infe",
                            "name": "Anti-Infective Agents"
                        },
                        {
                            "abbrev": "AA",
                            "name": "Amino Acids"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT03909867",
                    "orgStudyIdInfo": {
                        "id": "IRB00056852"
                    },
                    "organization": {
                        "fullName": "Wake Forest University Health Sciences",
                        "class": "OTHER"
                    },
                    "briefTitle": "Emission Patterns of Respiratory Syncytial Virus",
                    "officialTitle": "Detection of the Human Aerosolization Patterns of Respiratory Syncytial Virus"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-07",
                    "overallStatus": "SUSPENDED",
                    "whyStopped": "The emergence of SARS-CoV-2 required a temporary hold of recruitment - emailed 8.28.23",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2021-09-17",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2025-09",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2025-09",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2019-04-03",
                    "studyFirstSubmitQcDate": "2019-04-08",
                    "studyFirstPostDateStruct": {
                        "date": "2019-04-10",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Wake Forest University Health Sciences",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "The purpose of this observational study is to describe the environmental aerosolization patterns burden of RSV in the air and on surfaces in surrounding adult patients in a real-life setting. Specific objectives are to determine the particle size distribution and the quantity of airborne pathogens dispersed by symptomatic participants, to establish a spatial model of airborne emission and subsequent surface burden of RSV emission and dispersal in clinical settings (emergency department and inpatient units; 1 foot vs. 3-6 feet vs. 8-10 feet), and to obtain information regarding the potential association of illness severity and risk factors to the scale of airborne dispersal (e.g., super spreaders). This study will be used to collect data of the emission patterns of RSV. Subsequent investigations will help guide policymakers in the assessment of the airborne exposure risk to RSV and the implementation of appropriate infection prevent measures such as respirators and face masks.\n\nThe investigators hypothesize that the airborne emission patterns of Respiratory Syncytial Virus varies between individual patients. The investigators are proposing to assess the particle size and spatial distribution of airborne RSV emitted by affected patients within a routine care environment:\n\n1. Characterize individuals who develop respiratory illnesses caused by RSV in terms of demographics, co-morbid conditions, prior vaccinations (e.g., influenza vaccine, DTAP), use of antivirals, and severity of illness (fever, respiratory symptoms, malaise).\n2. Determine the particle size distribution patterns and quantities of the pathogen in two settings, an emergency department and an inpatient unit (ICU and non-ICU settings).\n3. Establish a spatial model (1 foot vs. 3-6 feet vs. 8-10 feet) of airborne pathogen dispersal and subsequent surface burden in two settings, an emergency department and an inpatient unit (ICU and non-ICU settings).\n4. Determine the correlation between the human aerosolization patterns and the severity of illness (fever, respiratory symptoms, malaise) in individual participants (super spreader?).",
                    "detailedDescription": "Research Design and Methods The main objective of this study is to identify and determine airborne emission and subsequent surface burden patterns of RSV in naturally infected patients.\n\nPatient Information:\n\nPatients seen at the Emergency Department( ED) or admitted to the hospital with respiratory symptoms and diagnosed with RSV are eligible for enrollment. The results of routine in-house laboratory diagnostic tests such as the Respiratory Viral Panel (RVP) will be used to identify patients.\n\nSetting:\n\nWake forest baptist medical center (WFBMC) is an 885 bed tertiary care teaching hospital. There are approximately 36,000 inpatient admissions and \\>89,000 ED visits annually (pediatric/adult). Air sampling is conducted in patient rooms under turbulent airflows (6 total air changes/hour) at approximately 20\u00b0C temperature and 40% Relative Humidity. Air is filtered by ANSI/ASHRAE 52.2 compliant endfilters with a minimum efficiency reporting value of 15.\n\nSampling:\n\nOne nasopharyngeal swab will be obtained from each subject. The sample will be used to confirm RSV infection and determine the amount of the pathogen carried by the individual. Samples will be inoculated into Becton Dickinson Universal Viral Transport System (VTM, BD Diagnostics, Franklin Lakes, NJ) for real-time reverse transcriptase PCR (rRT-PCR) analysis.\n\nOne-time air samples will be collected using six-stage Andersen air sampling devices and settle plates at three locations, head of bed/chair two feet away from patient head, foot of bed/chair eight feet away from head, and at the exit of the patient room (11):\n\nSamples will be collected in viral transport media (VTM), supplemented with RNA stabilization buffer (Qiagen AVL buffer) and carrier RNA and then stored at -80C. Carrier RNA will serve as both a carrier and an internal control by containing genomic RNA of the plant tobacco mosaic virus. A 540 ul volume of RNA sample will be purified with the QIAmp Viral RNA Mini Extraction Kit and concentrated approximately 10-fold. RSV serotypes A and B as well as the control viral tobacco mosaic virus RNA will be detected by reverse transcription and quantitative PCR. Additionally, nNasopharyngeal swab with also be used for cultures with inoculation in petri dish containing RSV specific media.\n\nThe surface burden of RSV will be assessed by placement of open standard Petri dishes filled with VTM at the three air sampling locations. The covers of the Petri dishes will be removed at the beginning of and closed after the air sampling session. Selected environmental surfaces will be sampled with sterile swabs moistened with VTM or TSB broth. A two square inch area will be swabbed once at three high-touch locations daily: head of the bed hand rail, middle of food tray table, and a table/horizontal surface at back of room (approximately 10 feet away past foot of bed). The swabs will be vortexed for 30 seconds, and processed as described for RSV detection in air samples.\n\nDuring the sampling health care professional (HCP) and study staff will wear respirators (N-95) to reduce the risk of external contamination due to potential RSV carrier status. The respirators will be collected and a two square inch midsection of the respirator will be cut out using sterile scissors. The cut-outs are placed in 2mLs VTM or TSB broth and frozen. After thawing, samples are vortexed/agitated, and further processed as described for the RSV samples."
                },
                "conditionsModule": {
                    "conditions": [
                        "RSV Infection",
                        "Aerosol Disease"
                    ]
                },
                "designModule": {
                    "studyType": "OBSERVATIONAL",
                    "patientRegistry": false,
                    "designInfo": {
                        "observationalModel": "CASE_ONLY",
                        "timePerspective": "CROSS_SECTIONAL"
                    },
                    "bioSpec": {
                        "retention": "SAMPLES_WITHOUT_DNA",
                        "description": "One nasopharyngeal swab sample from each participant will be used to confirm RSV infection and determine the amount of the pathogen carried by the individual.\n\nOne-time air samples will be collected using six-stage Andersen air sampling devices and settle plates at three locations, head of bed/chair two feet away from patient head, foot of bed/chair eight feet away from head, and at the exit of the patient room."
                    },
                    "enrollmentInfo": {
                        "count": 29,
                        "type": "ESTIMATED"
                    }
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "airborne emission patterns of Respiratory Syncytial Virus",
                            "description": "Determine the particle size distribution patterns and quantities of RSV pathogen, establish a spatial model (1 foot vs. 3-6 feet vs. 8-10 feet) of airborne pathogen dispersal and subsequent surface burden in two settings, an emergency department and an inpatient unit (ICU and non-ICU settings)",
                            "timeFrame": "30min - 1 hour"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Risk of RSV infection based on emission pattern",
                            "description": "Determine the correlation between the human aerosolization patterns and the severity of illness (fever, respiratory symptoms, malaise) in individual participants (super spreader?).",
                            "timeFrame": "72 hours"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients \\> age 18, seen at the Emergency Department or admitted to the hospital with respiratory symptoms and diagnosed with RSV infection\n\nExclusion Criteria:\n\n* less than age 18\n* Mechanically intubated patients",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ],
                    "studyPopulation": "Patients seen at the Emergency Department or admitted to the hospital with respiratory symptoms and diagnosed with RSV are eligible for enrollment. The results of routine in-house laboratory diagnostic tests such as the Respiratory Viral Panel (RVP) will be used to identify patients.",
                    "samplingMethod": "NON_PROBABILITY_SAMPLE"
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Werner Bischoff, MD",
                            "affiliation": "Wake Forest University Health Sciences",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Wake Forest School of Medicine",
                            "city": "Winston-Salem",
                            "state": "North Carolina",
                            "zip": "27157",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.09986,
                                "lon": -80.24422
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D018357",
                            "term": "Respiratory Syncytial Virus Infections"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D018186",
                            "term": "Pneumovirus Infections"
                        },
                        {
                            "id": "D018184",
                            "term": "Paramyxoviridae Infections"
                        },
                        {
                            "id": "D018701",
                            "term": "Mononegavirales Infections"
                        },
                        {
                            "id": "D012327",
                            "term": "RNA Virus Infections"
                        },
                        {
                            "id": "D014777",
                            "term": "Virus Diseases"
                        },
                        {
                            "id": "D007239",
                            "term": "Infections"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M10283",
                            "name": "Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6368",
                            "name": "Communicable Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17522",
                            "name": "Virus Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20494",
                            "name": "Respiratory Syncytial Virus Infections",
                            "asFound": "RSV Infection",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M20330",
                            "name": "Paramyxoviridae Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20778",
                            "name": "Mononegavirales Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15149",
                            "name": "RNA Virus Infections",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC01",
                            "name": "Infections"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06651255",
                    "orgStudyIdInfo": {
                        "id": "2022_0508"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "2023-A01508-37",
                            "type": "OTHER",
                            "domain": "Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9"
                        }
                    ],
                    "organization": {
                        "fullName": "University Hospital, Lille",
                        "class": "OTHER"
                    },
                    "briefTitle": "Algorithm-based Management to Reduce the Recurrence of Gastrointestinal Bleeding and Severe Epistaxis in Von Willebrand Disease",
                    "officialTitle": "Algorithm-based Management to Reduce the Recurrence of Gastrointestinal Bleeding and Severe Epistaxis in Von Willebrand Disease: WILL MANAGE Trial",
                    "acronym": "WILL MANAGE"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "NOT_YET_RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2025-01-06",
                        "type": "ESTIMATED"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2034-01-06",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2034-12-06",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2024-10-18",
                    "studyFirstSubmitQcDate": "2024-10-18",
                    "studyFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "University Hospital, Lille",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "WILL MANAGE is a prospective multicenter controlled open label randomized trial comparing an algorithm-based multidisciplinary management to a standard of care to reduce the incidence of bleeding (GI bleeding or severe epistaxis) recurrence in von Willebrand disease."
                },
                "conditionsModule": {
                    "conditions": [
                        "Von Willebrand Disease (VWD)"
                    ],
                    "keywords": [
                        "Von Willebrand disease",
                        "gastrointestinal bleeding",
                        "angiodysplasia",
                        "epistaxis"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 66,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Optimized management",
                            "type": "EXPERIMENTAL",
                            "description": "systematic gastrointestinal and nasal endoscopic exploration, local endoscopic treatment whenever applicable,prophylaxis with stepwise dose escalation of VWF concentrate and use of antiangiogenic drugs in patients with severe GI angiodysplasia-related bleeding",
                            "interventionNames": [
                                "Procedure: Optimized management"
                            ]
                        },
                        {
                            "label": "Standard of care management",
                            "type": "OTHER",
                            "description": "Standard of care management",
                            "interventionNames": [
                                "Procedure: Standard of care management"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "PROCEDURE",
                            "name": "Optimized management",
                            "description": "systematic gastrointestinal and nasal endoscopic exploration, local endoscopic treatment whenever applicable,prophylaxis with stepwise dose escalation of VWF concentrate and use of antiangiogenic drugs in patients with severe GI angiodysplasia-related bleeding",
                            "armGroupLabels": [
                                "Optimized management"
                            ]
                        },
                        {
                            "type": "PROCEDURE",
                            "name": "Standard of care management",
                            "description": "Standard of care management",
                            "armGroupLabels": [
                                "Standard of care management"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "cumulative incidence of bleeding (GI bleeding or severe epistaxis) recurrence during follow-up",
                            "description": "- GI bleeding is defined as: Any hematemesis or melena Or hematochezia with at least a 2g/dL drop in hemoglobin Or occult bleeding: iron deficiency anemia with at least a 2g/dL drop in hemoglobin\n\n- Severe epistaxis is defined as: A nose bleed requiring red blood cells transfusion or treatment with VWF concentrates",
                            "timeFrame": "Until the visit 7 (72 months \u00b12months)"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Number of GI bleeding and severe epistaxis recurrence during follow-up",
                            "timeFrame": "Until the visit 7 (72 months \u00b12months)"
                        },
                        {
                            "measure": "Number of days of hospitalization for GI bleeding or severe epistaxis recurrence during follow-up",
                            "timeFrame": "Until the visit 7 (72 months \u00b12months)"
                        },
                        {
                            "measure": "Number of transfused red blood cells units, the total amount of iron supplementation (mg) and number of units of VWF concentrates administred (IU/kg) during follow-up",
                            "timeFrame": "Until the visit 7 (72 months \u00b12months)"
                        },
                        {
                            "measure": "Change in haemoglobin and serum ferritin levels from inclusion to 3-years",
                            "timeFrame": "from inclusion to 3-years"
                        },
                        {
                            "measure": "Change in bleeding score (ISTH BAT) from inclusion to 3-years. The bleeding score will be calculated for the 3-year period before the evaluation.",
                            "timeFrame": "from inclusion to 3-years"
                        },
                        {
                            "measure": "Change in quality of life assessed by a standardized questionnaire validated for VWD (WISH-QoL scores) from inclusion to 3 years",
                            "timeFrame": "from inclusion to 3-years"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Males and females adults aged \\> 18 years\n* With a constitutional von Willebrand Disease (according to the phenotypic criteria of the French Reference Center of von Willebrand Disease)\n* With a GI bleeding \\[either overt (any hematemesis, any melena or hematochezia with at least a 2g/dL drop in hemoglobin) or occult (iron deficiency anemia with at least 2g/dL drop in hemoglobin)\\] with the presence of angiodysplasia or a negative finding on digestive conventional endoscopy OR with a severe epistaxis (requiring red blood cells transfusion or treatment with VWF concentrates)\n* Be affiliated to a social security scheme\n* Written informed consent obtained\n\nExclusion Criteria:\n\n* Acquired von Willebrand Disease\n* Presence of an inhibitor to VWF or a contra indication to VWF concentrates\n* Contra-indication to videocapsule endoscopy\n* Refusal of the procedures part of the study\n* Pregnant women or breastfeeding\n* Short-life expectancy\n* Liver cirrhosis Child-Pugh C or diagnosed portal hypertension\n* Cancer currently undergoing chemotherapy\n* Inability to provide informed consent\n* Patient under justice protection",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Marie Caillierez",
                            "role": "CONTACT",
                            "phone": "0033320444145",
                            "email": "DRC@chru-lille.Fr"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Sophie Susen, MD, Professor",
                            "affiliation": "Lille University Hospital",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "CHU Lille",
                            "city": "Lille",
                            "state": "Nord",
                            "zip": "59000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chru-lille.fr"
                                },
                                {
                                    "name": "Sophie Susen, MD, Professor",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 50.63297,
                                "lon": 3.05858
                            }
                        },
                        {
                            "facility": "CHU Amiens",
                            "city": "Amiens",
                            "zip": "80000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chru-lille.fr"
                                },
                                {
                                    "name": "Annelise Voyer, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 49.9,
                                "lon": 2.3
                            }
                        },
                        {
                            "facility": "CHRU Brest",
                            "city": "Brest",
                            "zip": "29200",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chru-lille.fr"
                                },
                                {
                                    "name": "Brigitte PAN-PETESCH, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 48.3903,
                                "lon": -4.48628
                            }
                        },
                        {
                            "facility": "H\u00f4pital cardiologique Louis Pradel",
                            "city": "Bron",
                            "zip": "69500",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Yesim Dargaud, MD, Pr",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 45.73333,
                                "lon": 4.91667
                            }
                        },
                        {
                            "facility": "CHU Caen",
                            "city": "Caen",
                            "zip": "14000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Yoann Repesse, MD, Pr",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 49.18585,
                                "lon": -0.35912
                            }
                        },
                        {
                            "facility": "CH Chambery",
                            "city": "Chambery",
                            "zip": "73000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chru-lille.fr"
                                },
                                {
                                    "name": "Val\u00e9rie GAY, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 45.56667,
                                "lon": 5.93333
                            }
                        },
                        {
                            "facility": "CHU Clermont-Ferrand",
                            "city": "Clermont-Ferrand",
                            "zip": "63000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chru-lille.fr"
                                },
                                {
                                    "name": "Aur\u00e9lien Lebreton, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 45.77966,
                                "lon": 3.08628
                            }
                        },
                        {
                            "facility": "CHU Dijon",
                            "city": "Dijon",
                            "zip": "21000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Fabienne Volot, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 47.31667,
                                "lon": 5.01667
                            }
                        },
                        {
                            "facility": "AP-HP H\u00f4pital Kremlin Bicetre",
                            "city": "Le Kremlin-Bic\u00eatre",
                            "zip": "94270",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Roseline Doiron, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 48.81471,
                                "lon": 2.36073
                            }
                        },
                        {
                            "facility": "AP-HM H\u00f4pital Timone",
                            "city": "Marseille",
                            "zip": "13005",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Vincent Ernest, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 43.29551,
                                "lon": 5.38958
                            }
                        },
                        {
                            "facility": "CHU Montpellier",
                            "city": "Montpellier",
                            "zip": "34000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Christine Biron, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 43.61092,
                                "lon": 3.87723
                            }
                        },
                        {
                            "facility": "CHU Nantes",
                            "city": "Nantes",
                            "zip": "44000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Marc Trossaert, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 47.21725,
                                "lon": -1.55336
                            }
                        },
                        {
                            "facility": "CHU Rennes",
                            "city": "Rennes",
                            "zip": "35000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Benoit Guillet",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 48.11198,
                                "lon": -1.67429
                            }
                        },
                        {
                            "facility": "CHU Rouen",
                            "city": "Rouen",
                            "zip": "76000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Pierre CHAMOUNI, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 49.44313,
                                "lon": 1.09932
                            }
                        },
                        {
                            "facility": "CHU Strasbourg",
                            "city": "Strasbourg",
                            "zip": "67000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Dominique DESPREZ, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 48.58392,
                                "lon": 7.74553
                            }
                        },
                        {
                            "facility": "CHU Toulouse",
                            "city": "Toulouse",
                            "zip": "31000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Marie Piel-Julian, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 43.60426,
                                "lon": 1.44367
                            }
                        },
                        {
                            "facility": "CHU Tours",
                            "city": "Tours",
                            "zip": "37000",
                            "country": "France",
                            "contacts": [
                                {
                                    "name": "Marie Caillierez",
                                    "role": "CONTACT",
                                    "phone": "+33320444145",
                                    "email": "DRC@chu-lille.fr"
                                },
                                {
                                    "name": "Laurent Ardillon, MD",
                                    "role": "PRINCIPAL_INVESTIGATOR"
                                }
                            ],
                            "geoPoint": {
                                "lat": 47.38333,
                                "lon": 0.68333
                            }
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D006471",
                            "term": "Gastrointestinal Hemorrhage"
                        },
                        {
                            "id": "D004844",
                            "term": "Epistaxis"
                        },
                        {
                            "id": "D014842",
                            "term": "Von Willebrand Diseases"
                        },
                        {
                            "id": "D006470",
                            "term": "Hemorrhage"
                        },
                        {
                            "id": "D012008",
                            "term": "Recurrence"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        },
                        {
                            "id": "D020969",
                            "term": "Disease Attributes"
                        },
                        {
                            "id": "D005767",
                            "term": "Gastrointestinal Diseases"
                        },
                        {
                            "id": "D004066",
                            "term": "Digestive System Diseases"
                        },
                        {
                            "id": "D025861",
                            "term": "Blood Coagulation Disorders, Inherited"
                        },
                        {
                            "id": "D001778",
                            "term": "Blood Coagulation Disorders"
                        },
                        {
                            "id": "D006402",
                            "term": "Hematologic Diseases"
                        },
                        {
                            "id": "D020147",
                            "term": "Coagulation Protein Disorders"
                        },
                        {
                            "id": "D001791",
                            "term": "Blood Platelet Disorders"
                        },
                        {
                            "id": "D006474",
                            "term": "Hemorrhagic Disorders"
                        },
                        {
                            "id": "D030342",
                            "term": "Genetic Diseases, Inborn"
                        },
                        {
                            "id": "D009668",
                            "term": "Nose Diseases"
                        },
                        {
                            "id": "D012140",
                            "term": "Respiratory Tract Diseases"
                        },
                        {
                            "id": "D010038",
                            "term": "Otorhinolaryngologic Diseases"
                        },
                        {
                            "id": "D012818",
                            "term": "Signs and Symptoms, Respiratory"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M14850",
                            "name": "Recurrence",
                            "asFound": "Recurrence",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M9556",
                            "name": "Hemorrhage",
                            "asFound": "Bleeding",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M9557",
                            "name": "Gastrointestinal Hemorrhage",
                            "asFound": "Gastrointestinal Bleeding",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7999",
                            "name": "Epistaxis",
                            "asFound": "Epistaxis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M17585",
                            "name": "Von Willebrand Diseases",
                            "asFound": "Von Willebrand Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M19234",
                            "name": "Angiodysplasia",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22700",
                            "name": "Disease Attributes",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8883",
                            "name": "Gastrointestinal Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7255",
                            "name": "Digestive System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21977",
                            "name": "Hemostatic Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5059",
                            "name": "Blood Coagulation Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M23095",
                            "name": "Blood Coagulation Disorders, Inherited",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9490",
                            "name": "Hematologic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21982",
                            "name": "Coagulation Protein Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5072",
                            "name": "Blood Platelet Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9560",
                            "name": "Hemorrhagic Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M23686",
                            "name": "Genetic Diseases, Inborn",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12604",
                            "name": "Nose Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14977",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12961",
                            "name": "Otorhinolaryngologic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15623",
                            "name": "Signs and Symptoms, Respiratory",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC06",
                            "name": "Digestive System Diseases"
                        },
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "BC09",
                            "name": "Ear, Nose, and Throat Diseases"
                        },
                        {
                            "abbrev": "BC15",
                            "name": "Blood and Lymph Conditions"
                        },
                        {
                            "abbrev": "BC16",
                            "name": "Diseases and Abnormalities at or Before Birth"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M22318",
                            "name": "Angiogenesis Inhibitors",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06571955",
                    "orgStudyIdInfo": {
                        "id": "CD/PT.03"
                    },
                    "organization": {
                        "fullName": "MOVMEDIX",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "ACL Reconstruction with a New Generation of LARS Artificial Ligament",
                    "officialTitle": "Anterior Cruciate Ligament (ACL) Reconstruction with a New Generation of LARS Artificial Ligament"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "ACTIVE_NOT_RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2021-12-22",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2024-03-28",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2024-12-31",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2024-07-15",
                    "studyFirstSubmitQcDate": "2024-08-22",
                    "studyFirstPostDateStruct": {
                        "date": "2024-08-26",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "MOVMEDIX",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "This clinical investigation is intended to demonstrate the safety of the new generation of LARS ligaments and compare this new generation (grafted ligament) of artificial ligament to the LARS current artificial ligament (non-grafted ligament) which is CE marked since 1997, in case of ACL injury. The new generation of LARS artificial ligament is expected to improve physiological response by enhancing fibroblast proliferation, fibroblast organization and collagen type I \\& III secretion. This physiological response leads to a better osseo-integration of the ligaments. Therefore, the study is expected to demonstrate the investigational device safety and biomechanical improvements.",
                    "detailedDescription": "Forty subjects over 40 years old with acute ACL injury will be included. A follow-up program is planned over 1 year per subject (days 7, 15, 30, 60, 90, 180, 365) based on physical therapy, biological analysis and biomechanical measurements."
                },
                "conditionsModule": {
                    "conditions": [
                        "ACL Injury"
                    ],
                    "keywords": [
                        "ACL",
                        "Artificial ligament"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "QUADRUPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 40,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "LARS grafted",
                            "type": "EXPERIMENTAL",
                            "description": "Patients implanted with grafted ligament (new generation)",
                            "interventionNames": [
                                "Device: Implantation of LARS artificial grafted ligament to treat ACL injury"
                            ]
                        },
                        {
                            "label": "Control",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Patients implanted with non-grafted ligament (current generation)",
                            "interventionNames": [
                                "Device: Implantation of LARS artificial non-grafted ligament to treat ACL injury"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DEVICE",
                            "name": "Implantation of LARS artificial grafted ligament to treat ACL injury",
                            "description": "Implantation procedure will be realized by a well-trained orthopaedic surgeon and will consist of ACL repair using LARS artificial grafted ligament.",
                            "armGroupLabels": [
                                "LARS grafted"
                            ]
                        },
                        {
                            "type": "DEVICE",
                            "name": "Implantation of LARS artificial non-grafted ligament to treat ACL injury",
                            "description": "Implantation procedure will be realized by a well-trained orthopaedic surgeon and will consist of ACL repair using LARS artificial non-grafted ligaments.",
                            "armGroupLabels": [
                                "Control"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Incidence of Serious Adverse Device Effect (SADE)",
                            "description": "Primary outcome will evaluate the safety of the grafted ligament by reporting the number of SADE(s) in the Experimental Arm.",
                            "timeFrame": "6 months"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Assessment of patients' opinion about their knee and associated problems",
                            "description": "Patient will answer the questionnaire KOOS (Knee Injury and Osteoarthritis Outcome Score) pre-surgery, 90, 180 and 365 days post-surgery.\n\nThis is a knee-specific instrument, developed to assess the patients' opinion about their knee and associated problems both on short-term and long-term. The KOOS questionnaire includes five dimensions that are relevant to patients: pain, symptoms, daily activities, sports and recreation, and quality of life. Each of these dimensions is scored separately, using a Likert scale with five possible answers ranging from 0 (no problems) to 4 (extreme problems). The scores for each dimension are calculated by summing the answers to the relevant questions. The resulting scores are then transformed to a scale from 0 to 100, with 0 representing extreme knee problems and 100 representing no knee problems. Answers to the questionnaire pre-surgery will be compared to the answers collected at 90, 180 and 365 days post-surgery.",
                            "timeFrame": "12 months"
                        },
                        {
                            "measure": "Assessment of patients' pain intensity",
                            "description": "The Visual Analogue Scale (VAS) will be used to measure the intensity or frequency of various symptoms, most commonly pain. Patients will be asked to mark a point on the line that represents their perception of their current state pre-surgery, 90, 180 and 365 days post-surgery. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the \"no pain\" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity. Scores obtained pre-surgery will be compared to the scores obtained at 90, 180 and 365 days post-surgery.",
                            "timeFrame": "12 months"
                        },
                        {
                            "measure": "Assessment of overall knee function",
                            "description": "The IKDC Subjective Knee Evaluation Form is used to evaluate the knee. The questionnaire looks at 3 categories: symptoms, sports activity and knee function. The symptoms subscale helps to evaluate things such as pain, stiffness, swelling and giving-way of the knee. The sports activity subscale focuses on functions such as; going up and down the stairs, rising from a chair, squatting and jumping. The knee function subscale asks patients 1 simple question - how is their knee at present versus how was their knee prior to injury.\n\nScores are obtained by summing the individual items and then transforming the crude total to a scaled number that ranges from 0 to 100. Higher scores indicate higher levels of function and lower levels of symptoms. Patients will complete the IKDC form pre-surgery, 90, 180 and 365 days post-surgery. Scores obtained pre-surgery will be compared to the scores obtained at 90, 180 and 365 days post-surgery.",
                            "timeFrame": "12 months"
                        },
                        {
                            "measure": "Assessment of posterior-anterior knee laxity",
                            "description": "Posterior-anterior knee laxity is measured using a KT-1000 arthrometer. The subject lies in a supine position with the knee flexed about 20\u00b0, a support is placed below the knee proximal to the popliteal space. The subject is told to relax in this position. The arthrometer is then placed above the tibia and attached firmly by two bands. After adjusting the zero, the tibia is pulled anteriorly using the handle on the arthrometer. An audible indication will be noticed at 15, 20 and 30 pounds (approx. 6, 9 and 13kg) of force. Moreover, a manual maximum measure is performed pulling the tibia with a hand on the back of the shank, until the foot is raised. Displacement is measured in millimeters and compared with the healthy leg measurements. The difference between the legs should be 1mm - 15mm.\n\nKnee laxity will be measured pre-surgery, 45, 90, 180 and 365 days post-surgery. Values at pre-surgery will be compared to the ones from post-surgery mesurements.",
                            "timeFrame": "12 months"
                        },
                        {
                            "measure": "Assessment of knee flexors-extensors strength",
                            "description": "Knee flexors-extensors strength assessment will be measured using an Isokinetic machine and superficial EMG evaluation. The subject performs an isokinetic concentric evaluation with a fixed velocity of 90\u00b0/s with a range of motion of 0-90\u00b0 of knee flexion. After warming-up, subject is asked to sit on the resting chair of the dynamometer, the subject is then secured with body straps. The starting position is 90\u00b0 flexion for the knee and 90\u00b0 for the hip joint. The subject is instructed to extend the knee till 0\u00b0 flexion and then to flex the knee back at 90\u00b0 with maximum exertion. The test is performed firstly on the healthy side and then on the injured side. Peak forces are compared between the legs.\n\nKnee flexors-extensors strength will be measured pre-surgery, 90, 180 and 365 days post-surgery. Values at pre-surgery will be compared to the ones from post-surgery mesurements.",
                            "timeFrame": "12 months"
                        },
                        {
                            "measure": "Assessment of stabilometry",
                            "description": "The subject is asked to stay still on a force platform for 10 seconds, firstly standing only on one leg with the arms folded across the chest. The test is then repeated on the other leg. The motion/change of the centre of pressure is used to quantify ellipse area to measure stability. Usually, ellipse area results for stabilometry test show differences between the healthy and the injured leg.\n\nStabilometry will be measured in both legs pre-surgery, 45, 90, 180 and 365 days post-surgery.",
                            "timeFrame": "12 months"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject is able to verbally confirm understanding of risks, benefits and treatment alternatives of receiving the grafted ligament\n* Subject provides written informed consent approved by the Ethics Committee prior to any clinical investigation related procedure\n* Subject must agree to undergo all clinical investigation plan - required clinical follow-up visits\n* Subject must agree not to participate in any other clinical investigation for a period of 1 year following the procedure\n* Male and female subjects over 40 years old\n* MRI positive for full acute ACL injury\n* Arthrometric evaluation (KT1000) with a side-to-side difference greater than 3 mm\n* Symptomatic subjects with no previous knee injury\n* Subjects without concomitant pathologies (fracture, infections, immunodepression, HIV, HCV) that could influence the outcome of the study or prevent the subject from following the post-operative follow-up program as per protocol\n* I and II degree chondral lesions\n\nExclusion Criteria:\n\n* Subjects under 40 years old\n* III and IV degree chondral lesions\n* Associated ligament injuries\n* Meniscus suture (e.g. hndle bucket meniscal tears) that compromise the rehabilitation program\n* History for sepsis\n* Subjects with concomitant pathologies (fracture, infections, immunodepression, HIV, HCV,) that could influence the outcome of the study or prevent the subject from following the post-operative follow-up program as per protocol\n* Previous knee injuries\n* Septic arthritis\n* Infected tissues\n* Pregnancy\n* Overweighed, obese subject (\\>100kg)\n* History of metabolic bone disease\n* Inflammatory joint disease\n* Known neoplastic disease\n* Medical treatment (e.g steroid)\n* HIV positive subject\n* Hepatitis positive subject\n* Allergy to Titanium, PET, Ugurol, Gentamicin, Polystyrene Sulfonate, other medication",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "41 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Guliano Cerulli, MD",
                            "affiliation": "Instituto di Ricerca Traslazionale Per l'Apparato Locomotore Nicola Cerulli (I.R.T.A.L)",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Instituto di Ricerca Traslazionale Per l'Apparato Locomotore Nicola Cerulli (I.R.T.A.L)",
                            "city": "Perugia",
                            "zip": "06100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 43.1122,
                                "lon": 12.38878
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000070598",
                            "term": "Anterior Cruciate Ligament Injuries"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D007718",
                            "term": "Knee Injuries"
                        },
                        {
                            "id": "D007869",
                            "term": "Leg Injuries"
                        },
                        {
                            "id": "D014947",
                            "term": "Wounds and Injuries"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M601",
                            "name": "Anterior Cruciate Ligament Injuries",
                            "asFound": "ACL Injury",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10738",
                            "name": "Knee Injuries",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10881",
                            "name": "Leg Injuries",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17685",
                            "name": "Wounds and Injuries",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC26",
                            "name": "Wounds and Injuries"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05966155",
                    "orgStudyIdInfo": {
                        "id": "PRO00104948_C"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "U01HG010225",
                            "type": "NIH",
                            "link": "https://reporter.nih.gov/quickSearch/U01HG010225"
                        }
                    ],
                    "organization": {
                        "fullName": "Duke University",
                        "class": "OTHER"
                    },
                    "briefTitle": "A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial)",
                    "officialTitle": "A Depression and Opioid Pragmatic Trial in Pharmacogenetics",
                    "acronym": "ADOPT PGx"
                },
                "statusModule": {
                    "statusVerifiedDate": "2023-07",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2021-08-10",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2024-04-27",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2024-04-27",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2023-07-21",
                    "studyFirstSubmitQcDate": "2023-07-21",
                    "studyFirstPostDateStruct": {
                        "date": "2023-07-28",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Duke University",
                        "class": "OTHER"
                    },
                    "collaborators": [
                        {
                            "name": "National Human Genome Research Institute (NHGRI)",
                            "class": "NIH"
                        },
                        {
                            "name": "University of Florida",
                            "class": "OTHER"
                        },
                        {
                            "name": "Vanderbilt University Medical Center",
                            "class": "OTHER"
                        },
                        {
                            "name": "Indiana University School of Medicine",
                            "class": "OTHER"
                        },
                        {
                            "name": "Icahn School of Medicine at Mount Sinai",
                            "class": "OTHER"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and the trial design. The three trials are the Acute Pain Trial, the Chronic Pain Trial, and the Depression Trial. Participants can enroll in only one of the three trials. All three trials were registered on ClinicalTrials.gov under NCT04445792. In July 2023 each of the three treatment trials was registered under a separate NCT# and NCT04445792 was converted to a screening record per recent guidance on master protocol research programs (MPRPs). This record is specific to the Depression Trial within the ADOPT-PGx protocol.\n\nThe Depression Trial is a prospective, multicenter, two arm randomized pragmatic trial. Participants meeting eligibility criteria will be randomly assigned to either immediate pharmacogenetic testing and genotype-guided anti-depressant therapy (Intervention arm) or standard care with 6-month delayed pharmacogenetic testing (Control arm). The investigators will test the hypothesis that pharmacogenetic testing and genotype-guided anti-depressant therapy will reduce depression symptoms in participants who's body processes some anti-depressants faster or slower than normal.",
                    "detailedDescription": "Pain and depression are conditions that impact substantial proportions of the US population. Finding safe and effective drug therapies for both conditions is challenging. In the case of treatment for acute and chronic pain, the challenge is finding effective therapy while minimizing adverse effects or opioid addiction (and the ensuing consequences). For depression, there are few clinically relevant predictors of successful treatment leading to multiple trials of inadequate therapy for some patients. Both opioid and antidepressant prescriptions can be guided by pharmacogenetics (PGx) data based on existing guidelines from the Clinical Pharmacogenetics Implementation Consortium (CPIC).\n\nThis study is designed to evaluate the impact of pharmacogenetic testing and genotype-guided pain or anti-depressant therapy on pain control or depression symptoms in a pragmatic setting.\n\nThe rationale for examining a genotype-guided approach to acute and chronic pain management is based on the importance of CYP2D6 for the bioactivation of tramadol, codeine, and hydrocodone and data from a pilot study supporting improved pain control in intermediate and poor CYP2D6 metabolizers in the genotype-guided arm who are taking these drugs at baseline. Similarly, the rationale for examining a genotype-guided approach to depression medication therapy is based on the demonstrated role of CYP2D6 in the bio inactivation and CYP2C19 oxidation of select, commonly used SSRIs. Secondly, data from industry sponsored trials support the hypothesis of improved depression symptom control in a genotype-guided arm.\n\nStudy objectives:\n\nDetermine if genotype-guided dosing or selection of antidepressants among participants with at least 3 months of depressive symptoms who require new or revised antidepressant therapy leads to improved control of depression, compared to usual care."
                },
                "conditionsModule": {
                    "conditions": [
                        "Depression"
                    ],
                    "keywords": [
                        "Pharmacogenetic",
                        "CYP2D6",
                        "CYP2C19"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "interventionModelDescription": "Immediate vs. delayed pharmacogenetic testing and genotype-guided pain or depression therapy",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 1461,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Depression - Immediate PGx Testing",
                            "type": "EXPERIMENTAL",
                            "description": "Immediate genetic testing of CYP2D6 and CYP2C19 and clinical decisions support for antidepressant prescribing to the healthcare provider",
                            "interventionNames": [
                                "Other: Pharmacogenetic testing",
                                "Other: Clinical decisions support"
                            ]
                        },
                        {
                            "label": "Depression - Delayed PGx Testing",
                            "type": "OTHER",
                            "description": "Delayed genetic testing of CYP2D6 and CYP2C19 and return of results after the conclusion of the 6-month follow-up period",
                            "interventionNames": [
                                "Other: Pharmacogenetic testing"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "OTHER",
                            "name": "Pharmacogenetic testing",
                            "description": "Genetic testing of CYP2D6 and CYP2C19",
                            "armGroupLabels": [
                                "Depression - Delayed PGx Testing",
                                "Depression - Immediate PGx Testing"
                            ]
                        },
                        {
                            "type": "OTHER",
                            "name": "Clinical decisions support",
                            "description": "Prescribing recommendations to the provider based on the pharmacogenetic testing results",
                            "armGroupLabels": [
                                "Depression - Immediate PGx Testing"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "3 Month Depression Symptom Control Change from Baseline",
                            "description": "Depression symptom control, defined as change in PROMIS depression T-scores from baseline to 3-months in genotypic or pheno-converted CYP2D6 ultra-rapid or poor metabolizers or CYP2C19 ultra-rapid, rapid, or poor metabolizers",
                            "timeFrame": "Baseline and 3 months"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "3 Month Change in PHQ of Depression Symptomatology Change from Baseline Scores",
                            "description": "Change in PHQ-8 scores between baseline and 3 months in genotypic or pheno-converted CYP2D6 ultra-rapid or poor metabolizers or CYP2C19 ultra-rapid, rapid, or poor metabolizers. Achieve 50% reduction in scores.",
                            "timeFrame": "baseline and 3 months"
                        },
                        {
                            "measure": "3 Month Medication Side Effect Burden Change from Baseline",
                            "description": "Side effect burden is defined as the number of side effects experienced from a specified list of possible side effects, weighted by the severity of each side effect in genotypic or pheno-converted CYP2D6 ultra-rapid or poor metabolizers or CYP2C19 ultra-rapid, rapid, or poor metabolizers",
                            "timeFrame": "3 months"
                        },
                        {
                            "measure": "3 Month Medication Adherence Change from Baseline",
                            "description": "Medication adherence score derived from the Voils Medication Adherence survey in genotypic or pheno-converted CYP2D6 ultra-rapid or poor metabolizers or CYP2C19 ultra-rapid, rapid, or poor metabolizers",
                            "timeFrame": "3 months"
                        },
                        {
                            "measure": "6 Month Depression Remission Change from Baseline",
                            "description": "Remission is defined as whether or not the summed raw responses to the PROMIS emotional distress depression survey is \u2264 16, corresponding to a participant respond \"rarely\" or \"never\" to most or all questions.",
                            "timeFrame": "6 months"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\nDepression Trial\n\n* Age \u2265 8 years\n* English speaking or Spanish speaking\n* Patients followed at psychiatry clinics or primary care clinics at an enrolling site (such as, but not limited to, Internal Medicine, Family Medicine, or Pediatrics)\n* Documentation of depression and/or provider report of depression\n* Evidence of depressive symptoms for at least 3 months based on patient interview or documentation in electronic health records\n* Recent initiation of SSRI therapy, recent revised SSRI therapy, or anticipated need for revised or new SSRI therapy per health care provider\n\nExclusion Criteria\n\nTrial-wide:\n\n* Life expectancy less than 12 months\n* Are too cognitively impaired to provide informed consent and/or complete study protocol\n* Are institutionalized or too ill to participate (i.e. mental or nursing home facility or incarcerated)\n* Have a history of allogeneic stem cell transplant or liver transplant\n* People with prior clinical pharmacogenetic test results for genes relevant for the study in which they will enroll (CYP2D6 for the pain studies and CYP2D6 or CYP2C19 for depression) or already enrolled in an ADOPT PGx trial\n\nDepression Trial\n\n* Plan to move out of the area within 6 months of enrollment\n* Have active psychosis or diagnosed psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, psychotic depression, substance induced psychosis, schizophreniform disorder)\n* Have dementia or other neurocognitive disorders due to any cause, such as Alzheimer's disease, vascular/subcortical, lewy body disease, frontotemporal lobar degeneration\n* Have cognitive developmental delay and/or cognitive disability, including autism spectrum disorders (Note: ADHD is not an exclusion criteria)\n* Has a seizure disorder\n* Have bipolar disorder",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "8 Years",
                    "stdAges": [
                        "CHILD",
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Hrishikesh Chakraborty",
                            "affiliation": "Duke University",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Nemours Children's Health System",
                            "city": "Wilmington",
                            "state": "Delaware",
                            "zip": "19803",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.74595,
                                "lon": -75.54659
                            }
                        },
                        {
                            "facility": "University of Florida - Gainesville",
                            "city": "Gainesville",
                            "state": "Florida",
                            "zip": "32610",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.65163,
                                "lon": -82.32483
                            }
                        },
                        {
                            "facility": "Nemours Children's Health System",
                            "city": "Jacksonville",
                            "state": "Florida",
                            "zip": "32207",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.33218,
                                "lon": -81.65565
                            }
                        },
                        {
                            "facility": "University of Florida - Jacksonville",
                            "city": "Jacksonville",
                            "state": "Florida",
                            "zip": "32209",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.33218,
                                "lon": -81.65565
                            }
                        },
                        {
                            "facility": "Nemours Children's Health System",
                            "city": "Orlando",
                            "state": "Florida",
                            "zip": "32827",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 28.53834,
                                "lon": -81.37924
                            }
                        },
                        {
                            "facility": "Eskenazi Health",
                            "city": "Indianapolis",
                            "state": "Indiana",
                            "zip": "46202",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76838,
                                "lon": -86.15804
                            }
                        },
                        {
                            "facility": "Indiana University",
                            "city": "Indianapolis",
                            "state": "Indiana",
                            "zip": "46202",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76838,
                                "lon": -86.15804
                            }
                        },
                        {
                            "facility": "Icahn School of Medicine at Mount Sinai",
                            "city": "New York",
                            "state": "New York",
                            "zip": "10029",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.71427,
                                "lon": -74.00597
                            }
                        },
                        {
                            "facility": "The Institute for Family Health",
                            "city": "New York",
                            "state": "New York",
                            "zip": "10035",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.71427,
                                "lon": -74.00597
                            }
                        },
                        {
                            "facility": "Duke University Medical Center",
                            "city": "Durham",
                            "state": "North Carolina",
                            "zip": "27710",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.99403,
                                "lon": -78.89862
                            }
                        },
                        {
                            "facility": "Sanford Health",
                            "city": "Fargo",
                            "state": "North Dakota",
                            "zip": "58104",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 46.87719,
                                "lon": -96.7898
                            }
                        },
                        {
                            "facility": "Meharry Medical College",
                            "city": "Nashville",
                            "state": "Tennessee",
                            "zip": "37208",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.16589,
                                "lon": -86.78444
                            }
                        },
                        {
                            "facility": "Nashville General Hospital",
                            "city": "Nashville",
                            "state": "Tennessee",
                            "zip": "37208",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.16589,
                                "lon": -86.78444
                            }
                        },
                        {
                            "facility": "Vanderbilt University Medical Center",
                            "city": "Nashville",
                            "state": "Tennessee",
                            "zip": "37232",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.16589,
                                "lon": -86.78444
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "38860639",
                            "type": "BACKGROUND",
                            "citation": "Hines LJ, Wilke RA, Myers R, Mathews CA, Liu M, Baye JF, Petry N, Cicali EJ, Duong BQ, Elwood E, Hulvershorn L, Nguyen K, Ramos M, Sadeghpour A, Wu RR, Williamson L, Wiisanen K, Voora D, Singh R, Blake KV, Murrough JW, Volpi S, Ginsburg GS, Horowitz CR, Orlando L, Chakraborty H, Dexter P, Johnson JA, Skaar TC, Cavallari LH, Van Driest SL, Peterson JF; IGNITE Pragmatic Trials Network. Rationale and design for a pragmatic randomized trial to assess gene-based prescribing for SSRIs in the treatment of depression. Clin Transl Sci. 2024 Jun;17(6):e13822. doi: 10.1111/cts.13822."
                        }
                    ],
                    "seeAlsoLinks": [
                        {
                            "label": "Rationale and design for a pragmatic randomized trial to assess gene-based prescribing for SSRIs in the treatment of depression",
                            "url": "http://pubmed.ncbi.nlm.nih.gov/38860639/"
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "ICF",
                            "hasProtocol": false,
                            "hasSap": false,
                            "hasIcf": true,
                            "label": "Informed Consent Form",
                            "date": "2023-07-14",
                            "uploadDate": "2023-11-14T16:28",
                            "filename": "ICF_000.pdf",
                            "size": 430296
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D003863",
                            "term": "Depression"
                        },
                        {
                            "id": "D003866",
                            "term": "Depressive Disorder"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D001526",
                            "term": "Behavioral Symptoms"
                        },
                        {
                            "id": "D019964",
                            "term": "Mood Disorders"
                        },
                        {
                            "id": "D001523",
                            "term": "Mental Disorders"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M7058",
                            "name": "Depression",
                            "asFound": "Depression",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7061",
                            "name": "Depressive Disorder",
                            "asFound": "Depression",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4818",
                            "name": "Behavioral Symptoms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21835",
                            "name": "Mood Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14473",
                            "name": "Psychotic Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4815",
                            "name": "Mental Disorders",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BXM",
                            "name": "Behaviors and Mental Disorders"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M4033",
                            "name": "Analgesics, Opioid",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4247",
                            "name": "Antidepressive Agents",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Analg",
                            "name": "Analgesics"
                        },
                        {
                            "abbrev": "CNSDep",
                            "name": "Central Nervous System Depressants"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "PsychDr",
                            "name": "Psychotropic Drugs"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01565655",
                    "orgStudyIdInfo": {
                        "id": "015K-CL-RA22"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "2011-006020-20",
                            "type": "EUDRACT_NUMBER"
                        }
                    ],
                    "organization": {
                        "fullName": "Astellas Pharma Inc",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis",
                    "officialTitle": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Patients"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2012-06-19",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2013-12-02",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2013-12-02",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2012-03-27",
                    "studyFirstSubmitQcDate": "2012-03-27",
                    "studyFirstPostDateStruct": {
                        "date": "2012-03-29",
                        "type": "ESTIMATED"
                    },
                    "dispFirstSubmitDate": "2014-12-01",
                    "dispFirstSubmitQcDate": "2014-12-01",
                    "dispFirstPostDateStruct": {
                        "date": "2014-12-16",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Astellas Pharma Global Development, Inc.",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true
                },
                "descriptionModule": {
                    "briefSummary": "The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis (RA) subjects",
                    "detailedDescription": "Subjects will take ASP015K or matching placebo orally with food for 12 weeks after randomization. Potential subjects who have previously used disease-modifying antirheumatic drugs (DMARDs) and/or biologic agents may be eligible to participate after completing a washout period. Subjects who complete the 12-week dosing period in this study may be eligible to participate in a long-term, open-label Extension Study."
                },
                "conditionsModule": {
                    "conditions": [
                        "Arthritis, Rheumatoid"
                    ],
                    "keywords": [
                        "Rheumatoid Arthritis",
                        "ASP015K"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "TRIPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 289,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "ASP015K lowest dose",
                            "type": "EXPERIMENTAL",
                            "description": "ASP015K lowest dose once daily",
                            "interventionNames": [
                                "Drug: peficitinib"
                            ]
                        },
                        {
                            "label": "ASP015K low dose",
                            "type": "EXPERIMENTAL",
                            "description": "ASP015K low dose once daily",
                            "interventionNames": [
                                "Drug: peficitinib"
                            ]
                        },
                        {
                            "label": "ASP015K medium dose",
                            "type": "EXPERIMENTAL",
                            "description": "ASP015K medium dose once daily",
                            "interventionNames": [
                                "Drug: peficitinib"
                            ]
                        },
                        {
                            "label": "ASP015K high dose",
                            "type": "EXPERIMENTAL",
                            "description": "ASP015K high dose once daily",
                            "interventionNames": [
                                "Drug: peficitinib"
                            ]
                        },
                        {
                            "label": "Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Matching placebo once daily",
                            "interventionNames": [
                                "Drug: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "peficitinib",
                            "description": "oral",
                            "armGroupLabels": [
                                "ASP015K high dose",
                                "ASP015K low dose",
                                "ASP015K lowest dose",
                                "ASP015K medium dose"
                            ],
                            "otherNames": [
                                "ASP015K"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "oral",
                            "armGroupLabels": [
                                "Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Percentage of subjects achieving American College of Rheumatology Criteria 20 (ACR 20) response",
                            "timeFrame": "Week 12"
                        },
                        {
                            "measure": "Trough plasma concentration of ASP015K and metabolite(s)",
                            "timeFrame": "up to Week 12 (6 time points)"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Percentage of subjects achieving ACR 50 response",
                            "timeFrame": "Week 12"
                        },
                        {
                            "measure": "Percentage of subjects achieving ACR 70 response",
                            "timeFrame": "Week 12"
                        },
                        {
                            "measure": "Change from baseline in Disease Activity Score using 28 joint count and C Reactive Protein (DAS28-CRP)",
                            "timeFrame": "Baseline and Week 12"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* \u2265 6 tender/painful joints; \u2265 6 swollen joints\n* C-Reactive Protein (CRP) of \u2265 0.8 mg/dL or Erythrocyte Sedimentation Rate (ESR) of \u2265 28 mm/hr\n* Subject meets the ACR 1991 Revised Criteria for Global Functional Status in RA Class I, II or III at Screening and Baseline\n* Use of non-steroidal anti-inflammatory drugs \\[NSAIDs\\], cyclooxygenase-2 (COX-2) inhibitors, or oral corticosteroids for the treatment of RA must be stable for at least 28 days prior to start of the study\n* Male and female subjects must be willing to comply with contraception requirements as well as restrictions regarding egg and sperm donation\n* Female subject must not be breastfeeding at Screening or during the study period, and for 60 days after the final study drug administration\n* Subject agrees not to participate in another interventional study while on treatment\n\nExclusion Criteria:\n\n* Positive Mycobacterium tuberculosis (TB) test within 90 days of Screening\n* Abnormal chest x-ray indicative of an acute or chronic infectious process or malignancy\n* Receipt of live or live attenuated virus vaccination within 30 days prior to the first dose of study drug\n* Known history of positive test for hepatitis B surface antigen (HBsAg) or hepatitis C antibody or history of a positive test for human immunodeficiency virus (HIV) infection\n* History of any other autoimmune rheumatic disease, other than Sjogren's syndrome\n* Previous history of clinically significant infections or illness (requiring hospitalization or requiring parenteral therapy) within 90 days of the Baseline visit, or a history of any illness that would preclude participation in the study\n* History of any malignancy, except for successfully treated basal or squamous cell carcinoma of the skin or in-situ carcinoma of the cervix.\n* Does not meet specified washout criteria for the following RA medications: gold, azathioprine, minocycline, penicillamine, etanercept, certolizumab, adalimumab, golimumab, infliximab, cyclophosphamide, and leflunomide\n* Previous intolerance to Janus kinase (JAK) inhibitors\n* Receipt of intra-articular or parenteral corticosteroid within 28 days prior to the first dose of study drug or is currently taking \\> 30 mg oral morphine (or narcotic equivalent) per day\n* Receipt of plasma exchange therapy within 60 days prior to the start of study drug\n* Receipt of any investigational agent within 30 days or 5 half-lives, whichever is longer, prior to first dose of study drug\n* Receipt of medications that are CYP3A substrates with narrow therapeutic range within 14 days prior to first dose of study drug\n* History of heart failure, defined as New York Heart Association (NYHA) grade 3 or greater\n* History of long QT syndrome or prolonged QT interval\n* Any ongoing severe, progressive, or uncontrolled renal, hepatic, hematological, gastrointestinal, metabolic, endocrine, pulmonary, cardiac, neurological, or infectious disease, or any ongoing illness which would make the subject unsuitable for the study\n* Subject has any condition possibly affecting oral absorption (e.g., gastrectomy, other malabsorption syndromes, or clinically significant diabetic gastroenteropathy)",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Senior Medical Director",
                            "affiliation": "Astellas Pharma Global Development",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Achieve Clinical Research, LLC",
                            "city": "Birmingham",
                            "state": "Alabama",
                            "zip": "35216",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.52066,
                                "lon": -86.80249
                            }
                        },
                        {
                            "facility": "University of California San Diego",
                            "city": "La Jolla",
                            "state": "California",
                            "zip": "92093-0943",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.84727,
                                "lon": -117.2742
                            }
                        },
                        {
                            "facility": "Desert Medical Advances",
                            "city": "Palm Desert",
                            "state": "California",
                            "zip": "92260",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.72255,
                                "lon": -116.37697
                            }
                        },
                        {
                            "facility": "Stanford University School of Medicine",
                            "city": "Palo Alto",
                            "state": "California",
                            "zip": "94304",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.44188,
                                "lon": -122.14302
                            }
                        },
                        {
                            "facility": "Pacific Arthritis Center Medical Group",
                            "city": "Santa Maria",
                            "state": "California",
                            "zip": "93454",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.95303,
                                "lon": -120.43572
                            }
                        },
                        {
                            "facility": "Arthritis Associates of Colorado Springs",
                            "city": "Colorado Springs",
                            "state": "Colorado",
                            "zip": "80910",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.83388,
                                "lon": -104.82136
                            }
                        },
                        {
                            "facility": "Jacksonville Center for Clinical Research",
                            "city": "Jacksonville",
                            "state": "Florida",
                            "zip": "32216",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.33218,
                                "lon": -81.65565
                            }
                        },
                        {
                            "facility": "Arthritis Associates",
                            "city": "Orlando",
                            "state": "Florida",
                            "zip": "32804",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 28.53834,
                                "lon": -81.37924
                            }
                        },
                        {
                            "facility": "Illinois Bone & Joint Institute; LLC",
                            "city": "Morton Grove",
                            "state": "Illinois",
                            "zip": "60053",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.04059,
                                "lon": -87.78256
                            }
                        },
                        {
                            "facility": "Deerbrook Medical Asssociates",
                            "city": "Vernon Hills",
                            "state": "Illinois",
                            "zip": "60061",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.21947,
                                "lon": -87.97952
                            }
                        },
                        {
                            "facility": "Center for Arthritis and Osteoporosis",
                            "city": "Elizabethtown",
                            "state": "Kentucky",
                            "zip": "42701",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.69395,
                                "lon": -85.85913
                            }
                        },
                        {
                            "facility": "The Center for Rheumatology and Bone Research",
                            "city": "Wheaton",
                            "state": "Maryland",
                            "zip": "20902",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.03983,
                                "lon": -77.05526
                            }
                        },
                        {
                            "facility": "PMG Research",
                            "city": "Hickory",
                            "state": "North Carolina",
                            "zip": "28602",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.73319,
                                "lon": -81.3412
                            }
                        },
                        {
                            "facility": "Health Research of Oklahoma",
                            "city": "Oklahoma City",
                            "state": "Oklahoma",
                            "zip": "73103",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.46756,
                                "lon": -97.51643
                            }
                        },
                        {
                            "facility": "Altoona Center for Clinical Research",
                            "city": "Duncansville",
                            "state": "Pennsylvania",
                            "zip": "16635",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.42341,
                                "lon": -78.4339
                            }
                        },
                        {
                            "facility": "Clincal Research Center of Reading",
                            "city": "Wyomissing",
                            "state": "Pennsylvania",
                            "zip": "19610",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.32954,
                                "lon": -75.96521
                            }
                        },
                        {
                            "facility": "Rheumatology Consultants, PLLC",
                            "city": "Knoxville",
                            "state": "Tennessee",
                            "zip": "37909-1907",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.96064,
                                "lon": -83.92074
                            }
                        },
                        {
                            "facility": "Austin Rheumatology Research PA",
                            "city": "Austin",
                            "state": "Texas",
                            "zip": "78705",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.26715,
                                "lon": -97.74306
                            }
                        },
                        {
                            "facility": "Mountain State Clinical Research",
                            "city": "Clarksburg",
                            "state": "West Virginia",
                            "zip": "26301",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.28065,
                                "lon": -80.34453
                            }
                        },
                        {
                            "facility": "MHAT Burgas",
                            "city": "Burgas",
                            "zip": "8000",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.50606,
                                "lon": 27.46781
                            }
                        },
                        {
                            "facility": "MHAT Plovdiv AD",
                            "city": "Plovdiv",
                            "zip": "4003",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.15,
                                "lon": 24.75
                            }
                        },
                        {
                            "facility": "MHAT \"Sv. Ivan Rilski\"",
                            "city": "Sofia",
                            "zip": "1612",
                            "country": "Bulgaria",
                            "geoPoint": {
                                "lat": 42.69751,
                                "lon": 23.32415
                            }
                        },
                        {
                            "facility": "Revmatologicky ustav",
                            "city": "Praha 2",
                            "zip": "128 50",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 50.08804,
                                "lon": 14.42076
                            }
                        },
                        {
                            "facility": "Revmatologicka ambulance",
                            "city": "Praha-Nusle",
                            "zip": "140 00",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 50.08804,
                                "lon": 14.42076
                            }
                        },
                        {
                            "facility": "MEDICAL PLUS, s.r.o. or REVMACENTRUM UH, s.r.o.",
                            "city": "Uherske Hradiste",
                            "zip": "68601",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 49.06975,
                                "lon": 17.45969
                            }
                        },
                        {
                            "facility": "PV-MEDICAL s.r.o.",
                            "city": "Zlin",
                            "zip": "760 01",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 49.22645,
                                "lon": 17.67065
                            }
                        },
                        {
                            "facility": "Rethy Pal Korhaz es Rendelointezet",
                            "city": "Bekescsaba",
                            "zip": "5600",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 46.68333,
                                "lon": 21.1
                            }
                        },
                        {
                            "facility": "Budai Irgalmasrendi Korhaz",
                            "city": "Budapest,",
                            "zip": "1027",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "facility": "Orszgos Reumatolgiai s Fizioterpis Intzet",
                            "city": "Budapest",
                            "zip": "1027",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "facility": "Revita Clinic Rheumatology",
                            "city": "Budapest",
                            "zip": "1027",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "facility": "Kenezy Hospital Institute of Clinical Pharmacology",
                            "city": "Debrecen",
                            "zip": "H-4043",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.53333,
                                "lon": 21.63333
                            }
                        },
                        {
                            "facility": "Cliditer S.A. de C.V.",
                            "city": "M\u00e9xico",
                            "state": "Distrito Federal",
                            "zip": "6700",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 19.42847,
                                "lon": -99.12766
                            }
                        },
                        {
                            "facility": "Dr Javier Orozco Alcala Private Doctor\u00b4s office",
                            "city": "Guadalajara",
                            "zip": "44650",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 20.66682,
                                "lon": -103.39182
                            }
                        },
                        {
                            "facility": "Centro de Investigacion Clinica de Morelia, S.C.",
                            "city": "Morelia",
                            "zip": "58070",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 19.70078,
                                "lon": -101.18443
                            }
                        },
                        {
                            "facility": "Szpital Uniwersytecki nr. 2 im. Dr. Jana Biziela",
                            "city": "Bydgoszcz",
                            "zip": "85-168",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 53.1235,
                                "lon": 18.00762
                            }
                        },
                        {
                            "facility": "NZOZ Centrum Medyczne ProMiMed",
                            "city": "Krakow",
                            "zip": "31-637",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 50.06143,
                                "lon": 19.93658
                            }
                        },
                        {
                            "facility": "Zespol Poradni Specjalistycznych, REUMED sp. Zo.o",
                            "city": "Lublin",
                            "zip": "20-582",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 51.25,
                                "lon": 22.56667
                            }
                        },
                        {
                            "facility": "ARS Rheumatica",
                            "city": "Warszawa",
                            "zip": "02-653",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.22977,
                                "lon": 21.01178
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "33068028",
                            "type": "DERIVED",
                            "citation": "Toyoshima J, Shibata M, Kaibara A, Kaneko Y, Izutsu H, Nishimura T. Population pharmacokinetic analysis of peficitinib in patients with rheumatoid arthritis. Br J Clin Pharmacol. 2021 Apr;87(4):2014-2022. doi: 10.1111/bcp.14605. Epub 2020 Dec 1."
                        },
                        {
                            "pmid": "28118538",
                            "type": "DERIVED",
                            "citation": "Genovese MC, Greenwald M, Codding C, Zubrzycka-Sienkiewicz A, Kivitz AJ, Wang A, Shay K, Wang X, Garg JP, Cardiel MH. Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis. Arthritis Rheumatol. 2017 May;69(5):932-942. doi: 10.1002/art.40054."
                        }
                    ],
                    "seeAlsoLinks": [
                        {
                            "label": "Link to results on the Astellas Clinical Study Results website",
                            "url": "https://astellasclinicalstudyresults.com/study.aspx?ID=323"
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "YES",
                    "description": "Access to anonymized individual participant level data collected during the study, in addition to study-related supporting documentation, is planned for studies conducted with approved product indications and formulations, as well as products terminated during development. Studies conducted with product indications or formulations that remain active in development are assessed after study completion to determine if Individual Participant Data can be shared. Further details on Astellas' data sharing policy can be found at https://www.clinicaltrials.astellas.com/transparency/.",
                    "infoTypes": [
                        "STUDY_PROTOCOL",
                        "SAP",
                        "CSR"
                    ],
                    "timeFrame": "Access to participant level data is offered to researchers after publication of the primary manuscript (if applicable) and is available as long as Astellas has legal authority to provide the data.",
                    "accessCriteria": "Researchers must submit a proposal to conduct a scientifically relevant analysis of the study data. The research proposal is reviewed by an Independent Research Panel. If the proposal is approved, access to the study data is provided in a secure data sharing environment after receipt of a signed Data Sharing Agreement.",
                    "url": "https://www.clinicaltrials.astellas.com/transparency/"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18",
                    "removedCountries": [
                        "Czech Republic"
                    ]
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D001168",
                            "term": "Arthritis"
                        },
                        {
                            "id": "D001172",
                            "term": "Arthritis, Rheumatoid"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D007592",
                            "term": "Joint Diseases"
                        },
                        {
                            "id": "D009140",
                            "term": "Musculoskeletal Diseases"
                        },
                        {
                            "id": "D012216",
                            "term": "Rheumatic Diseases"
                        },
                        {
                            "id": "D003240",
                            "term": "Connective Tissue Diseases"
                        },
                        {
                            "id": "D001327",
                            "term": "Autoimmune Diseases"
                        },
                        {
                            "id": "D007154",
                            "term": "Immune System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M4476",
                            "name": "Arthritis",
                            "asFound": "Arthritis",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4480",
                            "name": "Arthritis, Rheumatoid",
                            "asFound": "Arthritis, Rheumatoid",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10621",
                            "name": "Joint Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12097",
                            "name": "Musculoskeletal Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15045",
                            "name": "Rheumatic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6323",
                            "name": "Collagen Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6464",
                            "name": "Connective Tissue Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4629",
                            "name": "Autoimmune Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10200",
                            "name": "Immune System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC05",
                            "name": "Musculoskeletal Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC17",
                            "name": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "abbrev": "BC20",
                            "name": "Immune System Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "C000608065",
                            "term": "Peficitinib"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D004791",
                            "term": "Enzyme Inhibitors"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D007166",
                            "term": "Immunosuppressive Agents"
                        },
                        {
                            "id": "D007155",
                            "term": "Immunologic Factors"
                        },
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M259039",
                            "name": "Peficitinib",
                            "asFound": "Attenuate",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7951",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10212",
                            "name": "Immunosuppressive Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10201",
                            "name": "Immunologic Factors",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05031780",
                    "orgStudyIdInfo": {
                        "id": "AG348-C-020"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "2021-001674-34",
                            "type": "EUDRACT_NUMBER"
                        }
                    ],
                    "organization": {
                        "fullName": "Agios Pharmaceuticals, Inc.",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)",
                    "officialTitle": "A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2022-02-11",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2025-12",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2030-02",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2021-07-29",
                    "studyFirstSubmitQcDate": "2021-08-30",
                    "studyFirstPostDateStruct": {
                        "date": "2021-09-02",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Agios Pharmaceuticals, Inc.",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "This clinical trial is a Phase 2/3 study that will determine the recommended dose of mitapivat and evaluate the efficacy and safety of mitapivat in sickle cell disease by testing how well mitapivat works compared to placebo to increase the amount of hemoglobin in the blood and to reduce or prevent the occurrence of sickle cell pain crises. In addition, the long-term effect of mitapivat on efficacy and safety will be explored in an open-label extension portion.",
                    "detailedDescription": "Mitapivat is a small molecule, oral activator of pyruvate kinase R (PKR). PKR is involved with maintaining health, energy, and longevity of red blood cells (RBCs). The study aims to evaluate the efficacy and safety of treatment with mitapivat in participants with sickle cell disease. The study is a Phase 2/3 study in which the recommended dose of mitapivat will be selected and further evaluated. The Phase 2 portion includes a 12-week randomized, placebo-controlled period in which participants will be randomized in a 1:1:1 ratio to receive 2 dose levels of mitapivat or placebo. The Phase 3 portion includes a 52-week randomized, placebo-controlled period in which participants will be randomized in a 2:1 ratio to receive the recommended mitapivat dose level or placebo. Participants who complete either the Phase 2 or Phase 3 portion will have the option to move into a 216-week open label extension period to receive mitapivat."
                },
                "conditionsModule": {
                    "conditions": [
                        "Sickle Cell Disease"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2",
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "SEQUENTIAL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "QUADRUPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 267,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Phase 2: Mitapivat 50 mg BID",
                            "type": "EXPERIMENTAL",
                            "description": "Double-blind Period: Mitapivat 50 milligrams (mg) twice daily (BID) for 12 weeks.",
                            "interventionNames": [
                                "Drug: Mitapivat"
                            ]
                        },
                        {
                            "label": "Phase 2: Mitapivat 100 mg BID",
                            "type": "EXPERIMENTAL",
                            "description": "Double-blind Period: Mitapivat 100 mg BID for 12 weeks.",
                            "interventionNames": [
                                "Drug: Mitapivat"
                            ]
                        },
                        {
                            "label": "Phase 2: Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Double-blind Period: Mitapivat-matching placebo for 12 weeks.",
                            "interventionNames": [
                                "Other: Mitapivat-matching placebo"
                            ]
                        },
                        {
                            "label": "Phase 2: Open-Label Extension Period",
                            "type": "EXPERIMENTAL",
                            "description": "Participants who received mitapivat 50mg BID in the double-blind period may choose to receive mitapivat 50mg BID for 216 weeks after.\n\nParticipants who received mitapivat 100mg BID in the double-blind period may choose to receive mitapivat 100 mg BID for 216 weeks after.\n\nParticipants who received mitapivat-matching placebo in the double-blind period, may be randomized to receive either mitapivat 50 mg or 100 mg BID for 216 weeks after.",
                            "interventionNames": [
                                "Drug: Mitapivat"
                            ]
                        },
                        {
                            "label": "Phase 3: Mitapivat 100 mg BID",
                            "type": "EXPERIMENTAL",
                            "description": "Double-blind Period: Mitapivat 100 mg BID for 52 weeks.",
                            "interventionNames": [
                                "Drug: Mitapivat"
                            ]
                        },
                        {
                            "label": "Phase 3: Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Double-blind Period: Mitapivat-matching placebo for 52 weeks.",
                            "interventionNames": [
                                "Other: Mitapivat-matching placebo"
                            ]
                        },
                        {
                            "label": "Phase 3: Open-Label Extension Period",
                            "type": "EXPERIMENTAL",
                            "description": "Participants may choose to receive mitapivat 100 mg BID for 216 weeks after the Double-blind Period.\n\nParticipants who received mitapivat-matching placebo in the double-blind period, may choose to receive mitapivat 100 mg BID for 216 weeks after the Double-blind Period.",
                            "interventionNames": [
                                "Drug: Mitapivat"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Mitapivat",
                            "description": "Mitapivat tablets",
                            "armGroupLabels": [
                                "Phase 2: Mitapivat 100 mg BID",
                                "Phase 2: Mitapivat 50 mg BID",
                                "Phase 2: Open-Label Extension Period",
                                "Phase 3: Mitapivat 100 mg BID",
                                "Phase 3: Open-Label Extension Period"
                            ],
                            "otherNames": [
                                "AG-348",
                                "Mitapivat Sulfate"
                            ]
                        },
                        {
                            "type": "OTHER",
                            "name": "Mitapivat-matching placebo",
                            "description": "Placebo to match 50 mg or 100 mg tablets",
                            "armGroupLabels": [
                                "Phase 2: Placebo"
                            ]
                        },
                        {
                            "type": "OTHER",
                            "name": "Mitapivat-matching placebo",
                            "description": "Placebo to match 100 mg tablets",
                            "armGroupLabels": [
                                "Phase 3: Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Phase 2: Percentage of Participants With Hemoglobin (Hb) Response",
                            "timeFrame": "Week 12"
                        },
                        {
                            "measure": "Phase 2: Percentage of Participants With Treatment-Emergent Adverse Events (AEs) and Treatment-Emergent Serious AEs (SAEs)",
                            "timeFrame": "Up to Week 12"
                        },
                        {
                            "measure": "Phase 3: Percentage of Participants With Hb Response",
                            "timeFrame": "Week 52"
                        },
                        {
                            "measure": "Phase 3: Annualized Rate of Sickle Cell Pain Crises (SCPCs)",
                            "timeFrame": "Up to Week 52"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Phase 2: Change From Baseline in Hb Concentration",
                            "timeFrame": "Baseline, Week 10 up to Week 12"
                        },
                        {
                            "measure": "Phase 2: Change From Baseline in Indirect Bilirubin",
                            "timeFrame": "Baseline, Week 10 up to Week 12"
                        },
                        {
                            "measure": "Phase 2: Change From Baseline in Lactate Dehydrogenase (LDH)",
                            "timeFrame": "Baseline, Week 10 up to Week 12"
                        },
                        {
                            "measure": "Phase 2: Change From Baseline in Absolute Reticulocytes Count",
                            "timeFrame": "Baseline, Week 10 up to Week 12"
                        },
                        {
                            "measure": "Phase 2: Change From Baseline in Percent Reticulocytes",
                            "timeFrame": "Baseline, Week 10 up to Week 12"
                        },
                        {
                            "measure": "Phase 2: Change From Baseline in Erythropoietin",
                            "timeFrame": "Baseline, Week 10 up to Week 12"
                        },
                        {
                            "measure": "Phase 2: Change From Baseline in Patient-Reported Outcomes Measurement Information System\u00ae (PROMIS\u00ae) Fatigue 13a Short Form (SF) Score",
                            "timeFrame": "Baseline, Week 10 up to Week 12"
                        },
                        {
                            "measure": "Phase 2: Annualized Rate of SCPCs",
                            "timeFrame": "Up to Week 12"
                        },
                        {
                            "measure": "Phase 2: Pharmacokinetic/Pharmacodynamic Relationship: Evaluate the Exposure of Mitapivat to the Change in Adenosine Triphosphate (ATP) and 2,3-Diphosphoglycerate (2,3-DPG)",
                            "timeFrame": "Day 1 up to Week 8"
                        },
                        {
                            "measure": "Phase 2: Mitapivat Concentration Over Time",
                            "timeFrame": "Day 1 up to Week 8"
                        },
                        {
                            "measure": "Phase 2: Mitapivat Area Under the Concentration",
                            "timeFrame": "Day 1 up to Week 8"
                        },
                        {
                            "measure": "Phase 2: Mitapivat Maximum (Peak) Concentration",
                            "timeFrame": "Day 1 up to Week 8"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in Hb Concentration",
                            "timeFrame": "Baseline, Week 24 up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in Indirect Bilirubin",
                            "timeFrame": "Baseline, Week 24 up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in Percent Reticulocytes",
                            "timeFrame": "Baseline, Week 24 up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in PROMIS\u00ae Fatigue 13a SF Scores",
                            "timeFrame": "Baseline, Week 24 up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Annualized Frequency of Hospitalizations for SCPC",
                            "timeFrame": "Up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in LDH Concentration",
                            "timeFrame": "Baseline, Week 24 up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in Absolute Reticulocytes",
                            "timeFrame": "Baseline, Week 24 up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in Erythropoietin",
                            "timeFrame": "Baseline, Week 24 up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Percentage of Participants With Improvement in the Patient Global Impression of Severity (PGIS) -Fatigue",
                            "timeFrame": "Baseline, Weeks 24, 28, 40, and 52"
                        },
                        {
                            "measure": "Phase 3: Percentage of Participants With Improvement in the Patient Global Impression of Change (PGIC) -Fatigue",
                            "timeFrame": "Baseline, Weeks 24, 28, 40, and 52"
                        },
                        {
                            "measure": "Phase 3: Time to First SCPC",
                            "timeFrame": "Up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Time to Second SCPC",
                            "timeFrame": "Up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Annualized Rate of Hospitalization Days for SCPC",
                            "timeFrame": "Up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Annualized Rate of Emergency Room Visits for SCPC",
                            "timeFrame": "Up to Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in 6-Minute Walk Test (6MWT)",
                            "timeFrame": "Baseline, Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in PROMIS Pain Intensity",
                            "timeFrame": "Baseline, Week 24 and 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) Pain Impact",
                            "timeFrame": "Baseline, Week 24 and 52"
                        },
                        {
                            "measure": "Phase 3: PGIC of Pain",
                            "timeFrame": "Baseline, Week 52"
                        },
                        {
                            "measure": "Phase 3: Change From Baseline in PGIS of Pain",
                            "timeFrame": "Baseline, Week 52"
                        },
                        {
                            "measure": "Phase 3: Percentage of Participants With Treatment-Emergent Adverse Events (AEs) and Treatment-Emergent Serious AEs (SAEs)",
                            "timeFrame": "Up to 56 weeks"
                        },
                        {
                            "measure": "Phase 3: Pharmacokinetic/Pharmacodynamic Relationship: Evaluate the Exposure of Mitapivat to the Change in ATP and 2,3-DPG Levels",
                            "timeFrame": "Day 1 up to Week 40"
                        },
                        {
                            "measure": "Phase 3: Mitapivat Concentration Over Time",
                            "timeFrame": "Day 1 up to Week 40"
                        },
                        {
                            "measure": "Phase 3: Mitapivat Area Under the Concentration Curve",
                            "timeFrame": "Day 1 up to Week 40"
                        },
                        {
                            "measure": "Phase 3: Mitapivat Maximum (Peak) Concentration",
                            "timeFrame": "Day 1 up to Week 40"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 16 years or older (18 years or older \\[France and Germany\\]); participants age 16 or 17 years must physically have completed puberty;\n* Documented diagnosis of sickle cell disease (SCD) (HbSS, HbSC \\[combined heterozygosity for hemoglobins S and C\\], HbS/beta 0- thalassemia, HbS/ beta plus thalassemia, or other sickle cell syndrome variants);\n* At least 2 SCPCs and no more than 10 SCPCs in the past 12 months;\n* Hemoglobin at least 5.5 and 10.5 gram per deciliter (g/dL) at the most. Hemoglobin concentration must be based on an average of at least 2 Hb concentration measurements (separated by \u22657 days) collected during the Screening Period;\n* If taking hydroxyurea, the hydroxyurea dose must be stable for at least 90 days before starting study drug. Discontinuation of hydroxyurea requires a 90-day washout prior to informed assent/consent;\n* Women capable of becoming pregnant must agree to use 2 forms of contraception.\n\nExclusion Criteria:\n\n* Pregnant, breastfeeding, or parturient;\n* Receiving regularly scheduled transfusions;\n* Hepatobiliary disorders including but not limited to significant liver disease or gallbladder disease;\n* Severe kidney disease;\n* Prior exposure to gene therapy or prior bone marrow or stem cell transplantation;\n* Currently receiving treatment with a disease-modifying therapy for SCD (eg, voxelotor, crizanlizumab, L-glutamine), with the exception of hydroxyurea. The last dose of voxelotor, crizanlizumab, and L-glutamine must have been administered at least 90 days before randomization;\n* Currently receiving treatment with hematopoietic stimulating agents; the last dose must have been administered at least 90 days before starting study drug;\n* Received treatment on another investigational trial within 90 days prior to start of study drug or plans to participate in another investigational drug trial;\n* Taking medications that are strong inhibitors of CYP3A4/5 or strong inducers of CYP3A4 that cannot be stopped in an acceptable timeframe before starting study drug (timeframe will be discussed with your doctor).",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "16 Years",
                    "stdAges": [
                        "CHILD",
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Agios Medical Affairs",
                            "role": "CONTACT",
                            "phone": "833-228-8474",
                            "email": "medinfo@agios.com"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "University of California San Diego",
                            "status": "RECRUITING",
                            "city": "La Jolla",
                            "state": "California",
                            "zip": "92037-1337",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.84727,
                                "lon": -117.2742
                            }
                        },
                        {
                            "facility": "UCLA Health",
                            "status": "RECRUITING",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90095-1678",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Children's Hospital Oakland",
                            "status": "RECRUITING",
                            "city": "Oakland",
                            "state": "California",
                            "zip": "94609",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.80437,
                                "lon": -122.2708
                            }
                        },
                        {
                            "facility": "University of Connecticut Health Center",
                            "status": "RECRUITING",
                            "city": "Farmington",
                            "state": "Connecticut",
                            "zip": "06030-0001",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.71982,
                                "lon": -72.83204
                            }
                        },
                        {
                            "facility": "Yale University",
                            "status": "WITHDRAWN",
                            "city": "New Haven",
                            "state": "Connecticut",
                            "zip": "06520",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.30815,
                                "lon": -72.92816
                            }
                        },
                        {
                            "facility": "Children's National Hospital",
                            "status": "RECRUITING",
                            "city": "Washington",
                            "state": "District of Columbia",
                            "zip": "20010-2916",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.89511,
                                "lon": -77.03637
                            }
                        },
                        {
                            "facility": "MedStar Washington Hospital Center",
                            "status": "RECRUITING",
                            "city": "Washington",
                            "state": "District of Columbia",
                            "zip": "20010",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.89511,
                                "lon": -77.03637
                            }
                        },
                        {
                            "facility": "Sylvester Comprehensive Cancer Center-Miami",
                            "status": "RECRUITING",
                            "city": "Miami",
                            "state": "Florida",
                            "zip": "33101",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 25.77427,
                                "lon": -80.19366
                            }
                        },
                        {
                            "facility": "Children's Healthcare of Atlanta",
                            "status": "NOT_YET_RECRUITING",
                            "city": "Atlanta",
                            "state": "Georgia",
                            "zip": "30342-3283",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.749,
                                "lon": -84.38798
                            }
                        },
                        {
                            "facility": "University of Chicago Medical Center",
                            "status": "RECRUITING",
                            "city": "Chicago",
                            "state": "Illinois",
                            "zip": "60637-1443",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.85003,
                                "lon": -87.65005
                            }
                        },
                        {
                            "facility": "Riley Hospital For Children",
                            "status": "RECRUITING",
                            "city": "Indianapolis",
                            "state": "Indiana",
                            "zip": "46202-5109",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76838,
                                "lon": -86.15804
                            }
                        },
                        {
                            "facility": "LSU Health Sciences Center - Shreveport",
                            "status": "RECRUITING",
                            "city": "Shreveport",
                            "state": "Louisiana",
                            "zip": "71103-4228",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.52515,
                                "lon": -93.75018
                            }
                        },
                        {
                            "facility": "National Heart Lung and Blood Institute",
                            "status": "RECRUITING",
                            "city": "Bethesda",
                            "state": "Maryland",
                            "zip": "20814",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.98067,
                                "lon": -77.10026
                            }
                        },
                        {
                            "facility": "Kaiser Permanente - Largo Medical Center",
                            "status": "RECRUITING",
                            "city": "Largo",
                            "state": "Maryland",
                            "zip": "20774-5374",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.89761,
                                "lon": -76.83025
                            }
                        },
                        {
                            "facility": "Massachusetts General Hospital",
                            "status": "RECRUITING",
                            "city": "Boston",
                            "state": "Massachusetts",
                            "zip": "02114-2621",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.35843,
                                "lon": -71.05977
                            }
                        },
                        {
                            "facility": "Boston Children's Hospital",
                            "status": "RECRUITING",
                            "city": "Boston",
                            "state": "Massachusetts",
                            "zip": "02115-5724",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.35843,
                                "lon": -71.05977
                            }
                        },
                        {
                            "facility": "Boston Medical Center & Boston University School of Medicine",
                            "status": "RECRUITING",
                            "city": "Boston",
                            "state": "Massachusetts",
                            "zip": "02118",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.35843,
                                "lon": -71.05977
                            }
                        },
                        {
                            "facility": "University of Michigan",
                            "status": "RECRUITING",
                            "city": "Ann Arbor",
                            "state": "Michigan",
                            "zip": "48109-5000",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.27756,
                                "lon": -83.74088
                            }
                        },
                        {
                            "facility": "Children's Hospital of Michigan",
                            "status": "RECRUITING",
                            "city": "Detroit",
                            "state": "Michigan",
                            "zip": "48201",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.33143,
                                "lon": -83.04575
                            }
                        },
                        {
                            "facility": "Mississippi Center for Advanced Medicine",
                            "status": "RECRUITING",
                            "city": "Madison",
                            "state": "Mississippi",
                            "zip": "39110-6115",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.46181,
                                "lon": -90.11536
                            }
                        },
                        {
                            "facility": "Cure 4 The Kids Foundation, A Division of Roseman University of Health Sciences",
                            "status": "RECRUITING",
                            "city": "Las Vegas",
                            "state": "Nevada",
                            "zip": "89106",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.17497,
                                "lon": -115.13722
                            }
                        },
                        {
                            "facility": "East Carolina University - Brody School of Medicine",
                            "status": "RECRUITING",
                            "city": "Greenville",
                            "state": "North Carolina",
                            "zip": "27834",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.61266,
                                "lon": -77.36635
                            }
                        },
                        {
                            "facility": "The Cleveland Clinic Foundation",
                            "status": "NOT_YET_RECRUITING",
                            "city": "Cleveland",
                            "state": "Ohio",
                            "zip": "44195-0001",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.4995,
                                "lon": -81.69541
                            }
                        },
                        {
                            "facility": "Penn State Health Milton S. Hershey Medical Center",
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Hershey",
                            "state": "Pennsylvania",
                            "zip": "17033",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.28592,
                                "lon": -76.65025
                            }
                        },
                        {
                            "facility": "Penn Medicine - University of Pennsylvania Health System",
                            "status": "RECRUITING",
                            "city": "Philadelphia",
                            "state": "Pennsylvania",
                            "zip": "19104-5127",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.95233,
                                "lon": -75.16379
                            }
                        },
                        {
                            "facility": "St. Christopher's Hospital for Children",
                            "status": "RECRUITING",
                            "city": "Philadelphia",
                            "state": "Pennsylvania",
                            "zip": "19134-1011",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.95233,
                                "lon": -75.16379
                            }
                        },
                        {
                            "facility": "Lifespan at Rhode Island Hospital",
                            "status": "NOT_YET_RECRUITING",
                            "city": "Providence",
                            "state": "Rhode Island",
                            "zip": "02903",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.82399,
                                "lon": -71.41283
                            }
                        },
                        {
                            "facility": "University of Texas Health Science Center of Houston",
                            "status": "RECRUITING",
                            "city": "Houston",
                            "state": "Texas",
                            "zip": "77030-1501",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.76328,
                                "lon": -95.36327
                            }
                        },
                        {
                            "facility": "Texas Children's Hospital",
                            "status": "RECRUITING",
                            "city": "Houston",
                            "state": "Texas",
                            "zip": "77030",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.76328,
                                "lon": -95.36327
                            }
                        },
                        {
                            "facility": "Virginia Commonwealth University",
                            "status": "RECRUITING",
                            "city": "Richmond",
                            "state": "Virginia",
                            "zip": "23298-5058",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.55376,
                                "lon": -77.46026
                            }
                        },
                        {
                            "facility": "Seattle Cancer Care Alliance, University of Washington",
                            "status": "RECRUITING",
                            "city": "Seattle",
                            "state": "Washington",
                            "zip": "98195",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.60621,
                                "lon": -122.33207
                            }
                        },
                        {
                            "facility": "H\u00f4pital Erasme",
                            "status": "RECRUITING",
                            "city": "Anderlecht",
                            "state": "Brussels",
                            "zip": "1070",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.83619,
                                "lon": 4.31454
                            }
                        },
                        {
                            "facility": "ZNA Stuivenberg",
                            "status": "RECRUITING",
                            "city": "Antwerpen",
                            "state": "Brussels",
                            "zip": "2060",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 51.21989,
                                "lon": 4.40346
                            }
                        },
                        {
                            "facility": "Universitair Ziekenhuis Antwerpen",
                            "status": "RECRUITING",
                            "city": "Edegem",
                            "state": "Brussels",
                            "zip": "2650",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 51.15662,
                                "lon": 4.44504
                            }
                        },
                        {
                            "facility": "CHR de la Citadelle",
                            "status": "RECRUITING",
                            "city": "Li\u00e8ge",
                            "zip": "4000",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.63373,
                                "lon": 5.56749
                            }
                        },
                        {
                            "facility": "Clinique CHC MontL\u00e9gia",
                            "status": "RECRUITING",
                            "city": "Li\u00e8ge",
                            "zip": "4000",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.63373,
                                "lon": 5.56749
                            }
                        },
                        {
                            "facility": "Multihemo Servicos Medicos S/A",
                            "status": "RECRUITING",
                            "city": "Recife",
                            "state": "Pernambuco",
                            "zip": "50070-460",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -8.05389,
                                "lon": -34.88111
                            }
                        },
                        {
                            "facility": "Hospital de Clinicas de Porto Alegre (HCPA) - PPDS",
                            "status": "RECRUITING",
                            "city": "Porto Alegre",
                            "state": "Rio Grande Do Sul",
                            "zip": "90035-903",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -30.03306,
                                "lon": -51.23
                            }
                        },
                        {
                            "facility": "Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (PUCRS)",
                            "status": "RECRUITING",
                            "city": "Porto Alegre",
                            "state": "Rio Grande Do Sul",
                            "zip": "90619-900",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -30.03306,
                                "lon": -51.23
                            }
                        },
                        {
                            "facility": "Hospital de Cl\u00ednicas da Unicamp",
                            "status": "RECRUITING",
                            "city": "Campinas",
                            "state": "S\u00e3o Paulo",
                            "zip": "13083-878",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -22.90556,
                                "lon": -47.06083
                            }
                        },
                        {
                            "facility": "Hospital Das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto - USP",
                            "status": "RECRUITING",
                            "city": "Ribeir\u00e3o Preto",
                            "state": "S\u00e3o Paulo",
                            "zip": "14051-140",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -21.1775,
                                "lon": -47.81028
                            }
                        },
                        {
                            "facility": "Praxis Pesquisa Medica",
                            "status": "RECRUITING",
                            "city": "Santo Andre",
                            "state": "S\u00e3o Paulo",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -23.66389,
                                "lon": -46.53833
                            }
                        },
                        {
                            "facility": "HEMORIO Instituto Nacional de Hematologia",
                            "status": "RECRUITING",
                            "city": "Rio De Janeiro",
                            "zip": "20211-030",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -22.90278,
                                "lon": -43.2075
                            }
                        },
                        {
                            "facility": "Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidad de S\u00e3o Paulo",
                            "status": "RECRUITING",
                            "city": "S\u00e3o Paulo",
                            "zip": "05403-010",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -23.5475,
                                "lon": -46.63611
                            }
                        },
                        {
                            "facility": "McMaster University - St. Joseph's Healthcare Hamilton",
                            "status": "RECRUITING",
                            "city": "Hamilton",
                            "state": "Ontario",
                            "zip": "L8N 4A6",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.25011,
                                "lon": -79.84963
                            }
                        },
                        {
                            "facility": "University Health Network",
                            "status": "RECRUITING",
                            "city": "Toronto",
                            "state": "Ontario",
                            "zip": "M5G2C4",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "CHU Montreal",
                            "status": "RECRUITING",
                            "city": "Montreal",
                            "state": "Quebec",
                            "zip": "H2X 3E4",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "McGill University Health Center",
                            "status": "RECRUITING",
                            "city": "Montreal",
                            "state": "Quebec",
                            "zip": "H3A 2B4",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "Hopitaux de La Timone",
                            "status": "RECRUITING",
                            "city": "Marseille",
                            "state": "Bouches-du-Rh\u00f4ne",
                            "zip": "13005",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.29551,
                                "lon": 5.38958
                            }
                        },
                        {
                            "facility": "H\u00f4pital Pellegrin, CHU de Bordeaux",
                            "status": "RECRUITING",
                            "city": "Bordeaux",
                            "state": "Gironde",
                            "zip": "33000",
                            "country": "France",
                            "geoPoint": {
                                "lat": 44.84044,
                                "lon": -0.5805
                            }
                        },
                        {
                            "facility": "CHU Guadeloupe",
                            "status": "RECRUITING",
                            "city": "Pointe-\u00e0-Pitre",
                            "state": "Guadeloupe",
                            "zip": "97159",
                            "country": "France"
                        },
                        {
                            "facility": "Institut Universitaire du Cancer de Toulouse - Oncopole",
                            "status": "RECRUITING",
                            "city": "Toulouse",
                            "state": "Haute-Garonne",
                            "zip": "31100",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.60426,
                                "lon": 1.44367
                            }
                        },
                        {
                            "facility": "H\u00f4pital Europ\u00e9en Georges Pompidou",
                            "status": "RECRUITING",
                            "city": "Paris",
                            "state": "Ile De France",
                            "zip": "75015",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.85341,
                                "lon": 2.3488
                            }
                        },
                        {
                            "facility": "CHU H\u00f4pital Henri Mondor",
                            "status": "RECRUITING",
                            "city": "Cr\u00e9teil",
                            "state": "Val-de-Marne",
                            "zip": "94000",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.78333,
                                "lon": 2.46667
                            }
                        },
                        {
                            "facility": "Universit\u00e4tsklinikum Essen",
                            "status": "RECRUITING",
                            "city": "Essen",
                            "zip": "45147",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.45657,
                                "lon": 7.01228
                            }
                        },
                        {
                            "facility": "Universit\u00e4tsklinikum Regensburg",
                            "status": "RECRUITING",
                            "city": "Regensburg",
                            "zip": "93053",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.01513,
                                "lon": 12.10161
                            }
                        },
                        {
                            "facility": "Korle-Bu Teaching Hospital",
                            "status": "WITHDRAWN",
                            "city": "Accra",
                            "country": "Ghana",
                            "geoPoint": {
                                "lat": 5.55602,
                                "lon": -0.1969
                            }
                        },
                        {
                            "facility": "Komfo Anokye Teaching Hospital",
                            "status": "WITHDRAWN",
                            "city": "Kumasi",
                            "country": "Ghana",
                            "geoPoint": {
                                "lat": 6.68848,
                                "lon": -1.62443
                            }
                        },
                        {
                            "facility": "HaEmek Medical Center",
                            "status": "RECRUITING",
                            "city": "Afula",
                            "zip": "1834111",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 32.60907,
                                "lon": 35.2892
                            }
                        },
                        {
                            "facility": "Rambam Medical Center",
                            "status": "RECRUITING",
                            "city": "Haifa",
                            "state": "\u1e24eif\u0101",
                            "zip": "31096",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 32.81841,
                                "lon": 34.9885
                            }
                        },
                        {
                            "facility": "Ziv Medical Center",
                            "status": "RECRUITING",
                            "city": "Safed",
                            "state": "\u1e24eif\u0101",
                            "zip": "13100",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 32.96465,
                                "lon": 35.496
                            }
                        },
                        {
                            "facility": "A.O.R.N. \"A. Cardarelli\"",
                            "status": "RECRUITING",
                            "city": "Napoli",
                            "state": "Campania",
                            "zip": "80131",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 40.85216,
                                "lon": 14.26811
                            }
                        },
                        {
                            "facility": "AOU dell'Universit\u00e0 degli Studi della Campania Luigi Vanvitelli",
                            "status": "RECRUITING",
                            "city": "Napoli",
                            "state": "Campania",
                            "zip": "80138",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 40.85216,
                                "lon": 14.26811
                            }
                        },
                        {
                            "facility": "Azienda Ospedaliero Universitaria Di Modena Policlinico",
                            "status": "RECRUITING",
                            "city": "Modena",
                            "state": "Emilia-Romagna",
                            "zip": "41100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.64783,
                                "lon": 10.92539
                            }
                        },
                        {
                            "facility": "IRCCS Ospedale Pediatrico Bambino Ges\u00f9 - INCIPIT - PIN",
                            "status": "RECRUITING",
                            "city": "Roma",
                            "state": "Lazio",
                            "zip": "00165",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "facility": "Ente Ospedaliero Ospedali Galliera",
                            "status": "RECRUITING",
                            "city": "Genova",
                            "state": "Liguria",
                            "zip": "16128",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.40478,
                                "lon": 8.94438
                            }
                        },
                        {
                            "facility": "Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello",
                            "status": "RECRUITING",
                            "city": "Palermo",
                            "state": "Sicilia",
                            "zip": "90146",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 38.13205,
                                "lon": 13.33561
                            }
                        },
                        {
                            "facility": "Kemri Usamru",
                            "status": "RECRUITING",
                            "city": "Kisumu",
                            "state": "Western",
                            "zip": "40100",
                            "country": "Kenya",
                            "geoPoint": {
                                "lat": -0.10221,
                                "lon": 34.76171
                            }
                        },
                        {
                            "facility": "Kondele Children's Hospital",
                            "status": "RECRUITING",
                            "city": "Kisumu",
                            "zip": "40100",
                            "country": "Kenya",
                            "geoPoint": {
                                "lat": -0.10221,
                                "lon": 34.76171
                            }
                        },
                        {
                            "facility": "Victoria Biomedical Research Institute (VIBRI)",
                            "status": "RECRUITING",
                            "city": "Kisumu",
                            "zip": "40100",
                            "country": "Kenya",
                            "geoPoint": {
                                "lat": -0.10221,
                                "lon": 34.76171
                            }
                        },
                        {
                            "facility": "KEMRI CRDR Clinical Research Clinic Nairobi",
                            "status": "RECRUITING",
                            "city": "Nairobi",
                            "zip": "00100",
                            "country": "Kenya",
                            "geoPoint": {
                                "lat": -1.28333,
                                "lon": 36.81667
                            }
                        },
                        {
                            "facility": "KEMRI/CRDR Siaya Clinical Research Annex",
                            "status": "RECRUITING",
                            "city": "Nairobi",
                            "zip": "00200",
                            "country": "Kenya",
                            "geoPoint": {
                                "lat": -1.28333,
                                "lon": 36.81667
                            }
                        },
                        {
                            "facility": "Strathmore University",
                            "status": "RECRUITING",
                            "city": "Nairobi",
                            "zip": "00200",
                            "country": "Kenya",
                            "geoPoint": {
                                "lat": -1.28333,
                                "lon": 36.81667
                            }
                        },
                        {
                            "facility": "Gertrude's Children's Hospital",
                            "status": "RECRUITING",
                            "city": "Nairobi",
                            "zip": "42325- 00100",
                            "country": "Kenya",
                            "geoPoint": {
                                "lat": -1.28333,
                                "lon": 36.81667
                            }
                        },
                        {
                            "facility": "American University of Beirut Medical Center",
                            "status": "RECRUITING",
                            "city": "Beirut",
                            "state": "Beyrouth",
                            "country": "Lebanon",
                            "geoPoint": {
                                "lat": 33.88894,
                                "lon": 35.49442
                            }
                        },
                        {
                            "facility": "Nini Hospital",
                            "status": "RECRUITING",
                            "city": "Tarablus",
                            "state": "Liban Nord",
                            "country": "Lebanon"
                        },
                        {
                            "facility": "Hammoud Hospital University Medical Center",
                            "status": "RECRUITING",
                            "city": "Sidon",
                            "country": "Lebanon",
                            "geoPoint": {
                                "lat": 33.55993,
                                "lon": 35.37564
                            }
                        },
                        {
                            "facility": "Erasmus MC",
                            "status": "RECRUITING",
                            "city": "Rotterdam",
                            "state": "Zuid-Holland",
                            "zip": "3015 GD",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 51.9225,
                                "lon": 4.47917
                            }
                        },
                        {
                            "facility": "Universitair Medisch Centrum Utrecht",
                            "status": "RECRUITING",
                            "city": "Utrecht",
                            "zip": "3584 CX",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.09083,
                                "lon": 5.12222
                            }
                        },
                        {
                            "facility": "National Hospital Abuja",
                            "status": "RECRUITING",
                            "city": "Abuja",
                            "state": "Abuja Capital Territory",
                            "country": "Nigeria",
                            "geoPoint": {
                                "lat": 9.05785,
                                "lon": 7.49508
                            }
                        },
                        {
                            "facility": "University of Abuja Teaching Hospital",
                            "status": "RECRUITING",
                            "city": "Abuja",
                            "state": "Abuja Capital Territory",
                            "country": "Nigeria",
                            "geoPoint": {
                                "lat": 9.05785,
                                "lon": 7.49508
                            }
                        },
                        {
                            "facility": "Lagos University Teaching Hospital",
                            "status": "RECRUITING",
                            "city": "Suru-Lere",
                            "state": "Lagos",
                            "zip": "101014",
                            "country": "Nigeria",
                            "geoPoint": {
                                "lat": 7.94099,
                                "lon": 5.05488
                            }
                        },
                        {
                            "facility": "University of Calabar Teaching Hospital",
                            "status": "WITHDRAWN",
                            "city": "Calabar",
                            "country": "Nigeria",
                            "geoPoint": {
                                "lat": 4.95893,
                                "lon": 8.32695
                            }
                        },
                        {
                            "facility": "The University of Nigeria Teaching Hospiatal",
                            "status": "WITHDRAWN",
                            "city": "Enugu",
                            "country": "Nigeria",
                            "geoPoint": {
                                "lat": 6.44132,
                                "lon": 7.49883
                            }
                        },
                        {
                            "facility": "Barau Dikko Teaching Hospital (BDTH), Kaduna",
                            "status": "WITHDRAWN",
                            "city": "Kaduna",
                            "country": "Nigeria",
                            "geoPoint": {
                                "lat": 10.52641,
                                "lon": 7.43879
                            }
                        },
                        {
                            "facility": "Sultan Qaboos University Hospital, Hematology Department, COM&HS",
                            "status": "RECRUITING",
                            "city": "Muscat",
                            "state": "Musqal",
                            "country": "Oman",
                            "geoPoint": {
                                "lat": 23.58413,
                                "lon": 58.40778
                            }
                        },
                        {
                            "facility": "King Khalid University Hospital",
                            "status": "RECRUITING",
                            "city": "Riyadh",
                            "state": "Ar Riya",
                            "zip": "11472",
                            "country": "Saudi Arabia",
                            "geoPoint": {
                                "lat": 24.68773,
                                "lon": 46.72185
                            }
                        },
                        {
                            "facility": "King Abdullah International Medical Research Center",
                            "status": "RECRUITING",
                            "city": "Riyadh",
                            "zip": "1515 (KAIMRC)",
                            "country": "Saudi Arabia",
                            "geoPoint": {
                                "lat": 24.68773,
                                "lon": 46.72185
                            }
                        },
                        {
                            "facility": "Hacettepe University",
                            "status": "TERMINATED",
                            "city": "Ankara",
                            "state": "Adana",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 39.91987,
                                "lon": 32.85427
                            }
                        },
                        {
                            "facility": "Acibadem Adana Hospital",
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Seyhan",
                            "state": "Adana",
                            "zip": "01130",
                            "country": "Turkey"
                        },
                        {
                            "facility": "Mersin University Medical Faculty",
                            "status": "WITHDRAWN",
                            "city": "Yenisehir",
                            "state": "I\u00e7el",
                            "zip": "33110",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 40.26444,
                                "lon": 29.65306
                            }
                        },
                        {
                            "facility": "Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi",
                            "status": "WITHDRAWN",
                            "city": "Istanbul",
                            "zip": "34093",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 41.01384,
                                "lon": 28.94966
                            }
                        },
                        {
                            "facility": "Ege Universitesi Tip Fakultesi Hastanesi",
                            "status": "WITHDRAWN",
                            "city": "Izmir",
                            "zip": "35040",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 38.41273,
                                "lon": 27.13838
                            }
                        },
                        {
                            "facility": "Evelina Children's Hospital",
                            "status": "RECRUITING",
                            "city": "London",
                            "state": "City Of London",
                            "zip": "SE1 7EH",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "facility": "Cambridge University Hospitals NHS Foundation Trust",
                            "status": "RECRUITING",
                            "city": "Cambridge",
                            "zip": "CB2 0QQ",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.2,
                                "lon": 0.11667
                            }
                        },
                        {
                            "facility": "Guy's and St Thomas' NHS Foundation Trust",
                            "status": "RECRUITING",
                            "city": "London",
                            "zip": "SE1 7EH",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "facility": "King's College Hospital NHS Foundation Trust",
                            "status": "RECRUITING",
                            "city": "London",
                            "zip": "SE5 9RS",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "facility": "Hammersmith Hospital",
                            "status": "RECRUITING",
                            "city": "London",
                            "zip": "W12 0HS",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "facility": "University College London Hospitals (UCLH)",
                            "status": "RECRUITING",
                            "city": "London",
                            "zip": "WC1E 6BT",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "facility": "Manchester Royal Infirmary, Manchester University NHS Foundation Trust",
                            "status": "RECRUITING",
                            "city": "Manchester",
                            "zip": "M13 9WL",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.48095,
                                "lon": -2.23743
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000755",
                            "term": "Anemia, Sickle Cell"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000745",
                            "term": "Anemia, Hemolytic, Congenital"
                        },
                        {
                            "id": "D000743",
                            "term": "Anemia, Hemolytic"
                        },
                        {
                            "id": "D000740",
                            "term": "Anemia"
                        },
                        {
                            "id": "D006402",
                            "term": "Hematologic Diseases"
                        },
                        {
                            "id": "D006453",
                            "term": "Hemoglobinopathies"
                        },
                        {
                            "id": "D030342",
                            "term": "Genetic Diseases, Inborn"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M4085",
                            "name": "Anemia, Sickle Cell",
                            "asFound": "Sickle Cell Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4070",
                            "name": "Anemia",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4073",
                            "name": "Anemia, Hemolytic",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9547",
                            "name": "Hemolysis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4075",
                            "name": "Anemia, Hemolytic, Congenital",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9490",
                            "name": "Hematologic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9539",
                            "name": "Hemoglobinopathies",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M23686",
                            "name": "Genetic Diseases, Inborn",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T5229",
                            "name": "Sickle Cell Anemia",
                            "asFound": "Sickle Cell Disease",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC15",
                            "name": "Blood and Lymph Conditions"
                        },
                        {
                            "abbrev": "BC16",
                            "name": "Diseases and Abnormalities at or Before Birth"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "C000634504",
                            "term": "Mitapivat"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D020536",
                            "term": "Enzyme Activators"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M352324",
                            "name": "Mitapivat",
                            "asFound": "Acellular Dermal Matrix",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": false
        }
    ],
    "nextPageToken": "NF0g5JKEkvAuyAY"
}